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ABSTRACT
In order to model epidemics of infectious diseases, particularly to estimate
probable numbers of cases with onset at any particular time, it is necessaiy to
incorporate a term for the incubation period frequency distribution. Sartwell's
hypothesis states that the incubation period frequency distribution for infectious
disease is generally a log-normal distribution, based on his examination of disease
with short incubation periods. However, it may not apply to diseases with long
incubation periods. During the course of an epidemic of a disease with a long
incubation period, left and right censoring makes direct observation of the
frequency distribution highly unreliable; in addition, time of infection is often
unknown. Therefore, for a previously undescribed disease, methods other than
direct observation must be employed. One method is to extrapolate from
information available for other diseases.
In evaluation of Sartwell's hypothesis as applied to diseases with long incubation
periods, examination of transfijsion-associated AIDS data was inconclusive.
Examination of data for experimental transmissible spongiform encephalopathy
(TSE)/prion disease in several species suggests that it may not apply. For natural
TSE/prion disease, age at onset is used generally as a 'proxy' for incubation period
since infection time is rarely known; the validity of this may vary with the disease
type and species being examined. Using this measure, again Sartwell's hypothesis
was not confirmed.
For both incubation period and age at onset, evidence presented suggests that
observed frequency distribution coefficient of skewness is associated with modal
age at onset (and thus indirectly with prior age at infection, where appropriate), an
earlier modal age at onset resulting in a larger observed coefficient of skewness.
The relationship of this association with Sartwell's findings is discussed; they are
not incompatible. In addition, an association between observed coefficient of
skewness and sample size is demonstrated and the implications discussed.
2
312
13
Table of Ccitcnlj
TABLE OF CONTENTS.
CONTENTS
ACKNOWLEDGEMENTS
ABBREVIATIONS USED IN THIS THESIS.
CHAPTERS
CHAPTER 1 iNCUBATION PERIOD: INTRODUCTION AND	 15
LITERATURE REVIEW
CHAPTER 2 AIDS: INTRODUCTION: THE INCUBATION PERIOD 	 25
CHAPTER 3 TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES 	 30
(TSE'S)/PRION DISEASE: INTRODUCTION
CHAPTER 4 DATA USED AND ANALYSIS METHODS NOT	 41
DESCRIBED ELSEWHERE
CHAPTER 5 AIDS: DATA ANALYSIS AND DISCUSSION	 44
CHAPTER 6 SHEEP: DATA ANALYSIS AND DISCUSSION: 	 51
Natural and Experimental TSEIPrion disease.
CHAPTER 7 GOATS: DATA ANALYSIS AND DISCUSSION: 	 71
Natural and Experimental TSEIPrion disease.
CHAPTER 8 PRIMATES: DATA ANALYSIS AND DISCUSSION: 	 86
Experimental TSE/Prion disease.
CHAPTER 9 RODENTS: DATA ANALYSIS AND DISCUSSION: 	 93
Experimental TSEIPrion disease.
CHAPTER 10 HUMANS: DATA ANALYSIS AND DISCUSSION: 	 117
Natural and latrogenic TSE/Prion disease.
CHAPTER 11 CATrLE: DATA ANALYSIS AND DISCUSSION: 	 135
BSE
CHAPTER 12 ASSOCIATION BETWEEN SAMPLE SIZE, STANDARD 	 148
DEVIATION, AND COEFFICIENT OF SKEWNESS FOR A
LOG-NORMAL FREQUENCY DISTRIBUTION.
CHAPTER 13 OVERVIEW OF MAJOR FINDINGS AND CONCLUSIONS. 	 154
3
Table of Contents
APPENDICES
APPENDIX 1 EXAMPLES OF HISTOGRAMS OF INCUBATION	 161
PERIOD FREQUENCY DISTRIBUTIONS, PLUS OTHER
DETAILS, FOR DISEASES WITH SHORT INCUBATION
PERIODS AS DISCUSSED IN CHAPTER 1.
APPENDIX 2 DETAILS OF SARTWELL'S METHOD FOR THE
	
165
EXAMINATION OF THE FREQUENCY DISTRIBUTION
OF AN INCUBATION PERIOD.
APPENDIX 3 EXAMPLES FROM SARTWELL'S TABLE OF
	
166
FREQUENCY DISTRIBUTION RESULTS FOR
OUTBREAKS IN WHICH HE FOUND A 'LOGARITHMIC
NORMAL' DISTRIBUTION.
APPENDIX 4 PRACTICAL DEMONSTRATION OF SARTWELL'S 	 167
METHOD USING TWO SETS OF OUTBREAK DATA
ALSO EXAMINED BY SARTWELL
APPENDIX 5 REVISED CASE DEFINITION OF AIDS (CDC, 1987). 	 169
APPENDIX 6 A BRIEF OUTLINE OF THE BACK-CALCULATION
	
170
METHOD USED (AFTER BROOKMEYER AND GAIL,
1988) TO OVERCOME THE PROBLEM OF LEFT AND
RIGHT CENSORING IN AIDS MODELLING.
APPENDIX 7 DIAGRAMMATIC REPRESENTATION OF THE
	
171
PRINCIPLES OF BACK-CALCULATION AND
COMPARTMENTAL MODELS ILLUSTRATED FOR ONE
INFECTION TIME POINT.
APPENDIX S EXAMPLES OF THE ESTIMATES OF THE INCUBATION
	
172
PERIOD FOR AIDS.
APPENDIX 9 INFORMATION SUPPLIED WITH THE TA-AIDS
	
173
DATASET DISCS.
APPENDIX 10 DETAILS OF DATA USED FOR TSEIPRION DISEASE
	
179
EXAMINATION, INCLUDING SOURCE, VARIABLES,
AND EXPERIMENTAL METHOD (WHERE
APPLICABLE).
APPENDIX 11 FILIBEN'S METHOD FOR FREQUENCY DISTRIBUTION	 196
ANALYSIS FOR COMPATIBILITY WITH NORMALITY
AND LOG-NORMALITY USING MINITAB STATISTICAL
SOFTWARE.
APPENDIX 12 THE METHOD DESCRIBED BY SNEDECOR AND 	 198
COCHRAN (1967) FOR ESTIMATION OF FREQUENCY
DISTRIBUTION COEFFICIENT OF SKEWNESS USING
MINITAB STATISTICAL SOFrWARE.
4
Table of Contents
APPENDIX 13 SHEPPARD'S METHOD FOR THE CORRECTION OF
	
200
THE ESTIMATE OF THE STANDARD DEVIATION FOR
FREQUENCY DISTRIBUTIONS WITH GROUP
INTERVALS.
APPENDIX 14 DISCRIMINATORY POWER OF THE TESTS USED TO
	
201
ESTIMATE COMPATIBILITY WITH NORMALITY AND
LOG-NORMALITY.
APPENDIX 15 TESTS USED IN THIS THESIS, APPLIED TO DISEASES
	
209
SIMILAR TO THOSE EXAMINED BY SARTWELL, PLUS
ONE WITH A 'PROXY' INCUBATION PERIOD AS USED
BY ARMENIAN AND LILIENFELD (1974).
APPENDIX 16 CONSTRUCTED LOG-NORMAL DISTRIBUTION FOR
	
213
SELECTED DATASETS FOR COMPARISON WITH
ACTUAL DATA.
APPENDIX 17 SELECTION OF DATA FOR ESTIMATING THE
	 216
INCUBATION PERIOD AND ITS FREQUENCY
DISTRIBUTION FOR TA-AIDS.
APPENDIX 18 METHOD OF TRANSFUSION-WEIGHTING FOR
	 218
ESTIMATING INCUBATION PERIOD IN TA-AIDS IN
MULTIPLE-TRANSFUSION CASES.
APPENDIX 19 BACK-CALCULATION METHOD TO ESTIMATE THE
	
220
MEAN INCUBATION PERIOD OF TA-AIDS.
APPENDIX 20 METHOD FOR ESTIMATING POTENTIAL SCRAPIE
	
222
CASE NUMBERS ADJUSTED FOR CULLING OF SHEEP
IN SCRAPIE INFECTED FLOCKS FROM DATA
COLLECTED BY WOOLDRIDGE (1991).
APPENDIX 21 PRIMATE TAXONOMY RELEVANT TO DATA
	
223
CLASSIFICATION USED IN THIS THESIS.
APPENDIX 22 PRIMATES: SELECTED NATURAL LIFE HISTORY
	
224
MEASURES BY GENUS, AND COMPARISON WITH
DATA USED IN ANALYSES.
APPENDIX 23 METHOD OF ESTIMATION OF DATA OVERLAP FOR
	
225
HUMAN TSEIPRJON DISEASE CASES WITH A GENETIC
MUTATION, FROM THE TWO DATA SOURCES Nifi
AND GLS.
APPENDIX 24 METHOD OF ADJUSTING DATASET FOR THE EFFECT 	 226
OF CULLING FOR BSE IN CATFLE AND AS APPLIED
TO CATTLE GROUP 3.
APPENDIX 25 BACK-CALCULATION METHOD TO ESTIMATE THE
	
228
MEAN INCUBATION PERIOD OF BSE.
Table of Cootenla
APPENDIX 26 CALCULATION OF THE THEORETICAL COEFFICIENT	 230
OF SKEWNESS OF A LOG-NORMAL FREQUENCY
DISTRIBUTION USING EXCEL STATISTICAL
SOFTWARE.
APPENDIX 27 METHOD FOR SIMULATION OF SAMPLES FOR 	 233
ESTIMATION OF COEFFICIENT OF SKEWNESS.
REFERENCES.	 235
6
Table of Contents
LIST OF TABLES
Table 3.1
	
TSEfpnon disease ipectnim.
Table 5.1.1
	
TA-AIDS; estimates oh/p foitlree datasets.
Table 5.1.2	 TA-AIDS; the effect of left and right censmg on the i/p.
Table 5.1.3	 TA-AIDS; estimates of i/p values and related data from back calculation.
Table 5.1.4
Table 6.1.1(i)
Table 6.1.1(u)
Table 6.1.2
Table 6.1.3
Table 6.1.4.1
Table 6.1.4.2(i)
Table 6.1.4.2(u)
Table 6.1.4.3
Table 6.2.1.1
Table 6.2.1.2
Table 6.2.2.1
Table 6.2.2.2
Table 6.2.3.1
Table 6.2.3.2
Table 6.3.1.1(i)
Table 6.3.1.1(n)
Table 6.3.1.2(i)
Table 6.3.1.1(u)
Table 7.1.1.1
Table 7.1.2.2(i)
Table 7.1.1.2(u)
TA-AIDS; i/o lid analyses by subgroup.
Natural sheep scrspie (Pany, 1962); a/o data.
Natural sheep scrapie (Parry, 1962); lid analysis.
Natural sheep scrapie (Woolclridge, 1991); lid analysis.
Natural sheep scrapie (VIDA) Pd analysis.
Natural sheep scrapie (GLS); fld analysi5
Natural sheep scrspie (GLS)r, a/o data by exposure status of dam.
Natural sheep scrapie (GLS); a/o lid by elgiosure status of dam.
Natural sheep scrapie (OLS); 'maximwn i/ji lid analysis.
Experimental TSE in sheep; full dataaet i Pd analysis.
Experimental TSE in sheep; full dataset; ANOVA results
Experimental scrapie in sheep; subgroup 1; i/p Pd analysis.
Experimental scrapie in sheep; subgroup 1; i/p data by passage status.
Experimental scrapic in sheep; subgroup 2(2 mIs of extract); i/p lid analysis.
Experimental scrapic in sheep; Subgroup 2; l/p data by volume of a/c inoculation.
Natural sheep scrapie, summazy of lid analyses.
Natural sheep scrapic descriptions of f7d.
Experimental TSE in sheep; sunmiaiy of fld analyses.
Experimental TSE in sheep; descriptions of i'd.
Natural goat scrapie (OLS); lid analysis.
Natural goat scrapie (GLS); a/o data by contact status.
Natural goat scrapie (OLS); sb lid by contact status.
Table 7.1.2	 Natural goat scrapie (VIDA); i/o lid analysis.
Table 7.2.1.1	 Experimental TSE in goals; full dataset; i/p Pd analysis.
Table 7.2.1.2	 Experimental TSE in goats; full dataset; ANOVA results.
Table 7.2.2.1	 Experimental scrapie in goats; subgroup 1; i/p lid analysis.
Table 7.2.2.2	 Experimental saapie in goats; subgroup 1; i/p by passage number.
Table 7.2.3
	
Experimental TSE in goats; subgroup 2; i/p Pd analysis.
Table 7.2.4
Table 7.3.1.1(i)
Table 7.3.1.1(u)
Table 7.3.1.2(i)
Table 7.3.1.2(u)
Table 8.1.1(i)
Table 8.1.1(u)
Table 8.2.1(i)
Table 8.2.1(u)
Table 8.3 (•i)
Experimental scrapie in goals; subgroup 3; i/p Pd analysis.
Natural goat scrapic sunvnasy of lid analyses.
Natural goat scrapis; descriptions of lit
Experimental TSE in goats; sunanaly of lid analyses.
Experimental TSE in goats; descriptions of lid.
Experimental TSE in primates; i/p data plus visual estimate of Pd skew, by primate
group.
Experimental TSE in primates; i/p lid analysis by primate group.
Experimental CR) in primates; subgroup 6; sample size, mean i/p. and visual estimate
of i/p Pd skew, by primate group.
Experimental Cii) in primates; subgroup 6; i/p Pd analysis by primate group.
Experimental Cii) in squirrel monkeys; subgroup 6: i/p data by inoculation route.
Table 8.3 (ii)	 Experimental CM) in squirrel monkeys; subgroup 6. i/p lid analysis by inoculation
route.
Table 8.4
	
Experimental TSE in primates; full dataset; comparison of analysis results with life
histoey measures; stratified by data representative of genus.
Table 8.5.1(i) 	 Expenmental TSE an primates; full dataset; descriptions of Pd.
7
Table of Contents
LIST OF TABLES CONTINUED
Table 8.5. 1(u)	 Experimental CJD in primates; subgroup 6; descriptions of lid.
Table 8.5.1(iii) 	 Experimental TSE in primates; homogeneity, size and lu skew companions.
Table9.1.1.1	 BSEinmiIldataaet,i,t7danalysia.
Table 9.1.2.1(i)	 BSE in mice inoculation age and i/p data by BSE group.
Table9.1.2.1(ii) 	 BSEinmice: i/pfidanalysisbyBsEgroup.
Table 9.1.2.2	 BSE in mice; inoculation age data and lid c/s analysis; group. A to H
Table 9.2.2
	
Scrapie in mice; i/p data by sciapie agent strain.
Table 9.2.3(i)	 Scrapie in mice; strain 22k i/p data by 'sinc' genotype.
Table 9.2.3(u)	 Scrapie in mice; strain 22k i/p lid analysis by ainc genotype.
Table 9.2.4(i)	 Scrapie in mice; strain ME7; i/p data by 'sind genotype.
Table 9.2.4(u)	 Scrapie in mice; strain MEl; i/p lid analysis by 'sind genotype.
Table 9.2.5
	
Scrapie in mice; analysis of strain & sine genotype by ANOVA
Table 9.3.1
	
CJD in guinea-pigs; full dataset; lid analysis.
Table 9.3.2(i)	 CJD in guinea-pip: i/p data by passage number.
Table 9.3.2(u)	 CJD in guinea-pip; effect of passage number on i/p.
Table 9.3.3
	
CJD in guinea-pigs, lid analyses for passage numbers 2-4.
Table 9.4.1.1(i)
Table 9.4.1.1(u)
Table 9.4.2.1(i)
Table 9.4.2.1(11)
Table 9.4.3.1
Table 9.4.3.1(u)
Table 10.1
Table 10.2.1(i)
Table 10.2.1(u)
Table 10.2.2.1
Table 10.2.2.2
Table 10.2.2.4
Table 10.3.1
Table 10.3.2.1
Table 10.3.2.2
Table 10.3.3
Table 10.4.1.1(i)
Table 10.4.1.1(11)
Table 10.4.1.2(i)
Table 10.4.1.2(u)
Table 10.4.1.4(i)
Table 10.4.1.4(11)
Table 11.1.1(i)
Table 11.1.1(u)
Table 11.1.2(i)
Table 1 1.1.2(u)
Table 11.1.3
Table 11.2.2(i)
Table 1 1.2.2(u)
BSE in mice; summary of lid analyses.
BSE in mice; descriptions of lid.
Scrapie in mice; summary of lid analyses.
Scrapie in mice; descriptions of lid.
CJD in guinea-pigs; summary of lid analyses.
CJD in guinea-pigs; descriptions of lid.
Sporadic TSE in humans; .10 lid analysis by data source.
Familial TSE in humans; a/o data by data source.
Familial TSE in humans; a/o lid analysis by data source.
TSE in humans: a/o data by PrP gene mutation.
TSE in humans; a/o lid analysis by PrP gene mutation category.
TSEa in humans; effect of met/val heterogeneity on mean alo.
Kuni in humai a/o lid analysis.
Pituitary injection cases in humans; first sd i/p lid analysis.
Pituitary injection cases in humans; French set; i/p lid analysis.
Dura grail cases in humans; i/p and i/o data.
Sporadic and familial TSE in humans; summary of i/o lid analyse..
Sporadic and familial TSE's in humans; mean i/o, and lid descriptions.
Recognised transmission route cases in humans; summary of a/o lid analyses.
Recognised transmission route cases in humans; sb lid descriptions.
TSE with known PrP gene mutation: summary of i/o l/d analyses.
TSE's with known PrP gene mutation: modal and mean i/o, and lid description.
BSE in cattle; i/o data by group.
BSE in cattle; .Jo lid analysis by group.
BSE in cattle; group 3Y; i/o data by calving cohoit
BSE in cattle; group 3Y; sb lid analysis by calving cohoit
BSE in cattle; groups 1 and 3Y; comparison of minimum and mean a/o's per cohorL
BSE in cattle: group 3/87: i/o data by feedflag status.
RSE in cattle: group 3 87: i/o lid by feedflag status.
8
Table of Contents
LIST OF TABLES CONTINUED
Table 11.4	 BSE an cattle; group 3; estimates of a/o data from back calculation: unadjusted and
(adjusted) for culling
Table 11.5.1.1(i)	 BSE in cattle; sunvnaly ofsio f7d analyses.
Table 1 1.5.1.1(u)	 BSE an cattle; a/o f7d descriptions.
Table 11.5.1.2	 BSE an castle; group 3Y; tld skewness description by coheit
Table 12.2(i)	 Comparison of observed and theoretical c/s by sample size and SD; 10 observations
per combination.
Table 12.2(u)	 Comparison of observed and theoretical cis by sample size and SD; 5000 observations
per combination.
Table A3
	
Examples from Sajiwell's table of frequency distribution rcanihs.
Table A4
	
Two sets of outbreak data examined by Saitwell.
Table AS	 Examples of estimates of the incubation period for AIDS.
Table A10.1
	
Data references; natural scrapie in sheep.
Table A10.2
	
Data references; experimental TSE in sheep.
Table A10.3
	
Data references; natural scrapie in goats.
Table A10.4
	
Data references; experimental TSE in goats.
Table A10.5
	
Data references and personal con munications experimental TSE in primates.
Table A10.6
	
Experimental TSE in primates; some major variables by primate group.
Table A10.7	 Data references; TSE in humans; OLS.
Table A10.8
	
TSE in humans; codon substitutioos recorded in data used, and resultant amino acid
change.
Table A14. 1	 Correlation coefficient critical value (at P 0.05) by sampk size.
Table All. 1 Time to disease onset: Comparison of !Clcanef data for Id, 2nd and 3rd transfusion
with estimates where unknown month (coded 99) has been replaced by month 07 (i.e.
mid-year), for transfusion, diagnosis, and report dates.
Table A20. 1
	
Natural sheep scrapie; culling pattern estimate (Wooldridge, 1991).
Table A22.1
	
Primates; comparison of recorded maximum longevity with mean and maximum lip
(and as a percentage) for full dataset by genera.
Table A22.2
	
Primates; comparison of adult weight with certain i/p measures, for full dataset by
Table A24. 1	 BSE in cattle: culling correction, and method as applied to group 3.
LIST OF FIGURES
Figure 5.1.2
	
TA-AIDS; mean i/p by year of transfusion.
Figure 5.1.4
Figure 6.1.1
Figure 6.1.3
Figure 6.1.4.1
Figure 6.1.4.3(a)
Figure 6.1.4.3(b)
Figure 6.2.1.1
Figure 6.2.2.1
Figure 6.2.2.2
Figure 62.3.1
Figure 62.3.2
Figure 6 3.1.2
Figure 6.3.3
Figure 7.1.1.1
Figure 7.1.1.2
Figure 7.1.1.3
TA-AIDS; subgroups A and B; i/p f7d.
Natural sheep scrapic Pany (1962) data; a/o 17d by sex.
Natural sheep scrapie; VIDA data; a/o f7d.
Natural sheep scrapie; OLS data; a/o f7d.
Natural sheep saapic OLS data; 'maximum i/p' f7d.
Natural sheep scrapie; GLS data; 'maximum l/p' by aged Id recorded exposure.
Experimental TSE in sheep; full dataset i/p lid
Experimental scrapie in sheep; subgroup 1; i/p lid.
Experimental scrapie in sheep; subgroup 1; i/p by age at infection.
Experimental scrapie in sheep; subgroup 2(2 mIs of extract); i/p lid.
Experimental scrapie in sheep, subgroup 2; i/p by dose.
Experimental scrapie in sheep; CNS and s/c inoculation, superimposition of modal
Natural sheep scrapie: sb f7d as percentage of cases by age, corrected for culling
Natural goat scrapie; OLS data; a/o lid.
Natural goat scrapie; GLS data; a/o f7d by contact status recorded.
Natural goat scrapic; OLS data; s/ by maximum age of exposure.
9
Table of Contents
LIST OF FIGURES CONTINUED
Figure 7.2.1.1
Figure 7.2.2.2(a)
Figure 7.2.2.2(b)
Figure 7.3.1.3
Figure 8.1.1
Figure 8.1.2
Figure 8.4
Figure 9.1.1.1
Figure 9.1.1.2
Figure 9.1.2.2
Figure 9.2.2
Figure 9.2.3
Figure 9.2.4
Figure 9.2.5
Figure 9.2.6
Experimental TSE in goats; full dataset; i/p fld.
Experimental scrapie in goats; subgroup 1; i/p by age at infection.
Experimental scrapie in goats; subgroup 1; i/p by dose.
Goat TSE; companson of natural a/o and experimental (s/c, i/d and oral) i/p lid;
modes overlayed.
Experimental TSE in primates; i/p lid by primate group.
Experimental TSE in primates; c/s by dataset size.
Experimental TSE in primates; comparison of certain i/p measures with mid-point of
adult weight range, by primate group.
BSE in mice; full dataset; i/p lid.
BSE in mice; Mi dataset; i/p by inoculation age.
BSE in mice; c/s by age at infection for groups A to H.
Scrapie in mice; full dataset; i/p lid by agent strain.
Scrapie in mice; strain 22A i/p Lid by 'sinc' genotype.
Scrapie in mice; strain ME7; i/p lid by sinc' genotype.
Scrapie in mice; mean i/p by sinc' genotype and strain.
Scrapie in mice; association between lid c/s and modal i/p.
Figure 9.3.1	 Cii) in guinea-pigs; full dataset; i/p lid.
Figure 10.1
	
Sporadic CM) in humans; UK dataset; a/o lid.
Figure 10.2.1	 Familial TSE in humans; a/o lid by data source.
Figure 10.2.2.1	 Familial TSE in humans; mean a/o by PrP gene mutation and data source.
Figure 10.2.2.2
Figure 10.2.2.3
Figure 10.3.1
Figure 10.3.2.2
Figure 10.4.1.1
Figure 10.4.1.4
Figure 11.1.1
Figure 11.1.2
Figure 11.2.1
Figure 11.2.2
Figure 11.3
Figure 12.2
Figure 12.3
Figure A1.1
Figure A1.2
Figure A1.3
Figure A1.4
Figure A1.5
Figure A4. I
Figure A4.2
Figure A7
Figure All
Figure A14.1
TSE in humans; a/o lid by PrP gene mutation.
TSE in humans; lid c/s by mean a/o and PrP gene mutation.
Kuru in humans; a/o lid.
Pituitary injection cases in humans; French dataset; i/p lid assuming infection in 1985,
plus lid of time from first treatment.
Sporadic and non-sporadic TSE in humans; NIH data; a/o lid; stacked composite.
TSE in humans; Lid skewness and modal alo; a comparison of three PrP gene
mutations.
BSE in cattle; group 3; a/o lid.
BSE in cattle; group 3Y: effect of censoring on a/o range, by calving cohort.
BSE in cattle; a/oby alp.
BSE in cattle; group 3/87; a/o lid by feedflag status.
BSE in cattle; group 3; effect of culling correction on a/o lid.
Association between sample size and c/s for different SD values: log-normal
distribution.
Coefficient of skewness frequency distribution for 5000 random-generations; SD of
theoretical distribution 1.5.
Frequency distribution: Serial interval for measles as an estimation of i/p (after
Stillerman & Thalheimer, 1944).
Frequency distributions for incubation periods for 5 outbreaks of Typhoid Fever'
reviewed by Miner (1922).
Details of i/p for Serum Jaundice'; Camp Polk series (after Parr, 1945)
Frequency distributions: Reported cases of GBS by period between vaccination and
onset in 1-week periods and 2-day periods (after Schonberger et al, 1979).
Frequency distribution: Experimental gonorrhoea using human volunteers; i/p lid
(after Mahoney et al, 1946).
Sartwells method plot for measles; data from Stillerman & Thalheimer, 1944.
Satwell's method plot for 'typhoid fever'; data from Sawyer, 1914.
Diagrammatic representation of the principles of back-calculation and compartmental
models illustrated for one infection time point.
Example of the normal probability plot produced by Minitab.
Composition of normal and log-normal distributions.
10
Table of Contents
LIST OF FIGURES CONTINUED
Figure A14 2
Figure A14.3
Figure A14.4
Figure A14.5
Figure A14.6
Figure A14.7
Figure A14.8
Figure A14.9
Figure A14.1O
Figure A14.11
Figure A16.1
Figure A16.2
Figure A 16.3
Figure A 16.4
Figure A16.5
Figure A18.1
Figure A21.1
Figure A23.1
The normal distribution Comparison by sample size.
The log-normal distribution: Comparison by sample size.
N=50; f7d; normality and non-normality.
N-50; f7d; log-normality and non-log-normality.
N-50; 17d; compatibility with both normality and log-normality.
N5; f7d; symmetry, normality and log-normality.
N=5; d asymmetry, normality and log-normality.
N=500; 17d; normality and non-normality.
N=500; d; log-normality (i).
N-500; lid; log-normality (ii).
Log-normal constnict for natural scrapie in sheep; OLS full dataset.
Log-normal constnict for experimental TSE in sheep; full datasel.
Log-normal constnict for scrapie in mice; strain 22A in 'sinc' s7p7 mice.
Log-normal constnict for TSE in humans (i); sporadic CJD, UK dataset.
Log-normal constnict for TSE in humans (ii); comparison of 3 datasets.
TA-AIDS; Single transfusion cases by proportion of transfusions per year.
Simplified taxonomy of the primates used in these experiments
TSE in humans; codon 198 mutation; comparison of lid for NIH and GLS dat&
11
Mmow
ACKNOWLEDGEMENTS
I wish to thank Mr Simon Cousens for his supervision, encouragement, and statistical advice
throughout the course of this project.
I am grateful to all the staff of the Epidemiology Department, Central Veterinaiy Laboratoiy,
Weybndge, for their support, but especially to Mr John Wilesmith MRCVS who initiated this
project and gave me both time and facilities to complete it; to Mr Robin Sayers for statistical help
and advice, and to Ms Sue Kidd and Mr Andy Mitchell for data retrieval from VIDA and the
BSE database.
Thanks are also due to the libraiy staff at the CVL, all of whom have been veiy willing to help
with my numerous requests for information.
In addition I wish to thank Professor Paul Fine, Mr Jamie Robinson, Dr Paddy Farringdon and Dr
Rosalind Ridley for useful discussions in the early stages of this project.
Datasets for use in the project were kindly supplied by Dr Hugh Fraser and Dr Nora Hunter, both
of the Neuropathology Unit, Edinburgh; Dr T Peterman, Centers for Disease Control, Atlanta,
Georgia, USA; Dr R Will, UK CJD Surveillance Unit, Edinburgh, and Mr Michael Dawson
MRCVS of the CVL.
In particular I thank Dr Paul Brown, National Institutes of Health, Bethesda, Maryland, USA, for
the valuable time I was able to spend in his laboratory, for his generosity in giving me access to
his extensive data collection, and for replying enthusiastically to all my faxes.
Finally, I would like to thank Dr M.Y.A. Gordon for many, many helpful discussions, and Dr
John Morris for encouragement along the way.
12
adj.
AIDS
ANOVA
a/o
a/p
APD
BSE
cc
CDC
CI
CJD
Cn
CNS
c/s
CN
CVL
CWD
DNA
exp
F
f/d
FF1
FSE
GBS
GLS
GSS
WV
lid
i/p
kg
L
Lit
MAFF
Abreviahons.
ABBREVIATIONS USED IN THIS THESIS
adjusted
acquired immune deficiency syndrome
analysis of variance
age at onset
age at purchase
atypical pnon disease
bovine spongiform encephalopathy
correlation coefficient - specifically indicates result of lid analysis
Centers for Disease Control, Atlanta, Georgia, USA
confidence interval
Creutzfeldt-Jakob disease
codon
central nervous system
coefficient of skewness
critical value for CC (at P=O.05 level unless otherwise stated)
Central Veterinaiy Laboratoiy, Addlestone, Surrey
chronic wasting disease of mule deer and elk
deoxyribonucleic acid
exponential
value calculated in a variance-ratio test for comparison with F distribution
frequency distribution
fatal familial insomnia
feline spongiform encephalopathy
Guillain-Barre syndrome
general literature search
Gerstmann-Straussler-Sheinker syndrome
human immunodeficiency virus
intra-dermal
incubation period
kilogram
left skewed
indicates data from GLS
Mini stzy of Agriculture, Fisheries and Food
max	 maximum
MBM	 meat and bone meal
met	 methionine
13
Abbce'iaüo.s.
ml
N
NAG
nc
NIH
NPU
NS
OlE
P
P.C.
Pg
PrP
PrPC
PrP&; PrP etc.
r
R
RNA
SAF
sic
SD
Sinc
Sip
TA-AIDS
mm
TSE
tx
UK
u/k
val
VIDA
millilitre
number (i.e. sample size)
National Algorithm Group Ltd
not able to be calculated (due to small sample size)
National Institutes of Health, Bethesda, Maiyland, USA.
Neuropathology Unit, Edinburgh.
not significant (i.e. not statistically significant; P> 0.05)
Office Internationale des Epizooties
probability
personal communication
passage
prion protein
normal cellular form of prion protein
abnormal isoform of prion protein associated with scrapie, CJD etc.
correlation coefficient - other than those calculated in lid analysis
right skewed
nbonucleic acid
scrapie-associated fibril
sub-cutaneous
standard deviation
'scrapie incubation period'; a gene in mice
'scrapie incubation period'; a gene in sheep
transfusion-associated (or transfusion-acquired) AIDS
transmissible mink encephalopathy
transmissible spongiform encephalopathy
transfusion or treatment
United Kingdom
unknown
valine
veterinaiy investigation diagnosis analysis (a database)
14
INCUBATION PERIOD: Iniroductioj
CHAPTER 1
iNCUBATION PERIOD: INTRODUCTION AND LITERATURE
REVIEW
1.1 The incubation period of a disease: Background and early
work.
1.1.1 The definition of incubation period and related measures for an
infectious disease.
1.1.2 Examination and uses of incubation periods for acute infectious
diseases: Field outbreaks.
1.1.3 Examination of incubation periods in acute infectious disease:
Experimental infection.
1.1.4 Patterns created by incubation period for acute infectious diseases.
1.1.5 Examination of incubation periods by Sartwell's method.
1.2 Examination of non-infectious, neoplastic and other diseases by use
of 'proxy' incubation periods.
1.2.1 Definitions of 'proxy' incubation periods.
1.2.2 Sartwell's method applied to 'proxy' incubation periods.
1.3 Infectious diseases with long incubation periods.
1.3.1 Definition of a 'long' incubation period.
1.3.2 Problems inherent in the investigation of incubation period in
diseases with long incubation periods.
1.4 Aims of this study.
15
INCUBATION PERIOD: Introduction
CHAPTER 1
INCUBATION PERIOD: INTRODUCTION AND LITERATURE REVIEW
1.1 The incubation period of a disease: Background and early work.
1.1.1 The definition of incubation period and related measures for an infectious disease.
The incubation period (up) of a disease is generally defined as the period of time from infection
with the disease-causing agent to onset of clinical signs (Benenson 1985; Thrusfleld, 1986).
The latent time or latent period is the time from infection to infectiousness (Becker, 1989;
Anderson & May, 1991); it will only equal lip if infectiousness and clinical signs occur
simultaneously. Latent period is, however, used by some authors to describe i/p (Meynell &
Meynell, 1958; Kondo, 1977).
Serial interval, or generation time, is time from a particular stage of disease in the infecting case
to the same stage in the infected case (Rodrigues, 1991); in measles, rash-to-rash is often used;
for statistical purposes it is the best measure of i/p obtainable (Stocks, 1931). It is equivalent to
latent period plus time from the start of infectiousness to transmission; duration is therefore
partly dependent upon contact rate with susceptible individuals. Anderson & May (1991) define
the generation time as the swn of average latent and infectious periods.
1.1.2 Examination and uses of incubation periods for acute infectious diseases: Field
outbreaks.
With acute diseases with short lip's, for example 'food poisoning', or many viral diseases of
childhood, the link between infection source and disease onset was originally noted precisely
because i/p is short; for example virtually all those affected remembered attending the same
function. Investigations of such outbreaks or epidemics, either to find infection source, or to
learn more on behaviour of epidemics, allowed description of i/p ranges for specific clinical
presentations, though an infectious agent may not have been identified.
Examples include an investigation into an outbreak described as typhoid fever (Sawyer, 1914),
and measles cases occurring in the same household (Stocks and Karn, 1928) using serial interval
(rash-to-rash).
Various explanations were advanced when the same disease in different host groups produced
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differing results. Stillerman and Thalheimer (1944), also looking at successive cases of measles
in the same household, report a serial interval range 018 to 19 days. They note a tendency for
younger children to experience longer intervals, particularly those aged from 12 to 23 months,
and suggest this may be connected ith 'velocity of infection' (figure Al.!); but for young
children contact and infection may be delayed. Benenson (1985) gives measles i/p as 8-13 days,
but occasionally longer or shorter.
With microbiological development, it became apparent that sometimes clinical presentation of
disease caused by different organisms was similar, resulting in refinement of i/p frequency
distribution (lid) estimates for some infections. The separate causal organisms of typhoid and
paratyphoid were first described in 1896 (Achard and Bensaude), but were still treated by Miner
(1922) as one disease, in his review of five outbreaks of'typhoid fever' in which infection time
was known (figure Al .2). He reported that i/p l/d for 'typhoid fever' appeared to vaiy with
outbreak, concluding that it is highly variable from one outbreak to another, possibly depending
on "virulence of infection". However, for outbreaks 1 and 2, foodborne as opposed to water-
borne, the i/p resembles that of paratyphoid fever (given as 1-10 days by Benenson, 1985), more
usually associated with foodborne outbreaks than with contaminated water (Huckstep, 1962).
Once the stability of many i/p's became documented, they were routinely used to trace outbreak
sources. Since i/p was short, from hours (salmonellosis; Benenson, 1985) to months (serum
hepatitis; average 2-3 months, Benenson, 1985), recall was comparatively accurate; this often
provided further refined i/p data.
Parr (1945) reported an incident involving contaminated yellow fever vaccine used for US Army
personnel, giving i/p details for serum jaundice (probably viral hepatitis type B). A standard
vaccine dose was given to many young healthy adults, mostly male, experiencing similar
lifestyle. Vaccination date and place was known, follow-up was good, and large vaccinee groups
were sent to different post-vaccination destinations, for example 'Camp Polk' (1004 cases)
(figure Al.3). Parr concluded that not enough importance had previously been attached to host
and environment in determining attack rate, i/p length, and disease severity, and that the
common practice of smoothing time-based data results in information loss.
Taylor et al (1974) report an outbreak of 132 cases of typhoid fever in Trinidad in 1971.
Taking typhoid fever i/p as approximately two weeks, they identified the source, contaminated
ice-cream, then calculated the actual lip; mean, 19.25 days; median, 19 days. Most cases were
children. Huckstep (1962) stated that i/p in children is generally shorter than the 10-14 days
of adults. However, the authors cite Hornick et al (1966) as showing that i/p varies inversely
with number of ingested typhoid organisms, conclude that this outbreak was probably caused
by low level contamination, and estimate contamination in organisms per gram of ice-cream.
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Increasing reports of Guillain-Barre syndrome (GBS) after influenza vaccination was noticed
during a United States nationwide vaccination programme (Schonberger et al; 1979).
Surveillance revealed 1098 cases, a rapid rise in recent vaccinees strongly suggesting an
association. Based on attack rates, the relative risk of GBS in those vaccinated compared with
those unvaccinated was greater than 1 (P < .05) for ten weeks post-vaccination, peaking at over
12 in weeks 2-3; the authors conclude that many cases were vaccination-related, and comment
on the non-randomness of the i/p f7d, with the mode, 10°%, on the 16-17th days post-vaccination
(figure A1.4).
Differences in i/p ranges for a given disease were specifically examined in a review of
children hospitalised for measles in Copenhagen from 1915 to 1925 (Aaby, 1991). Using rash-
to-rash to estimate i/p. fatal secondaiy cases had a shorter mean serial interval (9.3 days; SD
2.0) than survivors (11.9 days; SD 2.6) (P <0.05). Since the prodromal period is also prolonged
in severe cases, the author warns that using the rash-to-rash interval, in severe cases, will lead to
an overestimation of i/p length.
1.1.3 Examination of incubation periods in acute infectious diseases: Experimental
infection.
Different infective doses, ages at infection, and other variables were suggested by several workers
as likely to affect i/p. In estimating i/p in natural disease, in humans and animals, often the
time of infection is unknown. Experimental infection can overcome some of these problems. In
an early example, Topley (1919) describes a series of experimental infections of rodents with an
organism called Bacillus danysz, undertaken to investigate the phenomenon of recurrent
epidemics, separated by considerable periods of time.
Unfortunately, although i/p information in experimental studies is usually obtainable, it is often
reported incompletely, if at all. This omission occurs in a study in human volunteers, of Vibrio
cholerae (Music et al, 1970). Although it is clear from experimental design that i/p data
could have been obtained, it is only reported for 2 of 27 cases; conversely, attack rates and
disease severity are reported in detail. In contrast, a study describing a canine model of Vibrio
cholerae (Sack & Carpenter, 1968) details i/p for 21 dogs; and for all 90 dogs in the study,
some i/p information was given, being less than 18 hours in 96% of the dogs.
Mahoney et al (1946) report a study in human volunteers, using experimental infection with
Neisseria gonorrhoeae, which causes gonorrhoea, giving detailed results from 30 separate
transmission experiments, most using several men. Although i/p was generally given, it was
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not specifically considered further by the authors, although strains of organism, techniques of
infection and attack rate were examined in detail. The range recorded was from less than 24
hours to 31 days; mode 3 days (21 of 76 cases) (figure A1.5). Benenson (1985) gives 2-7 days for
natural disease but some infection techniques used were unlikely to have simulated natural
transmission.
Experimental work was used to investigate biological changes during the apparently 'silent' i/p.
serial sacrifice and post-mortem examination being undertaken before onset of clinical signs.
Extensive investigation into pathological mechanisms in bacterial infections using this method
with mice was undertaken by Orskov and collaborators (e.g. Orskov, 1932; reported in detail by
Masden, 1937). Sterile autopsies allowed organ and tissue culture to follow bacterial routes
through the body during i/p. Similarly for viral pathology; using infectious ectromeha of mice as
a model for smallpox, both the epidemiology, including i/p f/d details under differing
circumstances, and the pathogenesis during i/p was described (Fenner, 1948a; 1948b). Clearly,
biological events were occurring during i/p, for both bacteriological and viral diseases.
Homick and Woodward (1966) investigated dose effect, both on i/p and disease severity, in an
investigation of typhoid vaccine efficacy in experimentally infected humans. Individual i/p's are
not given but the authors state that they were inversely related to size of infecting dose, range
being 3-26 days. Further evidence for a dose effect on i/p is reported (Wear ct al, 1968);
intracerebral inoculation of measles virus into mice showed association between high dose and
short i/p. Similarly, vaccination of humans with attenuated measles virus resulted in i/p's
from 7 to 14 days; duration varied inversely with numbers of virus particles injected (Aaby,
1985).
1.1.4 Patterns created by incubation periods for acute infectious diseases.
The earliest recorded use of modelling in the context of dynamics and mathematical properties of
infectious disease concerns smallpox (Bernoulli, 1760). The mathematical theoiy of epidemics,
including the phenomenon of epidemic periodicity was specifically considered by, for example,
Hamer (1906) and Ross (1915, 1916, 1917).
Studying patterns created both by disease outbreaks, and 'waves' of disease within more extensive
epidemics resulted in the description of serial interval, and differentiation between primary and
secondary cases, for example using measles (Stocks & Karn, 1928). Hope-Simpson's (1952)
derivation of "susceptible exposure attack rate" distinguishes between several secondary cases
all with onset within a single lip, and the same number of cases arranged with onset in 'waves'
(i.e. as a series of secondary, tertiary, etc. cases), within successive i/p's. He then assigns to the
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two situations high infectiousness and lower infectiousness respectively, on the basis of these two
patterns.
Many mathematical models of epidemics, for example that of Soper (1929), and fluiher
derivations incorporating the concept of chance, as in the Reed-Frost model (Abbey, 1952), rely
on a constant known i/p to describe the behaviour of the epidemic and to predict expected
numbers in successive epidemic waves. From around 1970, the publishing of papers on
dynamics and mathematical properties of infectious diseases increased rapidly (Bailey, 1975),
generally based on observations of diseases with short i/p's. However, modelling of aspects of
tuberculosis (ReVelle, Lynn & Feldmann, 1967) and leprosy (Lechat, 1971), two long i/p
diseases, also began, paving the way for work on acquired inununocleficiency syndrome (AIDS).
1.1.5 Examination of incubation periods b y Sartwell's method.
Sartwell (1950, 1952, 1966) examined i/p fYd for outbreaks of relatively acute infectious
diseases, mainly from published data; the stated purpose was to demonstrate a consistent lid
pattern. Having observed that i/p fld's usually had some resemblance to a normal curve, he
plotted cumulative distributions on normal probability paper, examining results for linearity. The
resultant plot was usually more nearly linear if the logarithm of the i/p was plotted; i.e. the data
usually more closely resembled a 'log-normal' curve than a normal curve. Using those 'log-i/p'
plots where the result was nearly linear, he fitted a straight line by inspection, and calculated the
"estimated median" and "dispersion factor" (detailed method; appendix 2).
He found a "logarithmic normal" distribution for 18 datasets treated as above, including
bacterial and viral diseases, amoebic dysenteiy and malaria (examples; appendix 3). Although
noting that a minority of datasets were otherwise, irregular, or with greater or lesser skewness,
he concluded that lid for most infectious diseases resembles a "logarithmic normal curve".
From examination of "dispersion factors", he also concluded that the "degree of dispersion of
incubation periods is proportionate to the usual length of incubation". This method
(reproduced; appendix 4), subsequently became known as 'Sartwell's method'.
When data did not fit the 'log-normal' pattern, it was often experimental data with a longer right
tail to the distribution (Sartwell, 1966), for example experimental gonorrhoea (Mahoney et al,
1946).
Although the longest i/p Sartwell examined was that for serum hepatitis (median lIp; 105 days),
he concluded that most diseases fitted the 'log-normal' pattern whether their i/p was 'short' or
'long'. Although he only examined graphed data by eye, applying no statistical test for log-
normality, and noted that this was not the best description for all datasets, 'log-normality'
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gradually passed into acceptance as THE i/p fYd for infectious diseases.
1.2 Examination of non-infectious, neo plastic and other diseases b y use of 'proxy'
incubation periods.
1.2.1 Definitions of 'proxy' incubation periods.
Many workers adopted Sartwell's methods to examine diseases of non-infectious or unknown
origin, including neoplasia and drug-induced disease, re-defining i/p as required; these time
periods are here called 'proxy' i/p's.
Cobb Ct al (1959) define malignant disease i/p as "the period of multiplication of an invading
strain of abnormal host cells", stating that "when exposure (to the causal agent) is prolonged or
continuous, the incubation period is almost always less than the appearance time after first
exposure"
Generally, however, for diseases of non-infectious aetiology, 'i/p is used simply to mean time
from exposure (to the assumed causal agent) to clinical disease onset (Armenian & Lilienfeld,
1974). For multiple or continuous exposure, 'l/p' generally denotes total duration of exposure
(from first exposure) plus any interval after exposure ceases, until disease onset (Kennaway,
1957, Armenian & Lilienfeld, 1974). These time intervals are also called latent period
(Armitage & Doll, 1961; Stuart & Kneale, 1970), induction time (Druckey, 1967) and 'time-to-
tumour' (Guess & Hoe!, 1977). Studying blood dyscrasia attributed to chioramphenicol, Polak et
al (1972) use 'latent period' for the period from last dose to first appearance of signs or symptoms.
'Latent period' is therefore often equated with i/p of an infectious disease.
In experimental work on neoplasia, latent period has also been described as the time from
initial exposure (to causal agent) to disease detection (Jones & Grendon, 1975). Since
detection, for example by X-ray, may precede clinical signs, use of this definition is significantly
different.
In diseases where interval from first clinical signs to death is generally rapid and early signs are
non-specific, i/p has been equated with time from exposure (to causal agent) to death, as in lung
cancer (Annenian & Lilienfeld (1974)).
For diseases of possible genetic origin, 'lip' has been equated to age at onset (a/o) of clinical
signs; with inherited human prion disease, for example Gerstmann-Straussler-Sheinker syndrome
(GSS), Baker et al (1991) have implied this definition. For congenital conditions, 'lip' has been
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equated with the mothers age at the birth under investigation, as in an investigation into causes of
twinning (Phillipe, 1990).
1.2.2 Sartwell's method applied to "proxy' incubation periods.
Armenian and Lilienfeld (1974) examine neoplasia using Sartwell's method, to "demonstrate the
possible usefulness, and range of application of the 'log-normal' model". Datasets include
bronchogenic carcinoma in asbestos workers (Selikoff & Hammond, 1968); thyroid cancer
following childhood radiation (Beach & Dolphin, 1962); bladder tumours following
occupational exposure (Goldblatt, 1949); several types of leukaemias (e.g. Court Brown & Doll,
1965; Tomonaga, 1962) and Burkitt's lymphoma (e.g. Latunde Odeku & Osuntokun, 1968). They
also examine data on pancytopenia after chioramphenicol (Polak et al, 1968).
Their conclusions are similar to Sartwell's; they also note that some datasets do not fit
particularly well, for example for Wilm's tumour after intra-uterine x-ray exposure (Stewart &
Kneale, 1970). They note that for a dataset collected from several different sources and
populations, the finding of log-normality should be viewed with caution, and discuss problems of
continuous exposure, and lack of precise exposure time. Nevertheless, they conclude that
Sartwell's model may have potential for application to chronic diseases.
Some investigators appear convinced of the probable universal validity of Sartwell's
conclusions, applying the hypothesis to totally different conditions. Phillipe (1990) examines
the mother's age (the 'lip') at the birth of twins, to investigate whether the likelihood of having
twins is congenital, or an effect of approaching menopause, conclusions being based on how
well the resultant Lid's of the mother's age, and of the remaining time to menopause, fitted log-
normality. They conclude that unlike-sex (di-zygotic) twins have their "causal origin in the
maternal pre-natal period, as the age of onset is definitely log-normal", whereas the situation for
like-sex twins (a mixture of mono- and di-zygotic) is less clear-cut.
Other diseases where a/o is considered as lip, and investigated by Sartwell's method include
various hereditaiy and metabolic diseases (Armenian & Khoury, 1981), giving a log-
normal distribution for a/o, and familial and sporadic Alzheimer's disease (Homer, 1987), with
similar results.
1.3 Infectious diseases with Ions incubation periods.
1.3.1 Definition of a 'Ion' incubation period.
Diseases considered to have a 'long' lip in this project generally have an i/p measured in
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years. However, there are exceptions, particularly for laboratoiy animal models of disease.
Therefore the definition used here is that these diseases usually take one or more years, but
occasionally less, to develop in their natural host range, and may often take less than a year in
artificially or abnormally acquired infections, or unusual hosts. Inherent biological variation
means that definition of a precise minimum period would be impractical.
1.3.2 Problems inherent in the investigation of incubation period in diseases with long
incubation periods.
Certain problems are inherent in investigating natural diseases with long i/p's. Infection is
generally long before disease onset, so often no connection is made. A disease may go
unrecognised as infectious for many years, with enduring aetiological uncertainty for some
diseases; for example motor neurone disease (Swash, 1991); multiple sclerosis (Fischman,
1981); grass sickness, a disease of eqwdae (Pavord & Fisher 1987); some types of neoplasia,
for example African Burkitt's lymphoma, nasophaiyngeal cancer, and Hodgkin's disease, all of
which are associated with higher antibody litres for Epstein-Barr vrnis (Evans, 1982).
Even when a disease is recognised as infectious, the distant time of infection may be unknown
or forgotten, making it impossible to trace infection source, or calculate i/p with accuracy.
Sometimes it is possible to demarcate an infection 'time-window'; often a/o is the only
information available. Mays & Ricketts (1975) describe a case of melioidosis with "a 26-year
interval between probable exposure and confirmed diagnosis"; Doyle (1953) report a leprosy
patient in Great Britain with a presumed i/p of between 8 and 13 years, exposed whilst on service
abroad.
Many diseases with long i/p's are insidious in development, with non-specific signs such as
weight loss, fatigue, a mild cough, or memoiy impairment; it may be impossible to accurately
record the time of disease onset. In some diseases, particularly tuberculosis, routine or post-
contact screening for subclinical infection, followed by treatment for humans (e.g. after contact
with infected elk; Fanning & Edwards, 1991), or culling for livestock (e.g. daiiy cattle infected
from a farmer, Englert & Milbradt, 1977) eliminates clinical disease onset, necessitating
amendment of i/p definition.
With a high disease prevalence, contact with potential infection may occur regularly, making it
impossible to evaluate which contact was responsible. Screening, as in the British BCG
vaccination programme (Sutherland & Springett, 1987), may indicate infection status at a
particular time, and thus indicate minimum or maximum i/p if disease subsequently occurs.
Nevertheless, accurate i/p data collection remains diflicult; Irgens (1985) describes some of the
problems in a study of leprosy.
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1.4 Aims of this study.
The emergence of acquired immune deficiency syndrome (AIDS) and bovine spongilorin
encephalopathy (BSE), both epidemic diseases with long i/p's. resulted in a need to predict
future epidemic behaviour, for AIDS, to plan health care facilities; for BSE, to ensure disposal
facilities; for both to plan financial resources and control spread.
In order to model epidemics of infectious diseases, particularly to estimate probable numbers of
cases with onset at any particular time, it is necessary to incorporate a term for the i/p f/d (Lui Ct
al, 1986; Gail & Brookmeyer, 1988). Sartwell's hypothesis may not apply to diseases with long
i/p's. During the course of an epidemic of a long i/p disease, left and right censoring makes
direct observation of this distribution highly unreliable (Peterman, 1987); in addition, time of
infection is often unknown. Therefore, for a previously undescribed disease, methods other than
direct observation must be employed. One method is to extrapolate from information available for
other diseases.
The main aim of this study is therefore to evaluate Sartwell's hypothesis in relation to the group
of diseases known as transmissible spongiform encephalopathies (TSE's) or prion disease, both
natural and experimental, utiuising information and methods from AIDS if appropriate;
complications include aetiological uncertainties for many fonns of prion disease, and unknown
date of infectionidisease initiation for natural disease, often necessitating the use of a/o as 'proxy'
i/p.
Underlying this aim is the attempt to validate, or otherwise, the incorporation of a log-normal i/p
(or alo) Lid term into BSE epidemic modelling.
A subsidiary aim is, where appropriate, to assess the effect of other variables on i/p (or a/o) and
its Lid.
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CHAPTER 2
AIDS: INTRODUCTION: TILE INCUBATION PERIOD
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2 1.1 The disease of AIDS - a summary.
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2.2 The incubation period in AIDS.
2 2.1 Predicting numbers of AIDS cases: Methods used, with special reference to
incubation period.
2 2.2 Published estimates of the incubation period of AIDS.
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CHAPTER 2
AIDS: INTRODUCTION: THE INCUBATION PERIOD
2.1 Introduction to AIDS
2.1.1 The disease of AIDS - a summary.
AIDS epidemiology had suggested an infectious aetiology (Peterman et al, 1985); most
investigators now accept this is human immunodeficiency virus (}11V). Gazzard (1990) considers
the evidence overwhelming; HIV is cultured from both donor and recipient lymphocytes in
transfusion acquired AIDS (TA-AIDS). The T-lymphotropic retrovirus was isolated in 1983
(Barre-Sinoussi et al, 1983; Gallo et al, 1984); evidence of infection was found in virtually all
AIDS patients (Peterman et al, 1985).
At sero-conversion, possibly several months post-infection (Hartsburgh et al, 1989; Longini &
Clarke, 1989), over 50% of patients experience a mononucleosis-like syndrome (Lilson et al,
1988; Tindall Ct al, 1988; ); incubation period (up) from infection to the development of AIDS
is long and variable.
The original definition of AIDS (CDC, 1982a) was modified in 1987 (CDC, 1987) (appendix 5),
encompassing wider recognition of possible manifestations (Peterman Ct al, 1985; Gazzard,
1990), and differences in world region being studied, depending on accessibility to laboratory
testing and prevalent local infections (Matondo, 1992).
Other classification systems include grouping by infection stage (CDC, 1987), and level ofT-
helper cells (OKT4 count) (Gazzard, 1990); some patients do not fit any category exactly.
2.1.2 The ep idemiolo y of AIDS - a summary.
AIDS was recognised in 1981; from October 1980 to May 1981 five cases of Pneumocystis
carinii pneumonia in young homosexual men in Los Angeles were recorded (CDC, 1981a)
whilst in New York and California, reported diagnoses of Kaposi's sarcoma in young homosexual
men increased markedly (CDC, 198 ib). By May 1985, there were 10,000 recorded United States
cases of AIDS (Petennanetal, 1985).
Cases were soon recognised in other groups; bisexual males, intravenous drug users (Selik et al,
1984), recipients of blood transfusions (Ammann et al, 1983) haemophiliacs (CDC, 1982b), and
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Haitian immigrants to the USA (CDC, 1982c). For TA-AIDS, traceable blood donors were often
in other recognised risk groups (Curran Ct a!, 1984), strengthening evidence for infection, which
also included direct links, for example sexual partners, or intravenous needle-sharers (Auerbach
Ct al, 1984; Curran et al, 1985a; Freidland & Klein, 1987)
Lack of denominator information in many risk groups made incidence rate estimation difficult
(Peterman et al, 1985).
Subsequently, disease was reported from Europe ( CDC, 1985a), Haiti (Pape et al, 1983), and
Africa (Van der Perre et al, 1984; Plot Ct al, 1984). In Europe, major risk groups were
homosexual males and intravenous drug users (Peterman et al, 1985), but in both Haitians and
Africans, heterosexual males and females (including many prostitutes) comprised the majority
of cases (Clumeck et al, 1984; Van der Perre et a!, 1984; Pitchenic et al; 1983).
Soon, heterosexual women and men with no identified risk factors, both in USA and Europe,
were diagnosed with AIDS (CDC, 1983; Harris et al, 1983); many had high risk group sexual
partners (Harris Ct al, 1983), or were born in Africa or Haiti (Curran ci al, 1985a), although
sometimes no risk factor was identified (CDC, 1984). Most areas of the world subsequently
experienced AIDS cases (Curran 1985; Quinn et al, 1986; Blattner, 1991).
Once tests were available for HIV antibody, it was realised that the number infected was far
greater than those with disease. Early evidence, and the probability of a long i/p for AiDS came
from the 'San Francisco cohort study' (Jaffe et al, 1985), originally set up to monitor hepatitis B
infection in male homosexuals, supported by studies on transfusion recipients (e.g. Eyster et a!,
1987; Lifson et al, 1988; Giesecke et al, 1988); thus the scale of the epidemic was realised.
Additional infection routes include needle-stick injuries (CDC, 1985b; Curran et a!, 1985a;
Peterman et al, 1985), transplants (Erice et a!, 1991), maternal transmission (Rogers et a!, 1987)
and transmission via breast-feeding (Zeigler ci al, 1985; Thiiy et al; 1985; WHO/UNICEF,
1992). Up to 65% of babies born to infected mothers develop AIDS (Scott et al, 1985; Rogers Ct
al, 1986; Thomas et a!, 1987); evidence suggests i/p is shorter in the veiy young (Curran et a!,
1985b; Medley et a!, 1987; Medley et a!, 1988a; Lui et a!, 1988.).
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2.2 The incubation period in AIDS.
2.2.1 Predicting numbers of AIDS cases: Methods used1 with special reference to
incubation period
Gail and Brookmeyer (1988) critically review three major methods; extrapolation, 'back
calculation', and compartmental (transmission) models; Anderson's (1988) review highlights
transmission models.
Earliest predictions extrapolated reported case numbers, usually with allowance for reporting lag
(e.g. Curran et al, 1985a; McEvoy & Tillet, 1985; Downs et al, 1987). However, ascertainment
bias alters with improved disease recognition; reporting lag changes with time; the mathematical
function assigned to the epidemic curve may be one of many which fit the data up to that point;
and no changes in transmission rate are allowed for. The method uses no up, infection rate, or
transmission method knowledge, and leads to wide variation in predictions, but was the obvious
choice early in the epidemic (Gail & Brookmeyer, 1988).
Additional information allowed for use of more complex methods. For data grouped by infection
cohort, left and right censoring reduces the apparent mean i/p over time, (Peterman, 1987);
conversely, grouping by diagnosis cohort causes the apparent mean i/p to increase (Rogers et al,
1987). 'Back calculation' is a parametric method (see appendices 6 and 7) to overcome the
censoring effect (e.g. Lw et al, 1986; Lw et al, 1988a; Kalbfleish & Lawless, 1989a; Day et al,
1989; Hendriks et al, 1992; Newton et al, 1993) but evaluating best i/p frequency distribution
(fYd) function (necessary for use in this method) from observed cases is complicated by unknown
infection time, multiple exposures, insidious onset, variable disease definitions, recording errors
(Brookmeyer & Gail, 1988; Geisecke Ct al, 1988; Kalbfleish & Lawless, 1989b; Peterman &
Ward, 1989).
These problems are exacerbated by the interaction of changing infection rates on the apparent up;
if stable, there is no problem. However if it increases, as in the early stages of any epidemic, or
decreases with behavioural alterations (Brookmeyer & Gail, 1988; Bacchetti & Moss, 1989), the
effect on apparent i/p depends on the rate of that change, since different numbers of cases infected
at different times will differentially weight the 'censoring effect' (Lw et al, 1986; Kalbfleish &
Lawless, 1988). Anderson (1988) concludes that the complete i/p f/d may take decades to
evaluate; hence the use of parametric curves which fit early data.
However, early in the epidemic, many functions may fit i/p data equally well; different functions
give different right 'tails', with widely differing predictions (Medley et al, 1987; Brookmeyer &
Gail, 1988; DoH, 1988; Kalbfleish & Lawless, 1989a; Day et al, 1989). The real i/p may change
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with time, due to drug therapy or other co-factors (Brookmeyer & Gail, 1988; Schechter et a!,
1989; Brookmeyer, 1991); or with risk group (Brookmeyer & Gail, 1988; Day Ct al, 1989). Much
i/p information comes from TA-AIDS cases, who may be less healthy at infection, or receive a
larger dose (Brookmeyer & Gail, 1988).
Parametric methods are applicable for short or (possibly) medium term estimates of case
numbers, which are not highly sensitive to i/p fld function; however, the calculated mean l/p, and
long-term estimates are extremely sensitive to the function used, and therefore differ widely (Gail
& Brookmeyer, 1988; Anderson, 1988).
With compartmental models based on transmission pathways (see appendix 7), (e.g. Anderson
Ct al, 1986; Blythe & Anderson, 1988; Longini & Clark, 1989; Velasco-Hernandez & Hsieh,
1994), classes are identified (e.g. susceptible, infected, diseased, dead), and transfer rates
between classes allocated, based on available information. The complexity of these models
depends on categories included, but still utilises unverified assumptions, including transfer rate
from infected to diseased dependant upon the i/p f/d, with the uncertainties previously discussed.
Incorporation of transmission rates allows simulation of different hypotheses, sub-sets, treatments
etc. for comparisons; they may eventually be useful for quantitative predictions (Gail &
Brookmeyer, 1988; Taylor, 1989a).
Other methods used in analysing the AIDS epidemic include survival analysis of a particular
infection cohort, which can give information on the i/p f/d and risk of developing AIDS (e.g.
Eyster Ct a!, 1987; Giesecke et a!, 1988), and other non-parametric methods (e.g. Bacchetti &
Moss, 1989; Kalbfleish & Lawless, 1989a). Rees (1987) investigated transfusion data utilising a
nonnal i/p fld, concluding that mean i/p was far longer than generally accepted at that time. For
this, and his methodology, he was heavily criticised (Barton, 1987; Costagliola & Downs, 1987;
Lw et al, 1987).
2.2.2 Published estimates of the incubation period of AIDS.
The estimated i/p of AIDS varies with method used and group studied, and tends to lengthen
over time (Taylor et a!, 1991). In addition, published i/p information is given in different ways
(see appendix 8).
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CHAPTER 3
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSE'S)/
PRION DISEASE: INTRODUCTION
3.1 The TSEIprion disease spectrum.
Characteristic of the group of diseases traditionally called transmissible spongiform
encephalopathies (TSE's) is neurodegeneration with vacuolation and amyloid fibrils (scrapie-
associated fibrils, SAFs), a variety of neuropathologically-associated clinical signs, fatal
outcome, experimental and iatrogenic transmissibility of infection, and a 'long' incubation period
(Kimberlin, 1990); additionally, there is no easily detectable immune reaction to the presence of
infectious agent (Bennett et al, 1992; Berg, 1994), precluding any simple method for identifying
infection. Hadlow (1959) drew attention to the similarity between scrapie and kuru, and Gajdusek
(1977) postulated similar aetiological mechanisms for scrapie, CJD and kuru.
It has since been recognised that all TSE's involve the presence of an aberrant isoform (PrP&) of
normal cellular prion protein (PrPC); it forms the main constituent of the amyloid deposits.
Presence of PrP is regarded by Roberts and Collinge (1990) as diagnostic of transmissible
dementias; the name 'prion disease' is recommended (Collinge & Prusiner, 1992).
There is, as yet, no consensus on terminology; nevertheless there is broad consensus on disease
range (table 3.1).
Table 3.1 TSE/prion disease spectrum
Human diseases
Sporadic CJD
Familial CJD
Gerstmann-Straussler-Scheinker syndrome (GSS)
Fatal familial insomnia (FF1)
latrogenic CJD
Kuru
Other species diseases
Scrapie
Bovine spongiform encephalopathy (BSE)
Feline spongiform encephalopathy (FSE)
Transmissible mink encephalopathy (TME)
Chronic wasting disease (CWD)
TSE of exotic ungulates
Prusiner and DeArmond. 1994
[S C	 Creutzfeldt-Jakob diseascj
Species
Sheep, goats
Cattle
Cats (domestic and large)
?nk
Elk, mule deer
Several. e g. nval& eland.
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Recent overviews include Prion Diseases of Humans and Animals' (1992) edited by Prusiner et
al; 'Molecular Biology of Prion Diseases' (1994), edited by Colhnge & Weissmann;
'Transmissible spongiform encephalopathies - Impact on animal and human health' (1993), edited
by F Brown; TSE's of animals are reviewed generally (OlE, 1992).
3.2. The diseases - summaries.
3.2.1 Scrapie: the prototype.
3.2.1.1 Natural disease.
Scrapie was first documented in sheep in England in about 1730 (Comber, 1772); Besnoit and
Morel (1898) describe associated neuropathology. Onset, usually between 2-5 years of age, is
generally insidious; signs valy, and include intense pruritis, hyperexcitability, incoordination,
ataxia and loss of condition; outcome is fatal (Mitchell & Stamp, 1983). Sudden death is possible
(Clark, 1991).
Classic pathology is confined to the CNS and includes non-inflammatory neurodegeneration with
vacuolation and spongiform change (Pany, 1983). Amyloid deposits are sometimes found (Beck
et al, 1964). Lesion severity varies, not necessarily correlated with clinical signs (Hadlow et al,
1982). Since there is no easily detectable immunological reaction to infection, diagnosis relies on
clinical signs and histopathological confirmation (Detwiler, 1992).
Scrapie has been reported in most world regions. Epidemiology in the United States (Hourrigan et
al, 1979; Hadlow, 1990) and Iceland (Sigurdsson,1954; Palsson, 1979) is described. Parry (1983)
extensively reviews historical and world epidemiology; Detwiler (1992) gives recent data.
Although an infectious origin was considered likely as far back as 1794 (Stockman, 1913, citing
Young, 1799), in 1848, Roche-Lubin suggested scrapie was caused by sexual excess, or
thunderstorms. Proponents of the infectious theory include M'Fadyean (1918) and Kimberlin
(1990). That the disease is transmissible, from sheep to sheep under experimental conditions, was
demonstrated by Cuille & Chelle (1936); Gordon et al (1939) reported iatrogenic scrapie by
contamination of louping-ill vaccine.
Conversely, Yorkshire sheep farmers considered scrapie to be hereditary (Stockman, 1913, citing
a report to the Board of Agriculture, 1812), as did French farmers (Chelle, 1942). Bosanquet et al
(1956) described the disease as a primary myopathy, probably of genetic origin, and Parry (1962,
1983) presented much data on which he based his 'recessive gene hypothesis'.
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As early as 1913, Stockman reported that 'some people' considered the disease to be both
infectious and hereditaiy; Prusiner and DeArmond (1994) also consider this possible. Pattison
(1974) concluded that two cases which he observed in genetically susceptible sheep had arisen
'spontaneously'. The aetiological debate surrounding natural scrapie is still unresolved.
General reviews of scrapie in sheep, documenting accumulation of information and changing
ideas, include those by Stockman (1913), Greig (1940a), Palmer (1959), Parry (1983) and
Detwiler (1992).
Natural scrapie in a goat was first reported by Chelle (1942). There is a paucity of information;
Wooldridge and Wood (1991) reviewed the epidemiological information available; pathology
(Wood & Done, 1992) and clinical history (Wood et al, 1992) is described for 20 cases.
Genetic studies have now identified mutations of the sheep PiP gene which have been associated
with increased susceptibility to natural scrapie. For example, at codon 136 in Shetland, Scottish
Halibred and Bleu du Maine breeds, valine is associated with scrapie whilst alanine is associated
with healthy animals (Hunter et al, 1994a), and in Suffolk sheep, homozygous codon 171
mutations are associated with disease (Westaway et al, 1994). No PiP gene mutations have been
reported as affecting susceptibility in goats.
3.2.1.2 Experimental scrapie; early work.
After experimental transmission of scrapie from sheep to sheep (Cuille & Chelle, 1936) further
landmarks include the following:-
1957: Experimental transmission, sheep to goats (Pattison, 1957).
1961: Experimental transmission to mice (Chandler, 1961).
1961: Oral transmission to sheep and goats (Pattison & Millson, 1961a).
1968: Sip (scrapie incubation period) gene found in sheep (Dickinson ci a!, 1968).
1969: Sinc (scrapie incubation period) gene found in mice (Dickinson et a!, 1969).
1969: Experimental transmission to monkeys (Gibbs & Gajdusek, 1969).
1980: Oral transmission to monkeys (Gibbs ci al, 1980).
Experimental transmission changed the focus of investigation from natural to experimental
disease; in particular, to disease in small laboratory rodents, since this reduced incubation periods
by several years (reviewed by Wooldridge, 1991). Transmission could be used for diagnosis, and
also allowed extensive pathology and pathogenesis studies, for example in goats (Hadlow, 1%!;
Eklund & Hadlow, 1969) and mice (Gibbs ci al, 1965; Eklund et al, 1967; Outram, 1976).
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Although the most efficient experimental transmission method was to use brain material from the
donor (PaUlson & Millson, 1962) inoculated into the CNS of the recipient, the involvement of the
lymphoreticular system was also identified; it's role in pathogenesis is reviewed by Fraser et al
(1992). Different 'strains' of scrapie agent are described, as is the effect of host genotype on
incubation period, which varies pith 'strain' (Dickinson & Mieckle, 1971; Bruce & Dickinson,
1979; Kimberlin & Walker, 1978).
Periodic reviews of accumulating infonnation on many aspects of both experimental and natural
scrapie include those in 'Slow, Latent and Temperate Virus Infections' (1965), edited by Gajdusek
et al, 'Slow Virus Diseases of Animals and Man' (1976), edited by Kimberlin, and 'Slow
Transmissible Diseases of the Nervous System' (1979), edited by Prusiner and Hadlow.
Pattison (1988; 1992) reviews early scrapie research in the UK, emphasising that natural disease
is not the same as experimental disease.
3.2.2 Bovine spongifonn encephalopathy: the epidemic.
Bovine spongiform encephalopathy (BSE) was first reported in 1987 in Great Britain (Wells et al,
1987); neuropathology with degenerative changes and vacuolation reminiscent of scrapie is
described. Subsequent pathological investigation indicates that, unlike scrapie, only one 'strain' of
agent is involved (Wells et al, 1992; Bruce, 1994), and no genetic association with differences in
incubation period has been found (Hunter et al, 1994b).
Epidemiological evidence strongly suggests foodborne infection with a scrapie-like agent derived
from ruminant tissues, from approximately 1981, with the first case in 1985 (Wilesmith et a!,
1988). Changes in rendering methods for producing meat and bone meal (MBM) are implicated,
particularly cessation of hydrocarbon solvent extraction (Wilesmith et al, 1991). Rapid epidemic
growth (Wilesmith et al, 1992) resulted in a statutoly ban on feeding of ruminant protein to
ruminants (Order, 1988). Incidence rapidly declined in cattle born subsequent to the ban
(Hoinville, 1994).
BSE in Northern Ireland is epidemiologically similar to Great Britain (Denny et a!, 1992).
Occasional cases from Switzerland (Anon, 1990a) France (Anon, 1991), Eire, the Faildand
Islands (Bradley & Lowson, 1992), Oman (Carolan et al, 1990) and Portugal (Telo, 1994) are
repoi1ei
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Onset is generally from 3-5 years of age (Wilesmith Ct al, 1988). Clinical signs vaiy; most
frequently recorded are apprehension, hyperaesthesia and ataxia; others include kicking, tremors,
loss of weight and reduced milk yield (Wilesniith et al, 1992; Austin, 1993). As with scrapie,
there is no test for infection; diagnosis relies on clinical signs and histopathology (Kimberlin,
1992).
Using brain-derived material, BSE has been transmitted to mice, both by intracerebral inoculation
(Fraser at al, 1988), and orally (Barlow & Middleton, 1990); to pigs (Dawson et al, 1990), to
sheep and goats (Foster et al, 1993), and to marmosets (Baker et al, 1993). Infectivity has also
been reported in the ileum (Wells Ct al, 1994). The disease is not simply inherited (Wijeratne &
Curnow, 1990), and thus far, no PrP gene mutations associated with susceptibility have been
found (Wilesmith, personal communication, 1995).
Recent reviews include Wilesniith (1994) on epidemiology, and a general review by Kimberlin
(1992), plus the Office International des Epizooties report (OlE, 1994).
3.2.3 Other veterinary TSE'slprion diseases.
Transmissible mink encephalopathy (TME) was first reported (Hartsough and Burger, 1965) as
several outbreaks, in Wisconsin, of a disease of unknown aetiology with similarities to scrapie. A
foodborne infection was hypothesised, possibly of bovine or ovine origin. Transmissibility was
demonstrated (Marsh et al, 1969). Subsequently, an outbreak where sheep had never been fed
suggested the possibility of unrecognised scrapie-like disease in cattle (Marsh and Hartsough,
1985). Marsh and Hadlow (1992) review TME.
Chronic wasting disease (CWD) has been reported in mule deer and elk, both species of the
family ceividae (Williams & Young, 1980; 1982). Williams and Young (1992) review the
disease; it is scrapie-like, occurring in both captive and free-living animals. It is not associated
with foodborne infection; lateral and probably maternal transmission occur.
Feline spongiform encephalopathy (FSE) was first reported in 1990 (Wyatt et al) in a domestic
cat; pathological findings were consistent with a TSE. Other cases followed (Legget et al, 1990;
Wyatt et al, 1991), including a captive puma (Willoughby Ct al, 1992), and several cheetah
(Kirkwood & Cunningham, 1994). Pearson et al (1993) review findings for 24 cases.
Transmission to mice is reported (Fraser Ct al, 1994). Kimberlin (1992) suggests contaminated
MBM in catfoods as the most likely source of infection.
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TSE of exotic ungulates was first observed in nyala in 1986, and subsequently in gemsbok
(Jeffrey & Wells, 1988), Arabian oiyx and greater kudu (Kirkwood Ct al, 1990) and eland
(Fleetwood & Furley, 1990), all species of the family bovidae. Kimberlin (1992) suggests that the
majority of these animals were fed contaminated MBM in their diets, however, for kudu, there is
evidence that maternal and lateral infection subsequently occurred (Kirkwood et al, 1992;
Kirkwood et al, 1993; Kirkwood eta!, 1994).
Wells (1993) reviews pathology of animal TSE's, whilst KirkWOOd and Cunningham (1994)
review epidemiology in captive wild animals.
3.2.4 Human TSE/nrion diseases.
Creutzfeldt-Jakob disease (Cm) was first described in the 1920's (Creutzfeldt, 1920; Jakob,
1929), characterised mainly by a rapidly progressive dementia. It is generally sporadic, but
around 15% are familial cases (Masters et al, 1979). Gerstmann-Straussler- Scheinker syndrome
(GSS) was first described in 1936 (Gerstmann et al), and is familial, with an autosomal dominant
pattern of inheritance (Brown, 1993); dementia is slowly progressive and ataxia often present
Families exist which exhibit both clinical syndromes (Ridley and Baker, 1993).
In 1957, Gajdusek & Zigas reported a localised epidemic of kuru in the Fore people of Papua New
Guinea, associated with ritual cannibalism (Klitzman et al, 1994). Typical progression is
locomotor ataxia, tremors, severe speech impairment and death (Zigas and Gajdusek, 1959).
Hadlow (1959) pointed out similarities to scrapie, suggesting transmission experiments which
proved successful both by inoculation (Gajdusek et a!, 1966), and orally (Gajdusek, 1979).
CJD was also transmitted experimentally to chimpanzees and monkeys (Gibbs and Gajdusek,
1969). Iatrogemc CJD has resulted from neurosurgeiy (Will & Matthews, 1982), dura-mater and
corneal grafts (Baker, 1990), and injections of pituitary extract (Gibbs et al, 1985), confirming its
transmissibility to other humans.
Fatal familial insomnia (FF1) was recognised as a prion disease in 1992 (Medori et al); sleep
disturbance is a particularly prominent sign; 'atypical' prion dementia (APD) is described by
Ridley & Baker (1993), identified by accumulation of PrP& or PrP gene mutation.
Brown (1993b) reviews the clinical picture, emphasising continuity of the spectrum across all
these diseases, and Kretzschmar (1993) reviews neuropathology. Masters et a! (1979) review
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worldwide epidemiology of Cm; Will et al (1992) review C epidemiology in the UK with
particular emphasis on occupation.
Many genetic mutations have been identified in the PrP gene in families with familial disease
(e.g. Hsiao et al, 1989, 1991a, 1992; Brown et al, 1991; Collinge Ct al 1992, 1993). Slovakian
cases are associated with mutation at codon 200 (Meyer et al, 1977; Goldfarb et al, 1990), as are
cases of Libyan Jewish ancestiy, where dietaiy factors (in particular sheep's eyes) were originally
suspect (Kahana et al, 1974; Hsiao et al, 1992b).
Polymorphism of the PrP gene at codon 129 is found in the general population, and in TSE
patients. The two allelic forms code for methionine (met) or valine (val), giving met/met, met/val,
or val/val (Collinge & Palmer, 1992). Codon 129 homogeneity is associated with susceptibility to
development of cm in pituitaiy hormone injection cases (Collinge et al, 1991; Deslys et al,
1994); homozygosity may also predispose to sporadic cm (Palmer et al, 1991). Polymorphism at
codon 129 may also affect clinical manifestation or age at onset in the presence of other PrP gene
mutations (Crow et al, 1992; Ridley & Baker, 1993). In the presence of codon 178 mutation,
codon 129 polymorphism may produce different clinical syndromes, cm and FF1 (Monari et al,
1994). There may be other genetic susceptibility factors (either on the PrP gene or elsewhere), as
yet undiscovered (Ridley & Baker, 1993).
Annual incidence of all forms of human spongifonn encephalopathies is usually given as no more
than one case per million population (Baker, 1990).
3.3 The aetioloical debate
Controversy on the aetiology of these diseases continues. There are two separate, but associated,
debates. That experimental transmission is possible is generally accepted.
3.3.1 The first debate: the biochemical nature of the transmissible a!ent.
The hypothesis that the agent is comprised of protein alone has developed largely from the 'prion'
hypothesis. Prusiner (1982) proposed a small proteinacious infectious particle, the prion, as the
transmissible scrapie agent, suggesting it might comprise either a tightly packed protein coat
surrounding a protected small nucleic acid, or an infectious protein alone, and that host genes
may code for both a protein-only scrapie prion and a related, necessazy protein. This hypothesis
was based on the agent's physico-chemical properties; it was unusually stable (e.g. Hunter &
Millson, 1964, Pattison, 1965c); smaller than viruses (Alper et al, 1966) and not isolated by
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conventional virus-isolation techniques (Hunter and Millson, 1967). Millson et al (1976) review
the agent's physico-chemical properties. Hunter (1992) summarises this early work.
Following publication of the 'prion' hypothesis, McKinley et al (1983) report that the
concentration of a protease-resistant protein designated PrP, from scrapie-infected hamster brain,
is proportional to infectivity, suggesting it as the major component of infectious prions. This PrP
assembles into filaments, which accumulates to form amyloid plaques (DeArmond et a!, 1985).
Oesch et al (1985) report that a cellular gene encodes for this protein, now called PrP2730, and
Basler Ct al (1986) show that PiP2730 and normal cellular PrP isoforms are encoded by the same
gene, suggesting differences are due to post-translational events. Safar et al (1990) report
diminished infectivity of scrapie precursor protein (now called PrP) preparations after addition
of polyclonal antibodies raised against PrP2730; biochemical and physicochemical analyses
indicate that PrP may be the only component of the infectious unit. PrP 2730 is present in cattle
brains after scrapie inoculation (Gibbs et a!, 1990).
Brown Ct al (1990) describe resistance of scrapie agent to autoclaving and formaldehyde
treatment, results compatible with replication initiation by nucleation and auto-patterning (e.g. by
an inorganic ciystal) of a configurational change in scrapie precursor protein, followed by
ciystalline growth, thus mimicking replication of a microbiological agent. A similar conclusion
was reached by Come et a! (1993). Jarrett and Lansbuiy (1993) review possible mechanisms.
Pan et al (1993) demonstrate conformational differences in PrPC and PrP, whilst Kocisko et al
(1994) report 'seeded' conversion of PrP to PrPSC in a cell-free medium. Work with transgenic
models indicates that mice producing no PrPC are resistant to scrapie (Bueler et al, 1993); and
that efficiency of interaction between PrPC and introduced PrP depends on the genetic source of
the two PrP's, with similar sources leading to increased efficiency of disease production, reduced
incubation times and reduction of the 'species bathe? (Scott et a!, 1989; Prusiner Ct al, 1990;
Weissmann, 199la; Scott et al, 1993); all add support to the possibility of conformational change
in native PrPC initiated by incoming, PrPCJtc.
The main problem with acceptance of the protein-only hypothesis is the existence of distinct
strains (Weissmann, 1991a); however, both protein-only and 'unified' theory of prion propagation
(in which nucleic acid is involved, but not necessary for infection) (Weissmann, 1989; 1991b) can
account for strain differences.
Aspects of both natural and experimental transmission in TSE's/pnon diseases are reviewed
(Prusiner, 1987), as well as the chemistry and neurochemistiy of prions and prion diseases
(Prusiner, 1989; DeArmond and Prusiner, 1993). Prusiner (1995) argues that the weight of
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evidence now accumulated indicates that the prion is a new class of pathogen, with prion disease
resulting from aberrations of protein conformation.
However, the agent was originally assumed to contain nucleic acid, its small size suggesting a
virus (Hunter 1965), and the search for nucleic acid continues. Sklaviadis et al (1989, 1990),
describe studies of the physical properties of the CJD agent, and conclude that infectivity is
associated with nucleic acid-protein complexes, the agent being of virus-like size; a nucleic acid
binding protein is described (Sklavadis et al, 1993). Narang (1990, 1992, 1993) describes a
single-stranded DNA as part of a SAF 'coat', Akowitz Ct al (1990) and Murdoch et al (1990)
report RNA, possibly of retroviral origin, as co-purifying with C infectivity, whilst Aiken Ct al
(1989, 1990) and Narang et al (1991) implicate mitochondnal DNA as involved in scrapie
infection. Aiken and Marsh (1990) review evidence for scrapie agent nucleic acid; they conclude
that evidence points to an agent with host-encoded protein protecting an infectious nucleic acid;
the virino hypothesis.
Schreuder (1993) reviews evidence for virus, virino, prion, and unified hypotheses, including
evidence from transgenic experiments.
Pnisiner was not the first to postulate an infectious agent devoid of nucleic acid. Results of
radiobiological experiments led Alper et al (1967) to suggest the agent might replicate without
nucleic acid; Gibbons and Hunter (1967) put forward the 'membrane hypothesis' that plasma
membrane is essential for infectivity. Alper (1993) argues the case for membrane fragment
involvement.
3.2.2 The second debate: the aetiolo2ical mechanism in natural disease.
The historical debate on the aetiology of scrapie has been outlined; that debate continues, and
extends to all TSE/prion disease. One viewpoint holds that all cases of TSE involve a
transmissible agent, linked, in certain cases to genetic susceptibility which may be hereditaiy or
the result of somatic mutation (Diringer et al, 1993).
Alternative theoiy allows for hereditary, infectious and sporadic disease initiation mechanisms
(DeArmond & Prusiner, 1993). Hereditary genetic mutations in the PrP gene may result in
instability of the PrPC (the initial gene product), allowing spontaneous post-translational change
to, for example, PrP, PrPGS5, PrP or PrPm dependant on the disease in question. Once
produced, this altered PrP is infectious if introduced, under appropriate conditions, into a suitable
host, as in experimental transmission, iatrogenic cm, kuru, BSE, and probably most scrapie
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cases; precise transmission pathway may be unknown. Under this scenario, sporadic CJD may be
either the result of transmission, possibly coupled with susceptibility (perhaps due to a somatic
mutation - an 'age effect') or spontaneous, again perhaps due to a somatic mutation.
That transgenic mice containing a mutant prion protein gene from a GSS patient spontaneously
developed neurodegenerative disease (Hsiao et al, 1990) lent early support to this theory; reviews
of subsequent supporting research and its interpretation include those of Hsiao and Prusiner
(1990), Prusiner and Westaway (1991) Prusiner (1994) and Prusiner and DeArmond (1994).
Nevertheless, there is still dispute regarding whether PrP gene mutation is sufficient aetiological
cause for disease, or merely a factor increasing susceptibility to infection or disease. Hunter et al
(1992) review the significance of PrP gene polymorphisms in natural scrapie.
Alper (1993) proposes a variant on the second theory, whereby genetic-mutation-derived
abnormal PrP results in failure of plasma membrane to develop correctly, thus eventually causing
disease. The infectious agent is not altered PrP alone, but PrP-Ioaded plasma membrane
vesicles, which incorporate into host membrane.
3.4 Relevance of animal TSE's to human public health
Epidemiological studies have not linked occurrence of CJD to exposure to scrapie (review:
Taylor, 1989b). However, the discovery, and subsequent epidemic of BSE in the UK led to
renewed speculation that animal TSE's could pass to humans, since the agent had apparently
crossed the 'species barrier' to cattle and cats; potential hazards are examined (Blakemore, 1989;
Taylor, 1989b; Collee, 1990; Kimberlin, 1990; Brown, 1993a). Conunittees (Southwood, 1989;
Tyrrell, 1990) were set up to investigate the epidemic, evaluate necessaiy research, and advise the
government; methods, including legal sanctions, used to contain the epidemic and minimise risk
to other species are summarised (Taylor, 1991; Kimberlin, 1992), and have recently been
extended (Anon, 1994).
Surveillance of human TSE cases in the UK has been established (Anon, I 990b), and monitoring
of the BSE epidemic by MAFF continues at the CVL; on 23/12/94 over 141 thousand confirmed
cases had been recorded. No BSE transmission to humans has yet been proven; it may be
impossible to prove that it never occurs (Matthews, 1990).
But there are other ways in which BSE can affect human health; at least one case of 'delusional
BSE' has occurred in a human (Lovestone, 1990).
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CHAPTER 4
DATA USED AND ANALYSIS METHODS NOT DESCRIBED
ELSEWHERE
4.1 Data used.
4.1.1 The AIDS dataset used.
Data comprises the set of 4010 TA-AIDS cases recorded in the USA up to and inclusive of
December 1990 and was kindly supplied on disc by T Petennan, CDC, Atlanta, USA.
Appendix 9 is a copy of the accompanying explanatory leaflet. Records supplied were as received
by CDC; they were not 'cleaned' (i.e. not checked for completeness or errors).
4.1.2 Data used for TSE/pnon disease examination.
Data was from 3 sources; a general literature search (GLS) for each disease, data supplied directly
by other investigators (either written or on disc), and data extracted directly from case records.
Appendix 10 gives details of data-source by species, and describes and explains the selection of
datasets and dataset subgroups used in the analyses in chapters 6 to 11.
4.2 Outline of data examination.
Chapters 5 to 11 have a similar construction. Each starts with a brief summary, followed by a set
of quantitative analysis results pertaining to TSE/prion disease in a particular type of animal (or
for chapter 5, AIDS in humans), and concludes with a qualitative discussion of those results.
Chapters 12 and 13 examine aspects of the overall findings.
For chapters 6 to 11, after selection of datasets and subgroups within these datasets (for details,
see appendix 10). each dataset is examined for incubation period (up) or age at onset (alo)
parameters. The i/p and/or a/o frequency distribution (lid) is then generally illustrated with a
histogram, examined statistically for compatibility with normality and log-normality, and the
coefficient of skewness (c/s) calculated. This initial pattern of analyses follows a broadly similar
format for each dataset, thus avoiding the necessity for lengthy, repetitive descriptions within the
analysis sections of each chapter. Additional analyses either on complete datasets or subgroups.
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for example to examine the effect of censoring, or of variables, or of culling, are undertaken
where appropriate and individually described or referenced.
4.3 Methods not described elsewhere.
4.3.1 Data stora2e.
All data was entered into specifically written databases in the epidemiological software
programme Epi Info, version 5.0 la (1991). Data on disc was transferred directly, other data was
entered manually.
4.3.2 Analyses; methods not described elsewhere.
Unless otherwise stated, analyses were performed using Epi Info as above, and methods given in
the reference manual (version 5). For non-parametric testing, Epi Info uses the Kruskal-Wallis
test (Siegel, 1956). The following additional methods were used frequently; other methods are
described or referenced when used.
Compatibility of the fld for normality or log-normality was tested by the method of Filiben
(1975), using Minitab statistical software, release 7.2 (1989) (see appendix 11). Evidence of
skewness in the untransformed and log-transformed data was tested for by the method of
Snedecor and Cochran (1967), again using Minitab software (see appendix 12). Regression
analysis and analysis of variance were also perfonned using Minitab statistical software, plus
methods given in the reference manual, release 7 (Minitab, 1989). For fYd's with cases grouped by
more than I time-unit, standard deviation was corrected by the method of Sheppard (1897) (see
appendix 13).
The meaning of the following abbreviations are explained in detail in method appendices 11 and
12 and are regularly used in the tables of results without further comment:-
Correlation coefficient, CC 	 Sample size, N
Critical value, C/v	 Probability, P
Coefficient of skewness, C/s
Appendix 14 gives an indication of the discriminatoiy power of the tests used to estimate
compatibility with normality and log-normality. Appendix 15 shows the application of these tests
to diseases with short i/p's. and appendix 16 illustrates constructs of log-nonnal distribution for
selected datasets for comparison with the observed fld.
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CHAPTER 5
AIDS: DATA ANALYSIS AND DISCUSSION
5. Summary
5.1 Incubation Period Analyses
5.1.1 Estimate of mean incubation period for three groups.
5.1.2 The effect of left and right censoring.
5.1.3 Back-calculation to overcome censoring.
5.1.4 Examination of incubation period frequency distribution.
5.2 Discussion
5.2.1 Mean incubation period estimates.
5.2.2 Incubation period frequency distribution.
5.2.3 Mean incubation period; comparison of back-calculation with direct
estimates.
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CHAPTER 5
AIDS: DATA ANALYSIS AND DISCUSSION
Summary.
The effect of censoring in an epidemic with a long
incubation period (lip) renders the observed mean
i/p estimation and lip frequency distribution (fld)
description liable to substantial errors until well into
the epidemic's course.
Back-calculation methods may be applied to other
epidemics in a similar fashion to that described
here, in an effort to overcome the problem of
censoring. However, since they rely on the assump-
tion of an lip f/d they do not help to elucidate the
true i/p f/d. They may give a closer approximation
to the true mean i/p if censoring is great, but valid-
ation is only possible once the true i/p f/d can be
found from other sources. Estimates of the mean and
maximum lip may vary greatly with lip f/d assumed,
rendering long-term predictions unsafe.
It is impossible to accurately estimate the mean i/p
or i/p f/d of a disease with a long lip, by using data
from within that epidemic, until several successive
stable i/p range infection cohorts have passed,
showing the maximum possible lip; and there has
been enough further time for such cohorts to have
been recorded, analysed, and identified; monitoring
is necessary for this stage to be recognised as soon
as possible.
Sartwell's hypothesis can not be verified, or refuted,
from this data, since the stage of stable lip range by
infection cohort has not been reached.
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5.1 Incubation period analyses.
5.1.1 Estimate of mean incubation period for three Eroups.
Estimates are given, in table 5.1.1, for cases with a single transfusion (tx) only, for those with a
traced suspect donor and for the most complete dataset possible, including both of these plus
cases with multiple transfusions (see appendix 17 for selection of data used, appendix 18 for
method of estimation of multiple transfusion infection date):-
Table 5.1.1 TA-AIDS; estimates of i/p (in months) for three datasets (see text).
Dataset	 N	 Mean i/p	 SD	 RangeJ
Singletx	 911	 52.5	 27.0	 3-208
Suspect donor	 53	 29.3	 15.1	 6-68
Complete	 2570	 55.1	 28.0	 1-415
5.1.2 The effect of left and n2ht censonn2.
In demonstrating censoring, to reduce infection date uncertainty, only single (or suspect donor)
transfusion cases are used. Table 5.1.2 gives i/p data by transfusion year.
Table 5.1.2 TA-AIDS; the effect of left and right censoring on the i/p.
Results:-
Complete set:
Ti year
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
Number
N
911
1
0
1
1
0
0
1
5
13
40
68
124
175
206
199
61
11
3
1
1
Mean i/p
(months)
52.5
208.0
189.0
181.0
155.0
126.4
97.8
89.1
74.8
63.7
53.6
45.0
37.9
34.6
24.8
31.7
6.0
3.0
Range	 SD
(months)	 (months)
3-208	 27.0
	
93-142
	
20.4
	
44-139	 27.3
	
47-125	 19.8
	
29-122
	
24.1
	
9-105
	
24.0
	
9-96	 20.2
	
3-86	 19.3
	
4-75	 15.9
	
8-62	 13.6
	
4-41
	
13.2
	
28-34
	
3.2
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The mean i/p decreases from 208 months (1970) to three months (1989) (figure 5.1.2).
Figure 5.1.2 TA-AIDS; mean i/p (in months) by year of transfusion.
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Regression analysis gave the annual mean i/p decrease as 9.7 months (95% CI 9.0-10.4)
(r= -0.67; F=743.95; P<0.001).
5.1.3 Back-calculation to overcome censoring.
The single transfusion dataset was again used. Back-calculation (kindly undertaken by R Sayers;
see appendix 19 for method, and assumptions made) was performed for three different i/p fYd
assumptions; gamma, Weibull, and log-normal. Several estimations were performed (data not
shown) each using different additional assumptions; all gave broadly comparable results. Chi-
square goodness-of-fit tests, and plausibility of assumptions made, were combined in selecting the
specific set of results shown (table 5.1.3). There were 724 cases in the final dataset used.
Table 5.1.3 TA-AIDS; estimates of i/p values (in months) and
related data from back calculation.
Distribution	 Percentiles
1%	 50%	 95%	 99%
Gamma	 6	 66	 189	 265
Weibull	 4	 66	 176	 234
Log-normal	 9	 93	 487	 968
Mean	 Mode	 Max log likelihood
Ganuna	 79.3	 39	 -1999.98
Weibull	 75.9	 40	 -2002.17
Log-normal	 154.4	 34	 1998.56*
As expected, for all f/d's the mean i/p has increased markedly from the 52.5 months for the
simple mean, to 6-7 years for gamma and Weibull distributions, and to almost 13 years for the
log-normal distribution, for which the maximum log-likelihood is actually the largest (although
all are close). Even more striking is the 99% value, at almost 20 years (234 months) for the
Weibull distribution, and over 80 years (968 months) for the log-normal distribution.
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Number of cases
500
400
300
200
100
0
C/s	 Pfor
c/s
	0.971	 <0.001
	
1.586	 <0.001
	
-1.056
	
<0.001
	
-1.738	 <0.001
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5.1.4 Examination of the incubation period frequency distributions.
Two subgroups were examined for i/p frequency distribution (fld); the single transfusion dataset
(subgroup A; 911 cases), and that obtained after weighting for multiple transfusion cases
(subgroup B; 2570 cases) (figure 5.1.4).
Figure 5.1.4 TA-AIDS; subgroup! A and B; i/p f/d.
-3	 .5	 -7	 -9	 .11	 -13	 -15	 -17	 -35
-2	 -4	 -6	 -8	 -10	 .12	 .14	 .16	 -18
Incubation period (years)
SubgroupA	 SubgmupB
[Note: Upscale: .1 indicates cases with onset within one year of transfusion etc.)
There is a difference in the mean of these subsets (P=0.004, non-parametric test), but both are right
skewed. Table 5.1.4 gives results of testing for normality, log-normality and skewness.
Table 5.1.4. TA-AIDS; a/o f/d analyses I
Sub-	 N	 FId under	 CC	 C/v at P=
roup	 analysis	 0.05
A	 911	 Nonnality	 0.977	 0.998
B	 2570	 0.964	 0.999
A	 911 Log-normality	 0.972	 0.998
B	 2570	 0.939	 0.999
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Neither subgroup is compatible with normality or log-normality; for both, right skew is too
extensive for normality but not extensive enough for log-normality, log-transformation resulting
in a left skew.
Examination of comparable lid analyses of data for transfusion cohorts, for individual years
1979-1985 for subgroup A (complete data not shown) gives, for each year, an lid compatible with
normality, and for only 1979 an lid also compatible with log-normality. P values for significance
of skew of the log-transformed data are: 0.089 (1979); 0.013 (198O) <0.001 (1981 - 1985).
5.2 Discussion.
5.2.1 Mean Incubation period estimates.
Mean i/p for single and multiple transfusion cases are similar. However, with a traced suspect
donor, the mean is much reduced. A donor is more likely to be traced for a recent transfusion,
and a short i/p case will have a more recent transfusion at the time of onset, resulting in bias. The
effect of left and right censoring on mean i/p is clearly demonstrated.
5.2.2 Incubation Period Frequency Distribution.
Sartwell (1950, 1966), and others using his method, have examined either outbreaks of acute
infectious disease, where case ascertainment was as complete as possible, or collections of data on
sporadic disease, gathered into one dataset for analysis. In either case, with large enough
numbers, it is assumed that the observed range of i/p's would be relatively complete.
During a major epidemic of a newly observed disease with long i/p. relatively complete case
ascertainment cannot occur until after the end of the epidemic, probably many years into the
future. Neither can there be confidence in complete case ascertainment for earlier subgroups, for
example those infected in a particular year, since it is unknown how long it will be before the last
case derived from that cohort will occur, this is particularly the situation early in the epidemic.
Once the tnie maximum possible i/p from the earliest cohort has passed, the maximum i/p
observed should tend to stabilise for subsequent infection cohorts (if numbers per cohort are
large), which will give an indication that this stage has been reached. Unfortunately, the AIDS
dataset used here covers a period prior to demonstrable i/p lid stability by infection cohort.
Results indicate that as the year of transfusion recedes, the resultant lid approximates more
closely to log-normality; a wider range of i/p's has been observed for the early transfusion years;
(r\
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the effect of left censoring appears to be less severe than that of right censoring; and i/p range
stability in any pair of sequential years is not yet demonstrable. It is therefore impossible to say
whether the theoretical maximum possible i/p has been observed.
Therefore, due to censoring, the dataset is virtually certain to be incomplete, and highly unlikely
to be representative of the full i/p fld. Although this dataset gives an i/p f7d which is less right
skewed than is compatible with log-normality, it is not possible to verify, or refute, the hypothesis
that the complete i/p f/d is a log-normal curve, or any other particular type of fld. The range may
well be incomplete.
5.2.3 Mean Incubation Period: com parison of back-calculation with direct estimates.
Taking into account the effect of censoring dramatically increases the estimated mean and
maximum i/p, particularly if assuming a log-normal f/d. The main difference in the three fYd's is
in the frequency and extent of cases in the right 'tail'. For the model illustrated here, if Sartwell's
hypothesis is correct, infection with HIV means a lifetime at risk of AIDS.
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CHAPTER 6
SHEEP: DATA ANALYSIS AND DISCUSSION: Natural and experimental
TSE/prion disease.
6. Summary.
6.1 Natural scrapie in sheep.
6.1.1 Data from Parry (1962).
6.1.2 Data from Wooldridge (1991).
6.1.3 Data from VIDA.
6.1.4 Data from general literature search.
6.1.4.1 Analysis of age at onset for full dataset.
6.1.4.2 Analysis of age at onset by exposure status of dam.
6.1.4.3 Analysis of incubation period.
6.2 Experimental TSE in sheep.
6 2.1. Full experimental dataset.
6.2.1.1 Analysis of incubation period.
6.2.1.2 Variables within the full experimental data set; analysis of variance
(ANOVA).
62.2 Subgroup 1: Experimental CNS inoculation of CNS tissue.
6.2.2.1 Analysis of incubation period.
6.2.2.2 Variables within subgroup 1; further analysis.
6 2.3 Subgroup 2: Infection by sub-cutaneous inoculation.
6.2.3.1 Analysis of incubation period.
6.2.3.2 Variables within subgroup 2; analysis of dose.
6.3 Discussion.
6 3.1 Age at onset and incubation period frequency distribution analysis findings.
6.3.1.1 Natural cases.
6.3.1.2 Experimental cases.
6.3.2 Effect of variables
6.3.2.1 Natural cases
6.3.2.1 Experimental cases
6.3.3 Culling.
6.3.4 Comparison with SartwelPs conclusions.
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CHAPTER 6
SHEEP: DATA ANALYSIS AND DISC(JSSION
Natural and experimental TSE/prion disease.
Summary.
In the absence of heavy culling or data truncation, and in
the presence of good flock observation and recording,
natural scrapie age at onset (a/o) frequency distribution
(fld) may have a very elongated right skew, more extreme
than that of log-normality, but this is rarely observed in
practice. Without a test for infection, it is impossible to be
certain that an exposed sheep will not succumb to disease,
whatever its age. Culling is likely to seriously affect only the
right extremity of the f/d, but in doing so may reduce the
observed right skewness.
From both the a/o and incubation period (up) datasets,
there is some indication that sample size is associated with
the observed f/d; smaller datasets may tend to be less right
skewed than larger sets.
Examination of variables in experimental TSE indicates
that passage status, preceding donor species, infection
route, and infecting substance affect mean i/p. The i/p f/d of
the full experimental dataset is very unlike any other f/d, for
either i/p or a/o; however, if the modal values for the
subcutaneous (s/c) and CNS inoculated cases of scrapie are
aligned, there is an approximation to a/o f/d of the natural
disease. For CNS inoculated cases, i/p f/d has a right skew
too extreme for log-normality.
Whilst findings broadly agree with those of Sartwell,
interpretation and conclusions differ. For natural or
experimental scrapie, log-normal i/p f/d cannot be assumed;
the underlying i/p f/d may be considerably more right
skewed than that, although not necessarily the observed f/d.
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6.1 Natural Scrap ie in Sheep.
6.1.1 Data from Parry
 (1962).
The histogram of the alo f/d (in months) is shown by sex (figure 6.1.1). (See appendix 10 for all
sheep data source and categorisation details, unless otherwise indicated).
Figur. 6.1.1 Natural sheep scrape; Parry (1962) data; ala fid by sex.
Both male and female data appears right skewed. For analysis results see tables 6.1.1(i) and
6.1.1(u).
Natural
Female	 930	 42.0
Male	 78	 36.2
I' Sheppard's correction applied]
1962): a/o data
SD* Range Mode Median
	
13.7	 21-123	 39	 39
	
8.9	 15-63	 33	 33
Females have a mean a/o at 3-4 years but a maximum of over ten years. For males, mean a/o at
just over 3 years is less than that for females (P <0.001, non-parametric test) and maximum
recorded age is just over 5 years. Sample sizes for males and females are very different.
Table 6.1.1(u) Natural sh
Subgroup	 N	 F/d under
analysis
Females	 930 Normality
Males	 78
Females	 930	 Log-
Males	 78	 normality
scrapie (data from Par
	
CC	 C/vat
P=o.05
	0.9 0	 .998
	
0.990	 .984
	
0.972	 .998
	
0.990	 .984
1962): f/d
C/s
2.366
0.498
1.143
-0433
For females, f/d is incompatible with both normality and log-normality; both distributions are
highly skewed to the right. Conversely, for males neither the hypothesis of normality nor log-
normality can be rejected.
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6.1.2 Data from Wooldridge (1991).
The histogram of a/o fld for the 1334 cases (not shown) has an obvious right skew. The modal
a/o, at 2 years (24-35 months) is veiy marked, and less than Pany's whole set modal a/o of 39
months. F/d analysis results are given in table 6.1.2.
Table 6.1.2 Natural sheep scrapie (Vooldridge, 1991); fld analysis.
N	 F/dunder	 CC	 C/v at P=	C/s	 Pforc/s
analysis	 0.05
1334	 Normality	 .987	 .999	 0.807	 <0.001
1334 Log-normality	.999	 .999	 0.027	 0.686
The hypothesis of normality is rejected, a right skew being present. However, f/d is compatible
with log-normality; log-transformed data has no marked skew.
6.1.3 Data from YLDA.
Figure 6.1.3 shows the histogram of the a/o fld (in years) for 2361 cases.
Figure 6.1.3 Natural sheep scrapie; VIDA data; a/o fid.
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A smoothly curved right skew is apparent. The mode is at 3 years, and cases are still being
recorded at 10 years, veiy close to the maximum age to which any sheep are likely to be kept.
A/o data (in years) for the 2361 cases:-
Mean:	 3.43
SD:	 1.33
Range:	 1-10
Mode:	 3
Median:	 3
F/d analyses are given in table 6.1.3.
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N
2361
2361
C/v at 1-
0.05
.999
.999
Table 6.1.3 Natural sh
F/d under	 CC
analysis
Normality	 0.979
)g-normalitv	 0.998
lid analysrs.
C/s	 Pforc/s
	1.093	 <0001
	
-0.054	 0.280
The hypothesis of normality is rejected; there is a marked right skew. Log-transformation of the
data results in an insignificant skew, although data just fails to be compatible with log-normality.
However, with large samples a small deviation may become significant.
6.1.4 Data from general literature search (GLS).
6.1.4.1 Analysis of age at onset for full dataset.
The histogram of a/o f/d (in months) for 'smoothed' data (see appendix 10 for smoothing method)
for 107 cases is shown (figure 6.1.4.1).
Figur. 6.1.4.1 Natural sheep scrapie; GLS data; aio lid.
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The histogram is not symmetrical, and appears to be right skewed. A/o data (in months) for the
107 cases:-
Mean:	 48.0
SD:	 21.1
Range:	 15-117
Modal region: 39-45
Median:	 43
AJo lid analysis results are given in table 6.1.4.1.
Table 6.1.4.1 Natural scrapie in sheep
N	 FId under	 CC	 C/v at
analysis	 0.05
107	 Normal	 0.949	 0 987
107 Log-normal	 0.989	 0 987
fid an
C/s
	 P for c/s
1.147	 <0.001
0.015
	
0.948
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The a/o fYd is incompatible with normality but compatible with log-normality. (Results and
conclusions are similar for unsmoothed data, not shown).
6.1.4.2 Analysis of age at onset by exposure status of dam.
'Smoothed' a/o data by 'pregcode' status (see appendix 10 for definition of 'pregcode' categories) is
given in table 6.1.4.2(i).
Table 6.1.4.2(i) Natural sheep scrapie (GLS); sb data (in months)
by exposure status (pregcode) of dam.
Status of darn	 N Mean sb	 SD	 Range Modal Median
Pregcode = 1	 55	 38.3	 14.9	 15-102	 14-44	 37
Pregcode = 0	 52	 58.3	 21.9	 27-117	 39-45	 50
For 'pregcode = 1', mean a/o is 20 months less than that for 'pregcode = 0' (P <0.001, non-
parametric test). There is also a difference in modal regions by pregcode. The histogram (not
shown) indicates an extended right skew for both groups. A/o fYd analysis results are given in
table 6.1.4.2(u).
Table 6.1.4.2(u). Natural sheep scrapie (GLS); a/o f/d by C
Status of	 N FId under	 CC	 C/v at P=
dam	 analysis	 0.05
Pregcode = 1	 55	 Normal	 0.938	 0.978
Pregcode = 0	 52	 0.949	 0.977
Pregcode = 1	 55	 Log-	 0.984	 0.978
Pregcode =0 52
	
normal	 0.976	 0.977
re status of dam.
C/s	 Pfor c/s
	1.62 	 <0.001
	
0.818	 0.015
	
-0.143	 0.633
	
0.356	 0.254
For both groups the hypothesis of normality is rejected; c/s is large and positive. The hypothesis
of log-normality is rejected only for 'pregcode = 0', although log-transformation of data results in
an insignificant skew for both groups.
6.1.4.3 Analysis of incubation period.
The histogram of 'maximum lip' (see appendix 10 for definition) lYd (in months) for 11 cases is
shown (figure 6.1.4.3(a)).
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FIgix. 6.1.4.3(a). Natural sh..p scrapie; GLS data; maximum I/p s f/d.
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A left skew is apparent but small sample size makes interpretation difficult. 'Maximum up' data
(in months):-
Mean:	 48.4
SD:	 14.1
Range:	 15-62
Modal region:	 52
Median:	 46
The two cases with maternal exposure recorded (marked D in the histogram) had by far the
shortest 'maximum' i/p's (and a/o's) of 15 and 26 months. The relationship between age at first
recorded exposure and 'maximum i/p' is plotted in figure 6.1.4.3(b).
Figur. 6.1.4.3(b). Natural sheep scrapie; GLS data; 'maximum up' by age at
let recorded exposure.
The two cases exposed from birth had a shorter 'maximum' i/p (mean: 20.5 months) than cases
exposed when older (mean: 49.7 months). However, the relationship is not obviously linear, and
numbers are small. 'Maximum up' Lid analysis results are given in table 6.1.4.3.
Table 6.1.4.3. Natural sheep
I N F/d under	 CC
11	 Normal	 0.968
11 Log-normal	 0.903
(GLS); 'maximum Up' lid analy
C/vat	 C/s	 Pfor
P= 0.05	 c/s
0.940	 -0.796	 0.154
0.940	 -1 497	 0.012
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In agreement with the graph, analysis gives a negative coefficient of skewness, although numbers
are small and it is not possible to reject the hypothesis of normality. However, the hypothesis of
log-normality is rejected; log-transformation of the data gives a marked left skew.
Ten cases with recorded exposure also had recorded a/a. In most flocks, age at exposure would
not be known, therefore overall mean alo (72.5 months; SD 30.5) would be the relevant statistic.
Here, however, the two cases with exposure from birth have a/o 's below 30 months (mean: 20.5,
SD 15.0). The remainder were not exposed until after this age, and have a mean a/o of 85.5
months (SD 15.0).
6.2 Experimental TSE in sheep.
6.2.1 Full experimental dataset.
6.2.1.1 Analysis of incubation period.
I/p data (in months) for the total 477 cases:-
Mean up:
	 20.0
SD:	 12.7
Range:	 4-57
Mode:	 8
Median:	 17
The i/p fid histogram (in months) is shown (figure 6.2.1.1).
Figure 6.2.1.1 Experimental TSE in sheep; fuN dataset; i/p fld.
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Alter a rapidly attained modal region, there is an extensive relatively high frequency, uneven
nght tail. The i/p f/d analysis results are given in table 6.2.1.1.
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Table 6.2.1.1 Experimental TSE in sheep; full dataset; i/p f/d analysis.
N	 F/d under	 CC	 C/v at P=	 C/s	 P for c/s
analysis	 0.05
447	 Normal	 .966	 .997	 0.682	 <0.001
447 Log-normal	 .984	 .997	 -0.200	 0.082
Data is incompatible with normality, having a marked right skew. Although the log-transformed
data is not statistically significantly skewed, CC is less than C/v, possibly due to kurtosis;
therefore the dataset is also incompatible with log-normality.
6.2.1.2 Variables within the full experimental data set; analysis of variance (ANOVA).
Stratification by variables recorded reduces each stratum to a very small number, therefore further
analysis uses ANOVA. After preliminary analyses (results not shown) four factors, passage
status, preceding donor, route of infection, and infecting substance are analysed. Two cases from
monkey donors, and three cases derived from dam inoculation are omitted; they can not
reasonably be grouped with anything else. The final dataset comprises 442 cases, grouped as
follows:-
Preceding donor sheep (427), other ruminants (goats & cattle) (15)
Passage status: from natural case (256), from experimental case (186)
Infection route: CNS inoculation (119), s/c inoculation (98), other routes, including mixed
(225).
Infecting substance: CNS (274), CNS + lymphoid mix (124), spleen (20), other tissues (24).
Log-transformation of i/p data is necessary to normalise residuals. Significance is attributed to
each of the factors. Results, table 6.2.1.2.
Table 6.2.1.2 Experimental TSE in sheep; full dataset; ANOVA results.
Variable Variable grouping 	 N	 F	 P	 Mean i/p
	 95% Cl
being	 (adj;
examined	 geometric)
Passage	 From natural case
	 256 99.91 <0.001	 27.0	 23.4-31.2
status	 Fromexperimentalcase	 186	 13.9	 11.8-16.4
Preceding	 Sheep	 427	 5.60	 0.018	 16.8	 15.5-18.2
donor	 Other ruminant	 15	 22.3	 17.0-29.1
Infection	 CNS inoculation	 119 75.78 <0.001
	 13.2	 11.4-15.4
route	 S/c inoculation	 98	 21.8	 18.2-26.0
Other routes/mixed	 225	 25.2	 2 1.8-29.3
Infecting	 CNS	 274	 14.36 <0.001	 14.7	 13.0-16.5
substance	 CNS + lymphoid: mix	 124	 18.1	 15.5-2 1.1
Spleen	 20	 19.1	 14.9-24.5
Other tissues	 24	 27.9	 22.2-35.2
There is no significant interaction between status and donor (F=0.05, P=0.832) or between status
and infection route (F=0.36, P = 0.70 1). Analysis of other interactions failed due to lack of data.
59
SHEEP: Data analysis & discussion.
Each factor examined appears to have a significant effect on the Up; an assumption of constancy
for each of the other factors gives differences in the mean (adjusted) i/ps as shown.
6.2.2. SubErou p 1: Experimental CNS inoculation of CNS tissue.
6.2.2.1 Analysi% of incubation period.
Details of i/p's (in months) for 77 cases:-
Mean Up:	 8.5
SD:	 5.7
Range:	 4-28
Mode:	 6
Median:	 6
The histogram of i/p f/d is shown (figure 6.2.2.1) and Vd analysis results given in table 6.2.2.1.
Figure 6.2.2.1 Expetimental scrapie in sheep; subgroup 1; lIp f/d.
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A marked right skew is apparent, but the frequency drops sharply from the mode, hence the right
tail is of low frequency.
Table 6.2.2.1 Exi
N	 F/d under
analysis
77 Normal
77 Log-norma]
rimental scrapie in sheep;
CC	 C/vatP=
0.05
0.853	 0.983
0.95 1
	 0.983
up 1; i/p f/d analysis
C/s	 Pforc/s
2.008	 <0.001
1.167	 <0.001
The hypotheses of both normality and log-normality are rejected, the right skew persisting even
in tog-transformed data.
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6.2.2.2 Variables within subgroup 1; further analysis.
Variable: Passage status.
The i/p data (in months) by passage status is given in table 6.2.2.2.
Table 6.2.2.2 Experimental scrapie in sheep; subgroup 1;
i/p data (months) by passage status.
Passage status	 N Mean SD Range Mode Median
From natural case	 30	 10.3	 6.8	 5-26	 6	 7
From exnerimental case 	 47	 7.3	 4.6	 4-28	 4	 6
The mean i/p for cases infected directly from natural cases is longer than for those infected from
experimental cases (P=0.020; non-parametric test).
On the histogram (not shown) there is no obvious difference between the two groups; both appear
similar to complete subgroup 1. F/d analysis results (not shown) are also similar to subgroup 1;
although there is a difference in mean i/p. there is no difference in conclusions regarding the f/d.
Variable: Age at Infection.
Figure 6.2.2.2 plots i/p and age at infection (all in months) for 38 cases.
Figure 6.2.2.2 Experimental scrapie in sheep; subgroup 1; I/p by age at
vifacdon
7	 9	 11	 13	 15	 17
Ag at kit eclion (months)
Although difficult to see graphically, regression analysis indicates a slight reduction of i/p with
increasing age at infection, of 0.20 months per month (r = -0.32, F = 4.13, P = 0.050).
Removal of the outlier (at i/p = 18 months) gives a much reduced reduction of only 0.05 months
per month (r=-0.18, F=0.46; P=0.511), but based on the skewed pattern of i/p data in this and
other data sets, there is no biological rationale for removing this outlier. There is no reason to
assume that it is an erroneous result
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Variable: Sheep breeds.
For 25 cases where donor and case were recorded as the same breed, mean i/p was 7.5 months
(SD = 5.8), and for the 50 cases where they were not so recorded, mean i/p was 8.8 months (SD =
5.8) (P=0.028, non-parametric analysis). Although one way ANOVA using the reciprocal of the
i/p did not normalise the residuals, it gave the closest visual approximation (F=4.49, P= 0.038).
However, neither test is particularly appropriate, as both make the assumption that the
distributions are similar, which was not the case.
Analysis of variables: ANOVA
Earlier analyses indicated that age at infection (as a covariate), passage status and case-
breed/donor-breed combination might affect i/p. Multiway ANOVA was therefore attempted
using these variables, for 38 cases with the same dose and known age at infection. Using raw i/p
data, residuals were not normally distributed. Neither log-transformation, nor taking the
reciprocal of the i/p normalised the residuals; log-log transformation was slightly more
successful. In all cases the data gave no statistical significance to any variable.
Attempts to reclassi1' variables for further analysis were unsuccessful, tending to remove the
ability to discriminate between factors of interest. Interpretation of the above is therefore veiy
diflicult, incomplete data and small numbers being the main problems. Conclusions on the effect
of these variables have therefore not been reached.
6.2.3 Sub grou p 2: Infection by sub-cutaneous inoculation.
6.2.3.1 Analysis of incubation period.
Eighty-nine cases each receiving 2 mIs of brain extract are used in i/p lid analysis. The histogram
of the i/p l/d is shown (figure 6.2.3.1) and lid analysis results given in table 6.2.3.1.
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Figure 8.2.3.1 ExperImental scrapi. in sheep; subgroup 2(2 mIs of .xtr.ct);
i/p f/d.
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Inspection of the graph suggests a slight, but not pronounced, right skew.
Table 6.2.3.1 Experimental scrapie in sheep; subgroup 2 (2 mIs of extract); i/p f/d analysis.
N	 F/d under	 CC	 C/v at P	 C/s	 P for
analysis	 0.05
89	 Nonnal	 0.980	 0.985	 0.751	 0.005
89	 Log-normal	 0.986	 0.985	 -0.511	 0.044
Data is incompatible with normality but compatible with log-normality, although for the log-
transformed data the c/s is just within the boundary of left-skew statistical significance.
6.2.3.2 Variables within subgroup 2; analysis of dose.
I/p details (in months) for 97 cases by dose are given in table 6.2.3.2.
Table 6.2.3.2. Experimental scrapie in sheep; subgroup 2;
i/p data (in months) by volume of s/c inoculation.
Dosage (mIs) of	 N	 Mean SD Range Mode Median
brain extract	 i/p
2	 89	 11.1	 3.2	 4-24	 11	 11
4	 2	 9	 0.0	 -	 -	 -
10	 6	 6 8	 2.5	 4-11	 4	 6.5
Although the case numbers for doses of 4 and 10 mIs are small the mean i/ps suggest that as
dosage increases, i/p decreases. Figure 6.2.3.2 plots this relationship.
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Flgur. 6.2.3.2 Exp.rim.ntal scrapi. Ni sheep; subgroup 2; I/p by dos..
0	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10
Do,. Un mis)
Regression analysis gives a decrease in i/p with increasing dosage of 0.54 months per ml
(r = -0.32, F=10.93, P = 0001), but sample size for 2 ml is much greater than for 10 mis, and
the minimum i/p is the same in each case.
6.3 Discussion.
6.3.1 A2e at onset and incubation period frequency distribution anal ysis findin2s.
6.3.1.1 Natural cases.
Summaiy of f/d analysis results is given in table 6.3.1.1(i).
Table 6.3.1.1(i). Natural sheep scrapie; summary of f/d analyses.
Data set
	 Mo	 N	 FId com patible with:-	 Skew for.-
or	 Normality	 Log-	 Raw	 Logged
i/p	 normality	 data	 data
Party: females	 a/o 930	 No	 No	 R	 R
Party: males	 "	 78	 Yes	 Yes	 NS	 NS
Wooldridge	 1334	 No	 Yes	 R	 NS
VIDA	 ' 2361	 No	 No	 R	 NS
GLS: all cases	 '	 107	 No	 Yes	 R	 NS
GLS: pregcode =
	 55	 No	 Yes	 R	 NS
GLS: pregcode = 0
	
•	 52	 No	 No**	 R	 NS
GLS: known exposure i/p 	 11	 Yes	 No	 NS	 L
[Notes on table:- 1) Significance level for both f7d compatibility with normality and log-normality.
and significance of skew i at the P0.05 level.
2)" indicates CC is equal to, or within 0.001 of c/vJ
Table 6.3.1.1(u) describes the f/d for each dataset. The cull guide is a vezy approximate estimate
of how much culling (or artificial data truncation) is suspected, particularly regarding maximum
longevity of the flock or maximum age recorded. A high number of asterisks suggests early,
heavy culling or data truncation; no asterisks means no information is available.
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Table 6.3.1.1(u) Natural sheep scrapie; descripi ons of f/d.
Data set	 A/o	 Description
	 Cull
or
	 guide
Parry: females
Pariy: males
Wooldridge
VIDA
GLS: all cases
GLS: pregcode = 1
GLS: pregcode =0
GLS: known expos
a/o	 Right skew; incompatible with Iog-nonnality
"	 Compatible with normal and log-normal
N	 Compatible with log-normal
Incompatible with log-normal (skew compatible)
N	 Compatible with log-normal
Compatible with log-normal
N	 Incompatible with log-normal (skew compatible)
i/i,	 Left skew
**
Females comprise over 92% of Pariy's dataset. They are the dataset most representative of
'natural' life-span and they have vety marked right skew, more extensive than expected for log-
normality. Nevertheless even here, culling has occurred. For males, with early heavy culling,
right truncation is expected to reduce the right skew, and this is observed.
Wooldridge's data is automatically truncated at five years due to survey design. That this is less
right skewed than Pariy's females is not therefore surprising. A complete description of the right
tail would probably increase right skewness. Since this data was all collected at the end of the
survey period, unlike Parry's, reduction in modal a/o may reflect farmers recall bias, an effect of
grouping animals by management factors, i.e. as adults from 2 years.
For VIDA recording, there is no maximum age, therefore no artificial data censoring. However,
VIDA data is 'VIC submitted', more likely for males than females - and males generally suffer
earlier culling. This, plus other factors (e.g. value, atypical age) bias VIC submissions
(Wooldridge, 1991; Wooldridge et al, 1992). Therefore VIC cases may exclude the oldest
animals, thus reducing right skew. Compared with Parry's females, this is observed. Converting
VIDA data into months (i.e. x 12) gives a similar mean to Parry's full dataset, with a/o's of4l.2
and 41.6 months respectively. However, since Parry's data was recorded in 6 monthly intervals,
and VIDA data grouped annually, methods are not identical.
One conclusion from this is that in the absence of heavy culling or data truncation of the right
extremity of the f/d, and in the presence of good flock observation and recording (e.g. Parry's
females), observation of scrapie onset is possible well into a sheep's old age. In these
circumstances the a/o f/d may have a very elongated right skew, more extreme than that of log-
normality, but this appears to be rarely observed in practice.
For cases aggregated from the literature, no overall comments regarding culling are applicable,
although there is likely to be a reporting bias. Some cases, although 'naturally transmitted', were
observed on experimental farms, where conditions may be atypical.
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The small i/p dataset is left skewed; truncation of the right tail by culling or flock dispersal is
possible (Greig, 1940). However, there is a slight impression that sample size may be associated
with skewness. Only one of the large datasets is extremely right skewed, and only the smallest is
left skewed. Other datasets examined (both a/o and Lip) but not included in this thesis tend to
reinforce this impression.
6.3.1.2 Experimental cases.
Summary of i/p f/d analysis results are given in table 6.3.1.2(i)
	
Table 6.3.1.2(i). Expet	 TSE in sheen: summ
Data set
	
N
	
FId com patible with:-
Normality	 Log-
Full set
	
447	 No	 No
Subgroup 1	 77	 No	 No
Subgroup 2	 89	 No	 Yes**
[Notes on table:- 1) Significance level for both f7d compatibility with normi
and significance of skew is at the P=0.05 level
2) indicates CC is equal to, or within 0.001 of dv]
Table 6.3.1.2(u) describes the fYd for each dataset.
01 lid analyses.
Skew for:-
Raw	 Logged
data	 data
R	 NS
R	 R
R	 L
Table 6.3.1.
Data set
Full set
Subgroup 1
Subgroup 2
TSE in sheep: descriptions of lid.
Incompatible with log-normal (skew compatible)
Right skew too elongated even for log-normality
Skew borderline between normal and log-normal
Most work was published before the mid-seventies. Greater danger of cross-contamination was
possible in early work, since the scrapie agent's extreme resistance to inactivation became
apparent only gradually.
Provided all animals in a given experiment are observed from infection to disease or death,
culling should not be relevant, although a high incidence of death from other causes would have a
similar effect. In fact there was evidence of this in one experiment (Dickinson et al, 1968) where
i/c inoculation resulted in high death rates due to bacterial contamination. It is likely that all
experimental animals were subjected to better observation and recording than the average flock,
although not necessarily better than Parry's flocks.
In the natural TSE disease situation, for any particular case where infection is suspected, the
specific infection source is usually unknown (for scrapie, it is usually assumed to be sheep but
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other possibilities have not been disproven; for example goats, bovines, environmental, or other
unsuspected sources). Infection route is also generally undetermined, although often assumed to
be peripheral. The possibility of de novo spontaneous generation of agent in the brain is not
disproven, and i/p may then approximate roughly to experimental CNS inoculation of agent. The
proportions of natural cases due to each of these potential aetiologies is unknown. There is thus
no legitimate reason for differentiating between experimental subsets in the first analysis.
However, the i/p lid of the full dataset is veiy unlike any other lid, either i/p or a/o, due to the
high variable frequencies in the extensive right tail. It appears unlikely that this particular
composite is a close reflection of any natural scrapie situation. Since the proportion infected
intracerebrally, and the proportion infected by CNS tissue were high, lack of overall similarity to
the findings in any natural scrapie disease situation is not surprising.
For subgroup 1 (CNS to CNS transmission), i/p lid is too right skewed for compatibility even
with log-normality, stratification by passage status giving similar results. This extensive skew
implies that even when the TSE aetiological agent is introduced directly into the CNS, there is
still extensive variation in the subsequent time to disease onset, despite the marked, rapidly
attained modal i/p. Clearly, other variables are involved (perhaps particularly genotype). This
suggests that by whatever route natural transmission occurs, once the agent reaches the CNS (or
in some cases is perhaps spontaneously generated de novo in the CNS) a variable, and
occasionally very lengthy i/p is still possible.
For s/c inoculation, a peripheral route perhaps more comparable to natural transmission (which
might be via wounds, mucous membranes, cornea, naso-phaxyngeal, or alimentary systems) the
i/p lid is less right skewed than that for CNS inoculation. It appears to lie between normal and
log-normal distributions. Inspection of the histogram suggests that this is at least partly due to the
longer duration and wider distribution of i/p values prior to the modal i/p, as compared with i/c
inoculation. Again other sources of variation are involved, as they would be in the natural
situation.
Peripheral transmission routes may therefore result in a wide variety of possible time intervals
before the agent reaches the CNS, perhaps associated more with the particular entry point rather
than genotype. If this variability in time taken for the agent to reach the CNS is superimposed
upon the wide variety of possible times to disease once the agent is in the CNS (which as has been
seen is right-skewed more extensively than log-normal), the result will be an even wider range of
possible i/ps, reflected in a wide range for alo, even if all infection occurs at the same age.
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Looking back to the full experimental dataset, the modal region of the CNS to CNS inoculated
cases can be identified, in advance of other transmission combinations. One possible hypothesis
is that if the modal values for the s/c and CNS inoculated cases are aligned, the overall lid
corresponds more closely to the observed l/d in a natural disease situation. Here the assumption
is that the majority of CNS inoculated cases would have taken on average an additional 5 months
(the difference in modal values), to reach their modal value if they had been peripheral
inoculations (perhaps the more probable natural transmission route), although a proportion may
be considered to represent the possibility of de novo agent generation in the CNS. Figure 6.3.1.2
illustrates this manoeuvre.
Figui-. 6.3.1.2 Experimental scrapie in sheep; CNS and s/c inoculation:
superimposition of modal point.
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There is an approximation to a/o lid of the natural disease situation, although the artificial
composite i/p mode, at 11 months, is much shorter than the natural alo mode, generally at 3-4
years. One possible explanation would be that natural infection (whatever the route) is less
efficient in terms of reaching the brain than s/c inoculation experimentally; another that natural
infection occurs on average at 2 years of age.
The veiy great differences in experimental conditions preclude any meaningful comment on
association between sample size and skew.
6.3.2 Effect of variables.
6.3.2.1 Natural cases.
The only additional variables which could be analysed for the natural cases were connected with
probable age at exposure. Recorded exposure of the dam to scrapie reduces both mean a/o and
mean i/p by about 20 months (see 6.1.4.2 and 6.1.4.3). Although numbers are small, figure
6.1.4.3(b) suggests a plateau for effect of exposure age on i/p. If all cases are transmission-
induced, maternal contact cases possibly receive higher doses (i.e. from dam plus pasture), or are
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infected pre-natally, and incubating at birth. Alternatively neonates may be more susceptible,
contracting infection earlier in the exposure period; or once infected, pathological processes in
neonates may evolve more rapidly, connected with immune system immaturity.
If there is an interaction between age at first exposure and subsequent lip, then one also exists
between a/o and length of preceding Lip, and hence time of infection. Unfortunately, no firm
conclusions can be reached with such small numbers.
6.3.2.2 Experimental cases.
Examination of variables within the full dataset indicate that passage status, preceding donor,
infection route, and infecting substance may have significant effects on mean lip, although
confounding by other variables is possible.
Within subgroup 1, passage status appears to affect mean lip, perhaps due to confounding;
perhaps because experimental passage in some way increases agent pathogenicity under certain
circumstances. Results for age at infection, and breed combinations are somewhat equivocal. The
effect of dose in shortening i/p (subgroup 2) appears more clear-cut, but with such a sample size
disparity, the range of possible values in animals given 2 mIs would be expected to be much
greater, particularly in the longer iíp end of the 2 ml i/p f/d, as a right skew might be expected.
The plot appearance tends to support this hypothesis, and may exaggerate any dose effect.
6.3.3 CulIin.
Natural case data suggests culling is likely to reduce the a/o fid right skew for observed scrapie in
sheep. Anecdotal information is available on sheep culling, but numerical estimates are rare.
An average culling pattern can be estimated for the breeding flock up to five years of age based
on a scrapie survey by Wooldridge (1991), and case numbers adjusted appropriately (see appendix
20). Dickinson (1976) plots a/o fld in scrapie in Suffolk sheep, corrected for culling (method
unknown), as proportions of scrapie cases by aio in months. Figure 6.3.3 compares these,
Wooldridge (1991) adjusted cases being converted to proportions by age, the a/o having been
taken as the mid-point of each year of age, and converted to months.
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Figure 6.3.3 Natural sh.ep sapi.; aIo f/d as percentag. of cases by ag•,
corr.cted for culling
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Both estimates give a modal a/o at 3 to 4 years, the earliest a/o at 18 months, and a marked
frequency reduction at around 54 months, although somewhat less for Wooldridge's data.
Dickinson shows a sizeable (and incomplete) continuation of the tail beyond nine years, giving a
coefficient of skewness of 1.143 for the 'truncated' graph. However, although scrapie cases may
occur in older sheep, they appear to be much less likely after about 4-5 years of age. In
conclusion, culling is likely to seriously affect only the right extremity of the f/d, but in doing so,
may reduce the observed f/d right skewness.
6.3.4 Com panson with Sartwell's Conclusions.
For experimental TSE's in sheep, an i/p l/d with right skew too extreme for log-normality occurs
in all 3 subgroup 1 datasets. Sartwell also noted the extreme right skew of some experimental
datasets.
For a/o f/d of natural disease, this extreme right skew is also possible, as demonstrated by Pariy's
carefully recorded data. Incomplete case ascertainment, particularly of older cases, by culling,
underestimating age for older animals, or biases in the data collected, may reduce observed skew
such that fld is frequently compatible with log-normality. However, although in an endemically
infected flock all sheep may be exposed from soon after birth, the actual time of infection is
unknown, making interpretation difficult. Nevertheless, an i/p fld of log-normality cannot be
assumed; it is possible that the underlying i/p lId is actually considerably more skewed than that.
Whilst these findings broadly agree with those of Sartwell, the interpretation and conclusions
differ.
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CHAPTER 7
GOATS: DATA ANALYSIS AND DISCUSSION: Natural and experimental
TSE/prion disease.
7. Summary.
7.1 Natural scrapie in goats.
7.1.1 Data from general literature search.
7.1.1.1 Analysis of age at onset for full dataset.
7.1.1.2 Analysis of age at onset by contact status.
7.1.1.3 Analysis of age at onset by age at last recorded exposure.
7.1.2 Data from VIDA.
7.2 Experimental TSE in goats.
7.2.1 Full experimental dataset.
7.2.1.1 Analysis of incubation period.
7.2.1.2 Variables within the full experimental data set; analysis of variance
(ANOVA).
7.2.2 Subgroup 1: Experimental CNS inoculation of CNS tissue.
7.2.2.1 Analysis of incubation period.
7.2.2.2 Variables within subgroup 1; further analysis.
7.2.3 Subgroup 2: Cases with a plausible 'natural' infection route.
7.2.4 Subgroup 3: Cases infected directly from natural sheep scrapie.
7.3 Discussion.
7 3.1 Age at onset and incubation period frequency distribution analysis findings.
7.3.1.1 Natural cases.
7.3.1.2 Experimental cases.
7.3.1.3 Comparison of natural age at onset and experimental incubation
period frequency distribution.
7.3.2 Effect of variables.
7.3.2.1 Natural cases.
7.3.2.2 Experimental cases.
7.3.3 Comparison with Sartwell's conclusions.
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CHAPTER 7
GOATS: DATA ANALYSIS AND DISCUSSION
Natural and experimental TSElprion disease.
Summary.
As for sheep, natural scrapie onset is possible well into a
goat's old age; the age at onset (aio) frequency distribution
(f/d) may again have a very elongated right skew, more
extreme than that of log-normality. Also as for sheep, there
is an indication that sample size is associated with the
observed f/d, with smaller datasets tending to be less right
skewed than larger sets.
Similar conclusions are reached for the incubation period
(lip) fld for experimental data. Examination of variables in
experimental data indicate that, as for sheep, passage
status, preceding donor, infection route and infecting
substance effect mean lip; age at infection, to 9 months of
age, does not. Reduction of agent dose results in an i/p
increase.
Overall, conclusions reached are therefore similar to those
for sheep. Sartwell's hypothesis of underlying log-normality
for i/p f/d is not confirmed; the underlying i/p f/d may be
considerably more right skewed than that.
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7.1 Natural scrapie in goats.
7.1.1 Data from 2eneral literature search.
7.1.1.1 Analysis of age at onset for full dataset.
The a/o data (in months) for the 66 cases is as follows (see appendix 10 for all goat data source
and categorisation details, unless otherwise indicated):-
Mean:	 45.6
SD:	 15.8
Range:	 24-113
Mode:	 42
Median:	 42
There was no statistically significant difference in mean a/o by sex (P= 0.857, non-parametric
test). The histogram of the a/o l/d (in months) for the 66 cases is shown (figure 7.1.1.1).
Figure 7.1.1.1. Natural goat scrapie; GIS data; alo t/d.
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An extensive marked right skew is apparent. The lid analysis is given in table 7.1.1.1
Table 7.1.1.1 Natural
N	 F/d under	 CC
66	 Normality	 0.865
66 Log-normality	0.948
apie (GLS); f/d analysis.
C/v at P=	C/s	 P for c/s
0.05
	0.98 	 2.267	 <0.001
	
0.980	 1.106	 0.001
Both the hypotheses of normality and log normality are rejected. There is a significant right skew
even for log-transformed data.
7.1.1.2 Analysis of age at onset by contact status.
The a/o data (in months) by contact status given in table 7.1.1.2(a).
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Table 7.1.2.2(i) Natural	 scrapie (GLS);
Contact status	 N	 Mean a/o SD Range Mode Mcdi
Dam scrapie +ve	 15	 41.9
	 5.3	 33-51	 39	 41
Flock/herd scranie +ve	 36	 45.8
	
17.3 24-1 13	 42	 42
There is no statistically significant difference in the mean a/o (P = 0.589 non-parametric test) by
contact status, but ranges are different (see figure 7.1.1.2).
FIgurs 7.1.1.2 Natural goat scrapis; GLS data; a/o fid by contact status
recorded.
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For dam-positive cases, a very small dataset, the fYd appears almost symmetrical whereas for
flock/herd contact, it appears right skewed. The a/o fYd analyses are given in table 7.1.1 .2(u).
Table 7.1.1.2(u) Natural goat scrap
Contact status N F/d under	 CC
Dam +ve	 15 Normality	 0.989
Flock/herd +ve 36	 N	 0.855
Dam +ve	 15	 Log-	 0.990
Flock/herd +ve 36	 nonnality	0.939
); a/ofldl
C/v at P=
0.05
0.938
0.949
0.938
0.949
contact status.
C/s	 Pforc/s
	0.14 	 0.769
	
2.228	 <0.001
	
-0.395	 0.427
	
1.007	 0.012
For flock/herd-positive cases, the hypotheses of both normality and log-normality are rejected,
with a right skew too elongated even for log-normality. Conversely, for dam-positive cases,
neither hypotheses are rejected, and there is no marked skew.
7.1.1.3 Analysis of age at onset by age at last recorded exposure.
The relationship between a/o and maximum age of known exposure (in months) is plotted in
figure 7.1.1.3.
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Figur. 7.1.1.3 Natural goat .ciapie; GLS data; alo by maximem eg. of
.xposur..
Regression analysis gives an additional 0.8 months at alo per month of possible additional
exposure (r 0.97, F= 105.27, P=0.000), with an apparent a/o clustering (mean 45.1 months,
range 39-52) for the seven animals removed from exposure by ten months of age.
7.1.2 Data from 'IDA.
A right skew is apparent on the histogram of the 28 cases (not shown). The a/o data (in years),
for the 28 cases:-
Mean:	 4.25
SD:	 1.8
R2nge:	 3-11
Mode:	 3
Median:	 4
The alo lid analysis is given in table 7.1.2.
Table 7.1.2 Natural go
N	 F/d under	 CC
analysis
28	 Normality	 0.926
28 Log-normality	0.985
pie (VIDA); a/o l/d analysis.
C/v at P=	C/s	 P for c/s
0.05
	
0.963	 2.106	 <0.001
	
0.963	 1.188	 0.008
The lid is incompatible with the hypothesis of normality; there is a marked right skew. However,
it is compatible with log-normality, although log-transformation of the data does not remove the
asymmetry.
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7.2 Experimental TSE in 2oats.
7.2.1 Full experimental dataset.
7.2.1.1 Analysis of incubation period.
The i/p data (in months) for the total of 400 cases:-
Mean lip:	 14.4
SD:	 8.0
Range:	 7-59
Mode:	 8-10
Median:	 12
There was no difference in mean i/p by sex (P=0.432, non-parametric test). The histogram of the
i/p l/d (in months) is shown (figure 7.2.1.1).
Fsgur. 7.2.1.1 Experimental TSE in goats; ful datasst lip fid.
Alter rapidly reaching the mode, the f/d has a vexy extended right skew. The i/p f7d analysis
results are given in table 7.2.1.1.
tal TSE in goats; full d
	
CC	 C/v at P=
0.05
	
0.866	 0.995
	
0.970	 0.995
set; i/p f/d analysis.
	
C/s	 P fort/s
	2. 76	 <0.00 1
	
1.042	 <0.001
Both the hypothesis of normality and log-normality can be rejected. Right skew is more extended
than expected from log-normally distributed data.
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7.2.1.2 Variables within the full experimental dataset; analysis of variance (ANOVA).
Stratification by variables recorded reduces each stratum to a veiy small number, as for sheep,
therefore further analysis uses ANOVA. After preliminaiy analyses (results not shown), four
factors (passage status, preceding donor, route of infection, and infecting substance) were used in
the analysis. Twelve cases with an unknown infection route were omitted. The final dataset
comprises 388 cases, grouped somewhat differently to sheep, as follows:-
Passage status: from natural case (21), from experimental case (367).
Preceding donor goat ( 258), sheep and goat mixed (18), other ruminants (sheep or cattle) (29),
unknown (but known to be either sheep or goats) (70), non-ruminants (13).
Infection route: CNS inoculation (361), s/c inoculation (27).
Infecting substance: CNS (337), any one of CSF, adrenal, sciatic nerve or spleen (39), any other
tissue (12).
The i/p reciprocal was used, in order to normalise residuals (Kirkwood, 1988). Each factor was
independently significant. Results are given in table 7.2.1.2.
Table 7.2.1.2 Experimental TSE in goats; full dataset; ANOVA results.
Variable Variable grouping 	 N	 F	 P	 Mean 95% CI
being	 i/p
examined	 (adj)
Passage	 From natural case	 21	 6.72	 0.010	 31.2	 22. 1-52.7
status	 From experimental case	 367	 20.6	 17.9-24.3
Preceding Goat	 258	 18.24 <0.001	 16.1	 14.1-18.9
donor	 Sheep & goat mixed	 18	 28.4	 20.2-47.4
Sheep or cattle	 29	 42.5	 28.8-81.7
	
U/k (but either sheep or goat) 70	 18.5	 15.4-23.2
Non-ruminants	 13	 37.2	 22.8-100.2
Infection	 Inoculation into CNS	 361	 15.71 <0.001	 19.1	 16.5-22.9
route	 S/c (or i/d) inoculation	 27	 35.2	 24.9-60.2
Infecting	 CNS	 337	 12.90 <0.001	 18.4	 16.4-21.0
substance CSF/adrenal/nervelspleen	 39	 22.7	 18.5-29.2
Other tissues	 12	 44.4	 25.7-165.7
There is no strong evidence of interaction between passage status and infecting substance
(F=1.13, P=0.324) or passage status and infection route (F=1.77, P0.185); analysis of other
interactions failed due to insufficient data.
Each factor examined appears to have an independent effect on up; the assumption of constancy
for each of the other factors gives differences in mean (adjusted) i/ps as shown. However, there is
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wide variation in variance, reflected in differences for CI ranges. ANOVA assumes variances are
similar so the validity of the test is reduced and the interpretation of results difficult.
7.2.2 Sub grou p 1: Experimental CNS inoculation of CNS tissue.
7.2.2.1 Analysis of incubation period.
The i/p f/d data (in months) for 201 cases:-
Mean Up:	 11.2
SD:	 3.7
Range:	 7-30
Mode:	 8
Median:	 10
The i/p histogram (not shown) is similar to that for the full set, although the right tail is less
extensive. The L/d analysis results are given in table 7.2.2.1.
Table 7.2.2.1 Experimental sci
N	 F/d under	 CC
201	 Normality	 0.916
201	 Lo-normalitv	 0.982
in goats; subgroup 1; i/p f/d analysis
	
C/v at P	 C/s	 P for c/s
0.05
	
0.991	 2.080	 <0.001
	
0.991	 0.875	 <0.001
The hypotheses of normality and log-normality are both rejected. The right skew is greater than
expected from a log-normal distribution.
7.2.2.2 Variables within subgroup 1; further analysis.
Passage number.
The i/p data (in months) by passage number is given in table 7.2.2.2.
Table 7.2.2.2 Experimental scrapie in goats; subgroup 1;
i/p (in months) by passage number.
Passage	 Donor.	 N Mean SD	 Range (or Mode
number	 species	 i/p	 values)
2
	
Goat	 31	 12.7	 3.6	 7-21	 14
3
	
N	 7	 9.9	 1.9	 7-12	 9
4
	
10	 10.3	 2.9	 7-16	 8
5
	
8	 9.5	 1.3	 8-11	 8
6
	
4	 9.3	 1.5	 8-11	 8
There is a decrease in mean i/p with passage number (P= 0.021, non-parametric test). Regression
analysis gives an average reduction of! month per passage (r-0.41, F1l.55, P0.001). Much
of this decrease appears to be from P2 to P3; removing P2 results in a statistically insignificant
reduction of 0.3 months per passage (r=-0.13, F =O.44, P=0.512).
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Age at Infection.
Figure 7.2.2.2 (a) plots the relationship of age at infection with i/p (in months) for 71 cases
FIgz. 7.2.2.2(a) Exp&imental scrapi. in goats; subgroup 1; l/p by ag. at
infection
1	 2	 3	 4	 5	 6	 7	 8	 9
Ag. at nf.clion (month.)
Regression analysis gives an insignificant decrease in mean i/p of 0.2 months per month as age
at infection increases (r = -0.15, F=1.64, P=0 205).
Dose - quantified as dilution of brain extract
Figure 7.2.2.2(b) plots the relationship of dose with i/p for 23 goats (smoothing was performed
by taking a three stage moving average).
Figur. 7.2.2.2(b) Experimental scrapi. In goat.: subgroup 1: I/p by do..
-
	
I:	 _________
- Smoothed v.I
	
7	 I	 I
I
	
5	 I	 I	 I	 I	 I	 I	 I
o	 0 0 0 0 0 0 0 0 0 0 0
NI NI N	 NI NI	 NI NI N
NI N 0 — N
	
N	 0
N	 NI
Dekition; 1 in -
The mean i/p per dose ranges from 8 months to 13 months, observed i/p's from 8 to 15 months.
There is an increase of mean i/p of 0.26 months per additional dilution (r=O.56, F3.17 P
0 090),
25
20
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a. 10
5
0
0
79
GOATS: Data analyali & discussion.
Other manipulations.
Formalin treatment (19 cases) increased the mean i/p to 12.5 months. Host pre-treatment with
CNS inoculation of normal goat brain 2.5 months before agent inoculation (15 cases) decreased
the mean i/p to 7.6 months (range 7-9; SD 0.63).
7.2.3 Subroup 2: Cases with a plausible 'natural' infection route.
The i/p data (in months) for 34 cases:-
Mean Up:	 27.5
SD:	 9.8
Range:	 11-49
Modal region: 21-34
Median:	 28
No marked skew is apparent from the histogram (not shown). There is an insignificant difference
between mean i/p's of the two infection routes, with 27.0 (SD 10.5) and 29.4 (SD1O.5) months
for s/c and oral routes respectively (P=
 0.898, non-parametric test). I/p fld analysis: table 7.2.3.
Table 7.2.3 Expe'
N	 F/dunder
analysis
34	 Normality
34	 Log-normali
ii TSE in goats; subg
CC	 C/vatP
0.05
0.983	 0.972
0.974	 0.972
; i/p (Id analysis.
C/s	 P (or c/s
	0. 3 	 0.364
	
-0.613	 0.108
Neither the hypothesis of normality, nor that of log-normality can be rejected. There is no marked
skew in either raw or log-transformed data.
7.2.4 Sub2roup 3: Cases infected directly from natural sheep scrapie.
The i/p data (in months) for the 14 cases:-
Mean l/p:
	
36.4
SD:	 10.9
Range:	 23-59
Mode:	 34
Median:	 34
The histogram (not shown) suggests the possibility of a right skew, but numbers are small. The
fid analysis results are given in table 7.2.4.
Table 7.2.4 xperir
N	 F/dunder
14	 Normality
14	 Log-normali
scrapie in goats; subgroup 3; i/p fld
CC	 C/v at P=	 C/s
	0.9 8	 0.938	 0.864
	
0.974	 0.938	 0 499
P for
c/s
0.102
0.330
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Neither the hypothesis of nonnality, nor that of log-normality can be rejected. The right skew is
not statistically significant.
7.3 Discussion
7.3.1 A2e at onset and incubation period frequency distribution anal ysis findin25.
7.3.1.1 Natural cases.
A sununaiy of a/o Lid analyses results is given in table 7.3.1.1(i).
Table 7.3.1.1(i) Natural goat scrapie; summary of lid analyses.
Dataset	 N	 FId compatible with:-	 Skew for-
Normality	 Log-	 Raw	 Logged
normality	 data	 data
GLS:allcases	 66	 No	 No	 R	 R
GLS: dam scrapie +ve	 15	 Yes	 Yes	 NS	 NS
GLS: flock/herd scrapie +ve 36	 No	 No	 R	 R
VIDA	 28	 No	 Yes	 R	 R
[Notes on table:- Significance levd of both fld con,atibility with normality and log-normality.
and significance of skew ii at the PO.O$ level.1
Table 7.3.1. 1(u) describes the f/d for each dataset. Although goats are known to be culled, no
general data on culling patterns is available.
Table 7.3.1.1(u) Natural goat scrapie; descriptions of lid.
Dataset	 Description
GLS: all cases	 Right skew too elongated even for log-normality
GLS: dam scrapie +ve	 Compatible with normal and log-normal
GLS: flock/herd scrapie +ve Right skew too elongated even for log-normality
VIDA	 Comuatible with normality (but asymmetric')
Twenty-eight (42%) of the 66 natural transmission cases were under observation until at least 60
months of age (Hourrigan Ct al, 1979) during an investigation into indirect pasture transmission.
The remainder were mainly kept singly or in small groups. No 'herd' information on culling is
available.
The full dataset, and the 36 cases of flock/herd-positive contact both have an Lid too right skewed
even for log-normality. The smaller dam-positive group a/o Lid is compatible with both normality
and log-nonnality. Whether this group biologically represents a different group to the flock/herd
contact group depends upon whether maternal transmission is possible by routes other than
lateral contact. If maternal transmission occurs, it may result in a tighter a/o l/d due to a similar
route and time of entry. However, lack of discrimination may simply reflect the small numbers
involved.
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The two tests for VIDA data give apparently conflicting results; i.e. compatible with log-
normality, but with right skewed asymmetiy in logged data. This may be a reflection of small
sample size. Bias may be as for sheep VIDA data (Wooldridge, 1991) but, since many goats are
kept singly, individual investigation may be more likely than for sheep thus reducing bias.
Nevertheless, there may be some element of right censoring.
As for sheep, therefore, scrapie onset is possible well into a goat's old age; the a/o fYd may again
have a veiy elongated right skew, more extreme than that of log-normality. Again as for sheep,
there is a suggestion of an association of sample size and observed f7d, the smallest dataset being
the least right skewed.
7.3.1.2 Experimental cases.
A summary of the i/p f/d analyses results is given in table 7.3. 1.2(i)
Table 7.3.1.2(i) Experimental TSE in goats; summ
Dataset	 N	 FId com patible with:-
Normality	 Log-
Full set	 400	 No	 No
Subgroup 1
	
201	 No	 No
Subgroup 2
	
34	 Yes	 Yes
Subroun 3	 14	 Yes	 Yes
ry of (/d analyses.
Skew for:-
Raw	 Logged
data	 data
R	 R
R	 R
NS	 NS
NS	 NS
otes on table:- aignuicance level 01 00111110 CofilpatibuIlty With normality an
log-normality, and significance of skew is at the P=O.05 level.J
Table 7.3.1. 1(u) describes the f/d for each dataset.
Table 7.3.
I Dataset
Full set
Subgroup 1
Subgroup 2
Subrou 3
TSE in goats; descriptions of (Id.
Description
Right skew too elongated even for log-normality
Compatible with normal and log-normal
As with sheep, most work was published before the mid 1970's. Comments on possible
contamination are therefore relevant also to goats.
For the complete set, 400 cases, the i/p fld is right skewed more extensively than is compatible
with log-normality. Maximum recorded i/p is 59 months, but some papers stated that animals
were still under observation. It may be that some of these developed disease after even longer
i/p's.
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Subgroup 1, 201 cases of goat-to-goat CNS-to CNS transmission (the group chosen to be the
most homogeneous possible) has a considerably reduced maximum i/p from that for the full set
(30 months). Minimum value remains at 7 months. Consequently the mean is also reduced, by
about 3 months. However, the lid retains a right skewness too extensive for log-normality. It is
hypothesised that if variability in all factors was genuinely reduced to negligible levels (in
practice likely to be an impossible situation), the i/p range would comprise a veiy tight band.
For subgroups 2 (plausible natural infection routes) and 3 (transmission from sheep, suspected
source of most goat scrapie), i/p f/d was compatible both with normality and log-normality. Both
datasets are small, and again artificial truncation by cessation of observation is possible.
Nevertheless, particularly for subgroup 2 (see figure 7.3.1.3), there does appear to be a more
prominent left tail (comparable to that of the GLS natural dataset) than for subgroup 1. The
modal region i/p for subgroup 2, 21-34 months, is considerably later than for subgroup 1, 8-12
months. This situation is similar to that for sheep, but the difference in time to reach the modal
regions is greater. For sheep the difference was only 5 months.
Conclusions are again therefore that i/p lid may sometimes have a right skew more extreme than
that of log-normality, and that smaller datasets tend to be less right skewed than larger sets.
Homogeneity of conditions may affect i/p f/d but, with a given number of experimental cases,
categonsing to increase homogeneity automatically reduces case numbers which itself may also
distort the i/p f/d. Complete separation of the two effects is therefore impossible in this study.
7.3.1.3 Com parison of natural ae at onset and experimental incubation period frequency
distribution.
As postulated for sheep, i/p f/d after CNS inoculation may mimic disease i/p lid development
from the point where natural peripheral infection has reached the CNS, as well as spontaneous
de novo disease development if that does in fact occur, whilst s/c, i/d and oral inoculation i/p lid's
may mimic complete natural transmission i/p lids. It might therefore be expected that i/p lid for
the latter has some similarity to natural case a/o lid if all natural cases are infected at
approximately the same time.
Figure 7.3.1.3 compares lid's of the GLS natural case dataset alo's with experimental subgroup 2,
the s/c, lid and orally transmitted case i/p's. The modal regions are 'overlayed' at the same time
point as it is distribution 'shape' which is being compared.
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Figure 7.3.1.3 Goat TSE; conarison of natural a/o and .xperimental (sic, l/d
and orall lip fld; mode. overlayed
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If there is any validity in overlying the modal regions, and if the experimental transmission
methods bear any resemblance to natural transmission, then the shift along the X-axis by 14
months of the i/p f/d might suggest that on average the natural cases were infected at around 14
months of age. Natural cases have a longer right tail. This may be connected with differences in
sample size (66 versus 34), artificial truncation of experimental data, variation in infection age
for natural cases or a genuinely different fld. The left tails are broadly similar in extent.
7.3.2 Effect of variables.
7.3.2.1 Natural cases
Analysis of the a/o by the latest date of recorded exposure suggests the possibility of a/o clustering
around 40-50 months for goats exposed from birth and infected within the first ten months of life,
but with only seven cases no firm conclusions can be drawn.
7.3.2.2 Experimental cases.
The amount of detail given, and therefore variables which can be examined, differs greatly. The
experimental method also varies; often only a small number of cases have been subjected to any
one protocol. Many of the variables alter mean i/p in ways which might be expected. In all
datasets lack of information means that some variables are unaccounted for. Inclusion of all
unknown (and in many cases unknowable) variables might considerably alter the results.
Examination of the full dataset indicates that, as for sheep, passage status, preceding donor,
infection route and infecting substance have independent statistically significant effects on the
mean i/p. Variables not taken into account include breed, dose, actual passage number and
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precise history ('strain') of agent. However, with respect to preceding donor, it is perhaps
surprising that there is little difference in mean i/p for cases from other ruminants (cattle and
sheep) and non-ruminants (mice and primates) although Cl's are wide.
For subgroup 1, the analysis of the effect of passage number indicates a statistically significant
i/p reduction only for P2, the first experimental passage. Age at infection has no statistically
significant effect up to 9 months of age.
The reduction of agent dose by the dilution of brain extract results in a gradual i/p increase to 13
months. Pattison (1965b) reports 3 cases in goats where donor brain inoculum was diluted to 1/10
(10%), and lml inoculated, however, there the donor goats were healthy, presumably incubating
disease, and i/p's are much longer at 23, 30 and 30 months. This extended i/p. if caused by a
reduction comparable in dose to that plotted in figure 7.2.2.2(b), suggests that under certain
circumstances (e.g. brain-to-brain, same species) incredibly small amounts of agent might be
infectious, a possibility supported by the existence of electrode-infected human cases of CJD.
Pre-treatment by inoculation with supposedly uninfected goat brain reduces mean i/p after
subsequent infectious inoculation, and was carried out 10 weeks before agent inoculation, i.e.
approximately 10 months before disease onset. Pattison (1965a) suggests an immune mechanism
'sensitises' the recipients. Contamination of the 'normal' brain preparation is another possibility.
If this was an accurate observation, unaffected by contamination, a parallel in natural cases could
be hypothesised, whereby haematogenous or neuronal pathway entry to the CNS target area by
'priming' material of some sort, either organic or maybe even inorganic, results in increased
susceptibility to disease.
7.3.3 Comparison with Sartwelt's Conclusions.
For experimental TSE's in goats, i/p fld with right skew too extreme for log-normality occurs in
the two largest of four datasets. For a/o f/d of natural disease, this extreme skew occurs in the
three largest of four datasets, although as with sheep, time of infection is unknown. Overall,
however, an i/p fYd of log-normality cannot be assumed; experimental results indicate the
possibility of a considerably greater right skew in natural disease.
Therefore, conclusions reached are broadly similar to those for sheep; Sartwell's hypothesis of
underlying log-normality for i/p f/d is not confirmed.
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CHAPTER 8
PRIMATES: DATA ANALYSIS AND DISCUSSION: Experimental
TSE/prion disease.
8. Summary.
8.1 Full dataset of each primate group.
8.1.1 Analysis of incubation period.
8.1.2 Association between dataset size and frequency distribution skewness
82 Datasets with greater homogeneity.
8.2.1 Analysis of incubation period.
8.2.2 Association between dataset size and frequency distribution skewness.
8.3 Squirrel monkeys; analysis of incubation period by inoculation route.
8.4 Comparison of incubation period with some life history measures, by
taxonomic grouping.
8.5 Discussion.
8.5.1 Incubation period frequency distribution analysis findings.
8.5.2 Association of incubation period with certain life history measures.
8.5.3 Comparison with Sartwell's conclusions.
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CHAPTER 8
PRIMATES: DATA ANALYSIS AND DISCUSSION.
Experimental TSE/pnon disease.
Summary.
For experimental TSEs in primates, the right skew of the
incubation period (up) frequency distribution (fld) appears
to increase with increasing size of the dataset.
Datasets with more than about 50 cases are frequently
found to have greater right skews than compatible with log-
normality; any artificial right truncation (e.g. early
cessation of experimental observation) would tend to mask
this skew. Focusing on a particular 'homogenous' subset of
cases does not necessarily reduce the skew. Some individual
i/p's in such a dataset are extremely long compared with the
modal i/p value.
It is concluded that the i/p f/d's of TSE's in primates are
unlikely to be log-normally distributed, having a more
extensive right skew; Sartwell's hypothesis is not confirmed.
A non-significant decrease in f/d right skewness with
increasing modal (and mean) i/p was noted; this
observation may be confounded by species differences,
sample size, and infection age. If all infection occurs at a
similar proportion of species lifespan, then the longer the
duration to modal i/p, the less subsequent mean lifespan
remains in which to observe a right skew. Examination of
f/d c/s for diseases with different modal i/p's, but the same
age at infection, in a single species using 'large' samples,
might clarify this observation.
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8.1 FuH dataset of each primate group
8.1.1 Analysis of incubation period
Figures 8.1.1 (a)-(h) illustrates the i/p fYd (in months) for each group (see appendix 10 for data
source details, and appendix 21 for relevant primate taxonomy).
Figure 8.1.1(a-h) Experimental TSE in primates: i/p f/d by primate group.
tNot: Vertical axes give an Indication of case numbers, but are minimised and aol t scaIeJ.
(a) Marmosets. N=50
(b) Capuchin. N=71
-.
(c) Squirrel monkeys. N=322
(d) Spider monkeys. N=57
I	 ILIILIJIJ..	 I
(e) African green monkeys. N=20
I	 LiI.
(1) Cynomolgus. N12
(g) Rhesus monkeys. N=30
111iLi.i
(h) Chimpanzees. N73
100	 200
I/p (months)
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The i/p data (in months), and a visual estimate of the I'd skew for each primate group are given
in table 8.1.1(i).
Table 8.1.1(i) Experimental TSE in primates; i/p data (in months) plus
visual estimate of fid skew, by primate group.
Group	 N Mean i/p SD	 Range Mode Media	 Skew
n
Marmoset	 50	 20.7	 19	 2-94	 8	 15	 R
Capuchin	 71	 43.8	 24	 11-168	 35	 39	 R
Squirrel M.	 322	 28.3	 17	 8-189	 26	 25	 R
SpiderM.	 57	 31.4	 11	 4-86	 27	 29	 R
African Green	 20	 47.5	 10	 14-58	 43	 50	 L
Cynomolgus	 12	 55.8	 16	 27-74	 53	 57	 None
Rhesus	 30	 62.9	 15	 30-102	 60	 63	 None
Chimp	 73	 23.8	 18	 10-86	 13	 17	 R
The mean i/p's for different primates are clearly different (P<0.00 1, non-parametric lest). The
modal values also vary greatly, from 8 to 60 months.
Visually, the five largest datasets (N= 50 to 322) appear right skewed. Of the remaining three
datasets (N= 12 to 30) one appears to be left skewed, and two have no clear skesiiess, suggesting
an association between sample size and skewness. The i/p I'd analyses are given in table
8 1.1(u).
Table 8.1.1(u). Experimental TSE in primates; i/p l/d analysis by primate group.
Group	 N F/d under	 CC	 C/v at	 C/s	 P for Skew
analysis	 P= 0.05	 c/s
Marmoset	 50	 Normality	 0.902*	 0.977	 1.919	 <0.00]	 R
Capuchin	 71	 "	 0.770*	 0.982	 3.762	 <0.001	 R
SquirrelM.	 322	 N	 0.680*	 0.995	 6.110	 <0.00]	 R
SpiderM.	 57	 0.916	 0.979	 1.774	 <0.001	 R
African green	 20	 0.889*	 0.950	 -1.936	 0.001	 L
Cynomolgus	 12	 "	 0.970	 0.926	 -0.630	 0.244	 NS
Rhesus	 30	 N	 0.942*
	
0.964	 0.506	 0.199	 NS
Chimp	 73	 N	 0.841*	 0.983	 1.991	 <0.001	 R
Marmoset	 50	 Log-	 0.988	 0.977	 -0.314	 0.320	 NS
Capuchin	 71	 normality	 0.938**	 0.982	 0.771	 0.009	 R
Squirrel M.	 322	 N	 0.926**	 0.995	 1.706	 <0.00 1	 R
SpiderM.	 57	 N	 0.897**	 0.979	 -1.901	 <0.001	 L
African green 20	 N	 0.776**	 0.950	 -2.970 <0.00 1	 L
Cynomolgus	 12	 N	 0.933	 0.926	 -1.058	 0.058	 NS
Rhesus	 30	 N	 0.941**
	
0.964	 -0.706	 0.081	 NS
Chimp	 73	 N	 0.937**	 0.983	 1.116	 <0.001	 R
iotes on lab	 indicates hypothesis of normality can be rejected at P =O.O5 level
indicates hypothesis 01 log-normality can be rejected at P0) levelJ
The hypothesis of normality can be rejected for all except the cynomolgus group (the smallest).
The skew in every group confirms the visual impression.
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The hypothesis of log-normality can be rejected for six of the eight groups. After log-
transformation the three largest sets, capuchin, chimp and squirrel monkey, are still right skewed
(N=71, 73, 322), whereas for spider and African green monkeys (N=57, 20), the skew is left. The
Rhesus f/d (N=30) is not compatible with log-normality, probably due to kurtosis, since there is
no skew after transfonnation.
Two datasets are compatible with log-normality, cynomolgus and marmoset (N=12, 50), having
no significant skew in the transformed data. The cynomolgus is a particularly small dataset,
which may be the reason for inability to reject either description.
8.1.2 Association between dataset size and frequency distribution skewness.
Regression analysis gives an increase in c/s of 0.021 units per additional case in the dataset
(r=O.84, F=13.93, P=0.010). Figure 8.1.2 plots this association.
Figure 8.1.2 Experimental TSE in primates; c/s by dataset size.
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8.2 Datasets with greater homozeneity; sub2roups I to 6.
8.2.1 Analysis of incubation period.
Analyses were performed for all subgroups (see appendix 10 for subgroup definitions) as in
section 8.1.1. Results for subgroup 6, the most homogeneous, are given. Table 8.2.1(1) gives
sample sizes, mean i/p and a visual estimate of skew taken from the histograms (not shown).
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Table 8.2.1(i) Experimental CJD in primates; subgroup 6; sample size, mean i/p (months),
and visual estimate of i/p f/d skew by primate group.
Group	 N	 Mean i/p	 Skew: by visual estimation
Mannoset	 8	 22.1	 R
Capuchin	 28	 44.7	 R
SquirrelM	 129	 27.6	 R
Spider M.	 20	 31.9	 None
African green	 13	 49.2	 None
Cynomolgus	 4	 56.0	 None
Rhesus	 17	 63.3	 L
Chimp	 24	 27.1	 R
The mean i/p is virtually unchanged for all groups, compared with the full set. All subgroups
with over 20 cases still appear right skewed. Smaller groups generally have no clear shape. Table
8.2. 1(u) gives the i/p lYd analyses.
Table 8.2.1(u) Experimental CJD in primates; subgroup 6;
i/p f/d analysis by primate group.
Group	 N	 F/d under	 CC	 C/v at	 C/s	 P for	 Skew
analysis	 P= 0.05	 c/s
Marmoset	 8	 Normality	 0.821*	 .905	 1.974	 0.002	 R
Capuchin	 28	 "	 0.641*	 .962	 4.379	 <0.001	 R
Squirrel m.	 129	 Ø•555*	 .988	 6.909	 <0.001	 R
Spider m.	 20	 "	 0.987	 .950	 0.406	 0.369	 NS
African green 13	 "	 0.988	 .931	 0.249	 0.631	 NS
Cynomolgus	 4	 N	 1.000	 .868	 1.155	 nc	 nc
Rhesus	 17	 "	 0.963	 .942	 -0.990	 0.051	 NS
Chimp	 24	 N	 0.885*	 .957	 1.328	 0.006	 R
Marmoset	 8	 Log-	 0.916	 .905	 1.402	 0.022	 R
Capuchin	 28	 normality	 0.818**	 .962	 2.964	 <0.001	 R
Squirrel m.	 129	 N	 0.844**	 .988	 3.046	 <0.001	 R
Spider m.	 20	 N	 0.975	 .950	 -0.403	 0.373	 NS
African green 13	 N	 0.989	 .931	 0.138	 0.789	 NS
Cynomolgus	 4	 N	 1.000	 .868	 1.155	 nc	 nc
Rhesus	 17	 N	 0.94l**	 .942	 -1.285	 0.015	 L
Chimp	 24	 N	 0.945**	 .957	 0.719	 0.101	 NS
[Notes on table:- • indicates hypothesis of normality can be rejected at P0.05 level
indicates hypothesis ot log-normality can be rejected at P=O.O level
nc indicates no calculation was completed; programme would not run on this small data set.J
The two largest subgroups have right skews too extensive for compatibility with log-normality.
The smaller datasets tend to be less right skewed. The calculated skew in evemy subgroup except
Rhesus monkeys confirms the visual estimate No overall fYd pattern emerges. Subgroups 1 to 5
give broadly similar results (not shown); again no overall f/d pattern emerges.
8.2.2 Association between dataset size and frequency distribution skewness.
Regression analysis gives a c/s increase of 0.051 units per additional case in the dataset (r=0.82,
F=12.12, P=0.013).
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8.3 Squirrel monkeys; analysis of incubation period by inoculation route.
Squirrel monkeys are the largest group, therefore further analyses are possible. The i/p data (in
months) for subgroup 6 is given by inoculation route: table 8.3(1).
Table 8.3(i) Experimental CJD in squirrel monkeys; subgroup 6;
i/p data Qn months) by inoculation route.
Inoculation route	 N	 Mean i/p	 SD	 Range	 Mode Median
CNS only	 53	 29.9	 23.4	 16-189	 26	 26
Multiple site	 76	 26.0	 16.1	 11-159	 24	 25
The difference in mean i/p by inoculation route is almost 4 months, (P =0.037, non-parametric
test), multiple site inoculation giving disease onset more rapidly. However, there appears to be
little difference in the very right skewed i/p fld histograms (not shown). The ranges show that
both inoculation protocols occasionally give a very long i/p. The lid analyses are given in table
8 3(u).
Table 8.3 (H) Experimental JD in squirrel monkeys; subgroup 6;
i/p f/d by inoculation route.
Inoculation	 N	 FId under	 CC	 C/v at P	 C/s	 P for Ske
route	 analysis	 0.05	 c/s	 w
CNS only	 53	 Normality	 0.559	 0.978	 6.137	 <0.001	 R
Multiple site	 76	 0.540	 0.983	 7.476	 <0.001	 R
CNS only	 53	 Log-	 0.83 1	 0.978	 3.299	 <0001	 R
Multinle site	 76	 normality	0.836	 0.983	 2.784	 <0.001	 R
The two inoculation routes have similar i/p fYd's, both more right skewed than compatible with
log-normality.
8.4 Comparison of incubation period with some life history measures, by taxonomic
Eroupin!.
Table 8.4 compares maximum recorded i/p (as a percentage of maximum recorded longevity) and
mid-point of the adult weight range for the genus (see appendix 21 for relevant taxonomy, and
appendix 22 for selected life history measures) with both the mean and the modal i/p and the c/s
for the full dataset groups (i.e. those described in section 8.1).
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Table 8.4 Experimental TSE in primates; full dataset; comparison of analysis results with
life history measures, stratified by data representative of genus.
Primate group	 Max i/p as % Adult weight: Mean	 Modal C/s (full
of max	 mid-range	 i/p	 i/p	 dataset)
longevity	 (kg)
Marmosets	 63	 0.25	 20.7	 8	 1.9
Capuchin	 35	 2.75	 43.8	 35	 3.8
Squirrel monkey	 75	 0.75	 28.3	 26	 6.1
Spider monkey	 36	 6.15	 31.4	 27	 1.8
Afncan green	 15	 4.10	 47.5	 43	 -1.9
Cynomolgus	 21	 10.25	 55.8	 53	 -0.6
Rhesus monkey	 29	 62.9	 60	 0.5
Chimpanzee	 16	 45	 23.8	 13	 2.0
Squirrel monkeys, with a large dataset, and thus the potential for a more complete i/p range, at
75%, had a maximum i/p which most closely approached the maximum recorded lifespan.
Regression analysis gives an increase in c/s of 0.9 units per 10% increase in maximum i/p as a
percentage of maximum recorded lifespan (r=0.75, F7.73, P=0.032).
Figure 8.4 plots the i/p relationship with the mid-point of the adult weight range, for each
primate group.
Figure 8.4 Experimental TSE in primates; comparison of certain I/p measures
with mid-point of adult weight range, by primate group.
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With the exception of chimps, which are far heavier than the other groups, there appear to be
associations between weight-range mid-point, and i/p mean, mode and c/s. Excluding chimps,
regression analysis gives an increase of 3.7 months in mean i/p (r0.86, F13.66, P0.014), and
of 3.1 months in modal i/p (r0.84, F=13.66, P=0.014) , and an insignificant decrease in c/s of
0.038 units (r=0.59, F=2.66, P=0. 164) per kilogram increase in weight range mid-point.
These results suggest an association between the mean (and modal) i/p and the c/s. Regression
analysis gives similar, insignificant results with or without chimps; including chimps, c/s
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decreases by 0.09 per additional month for mean i/p (r=0.53, F=2.35, P=O. 176), and by 0.07 per
additional month for modal i/p (r=0.48, F= 1.77, P=O.232).
8.5 Discussion.
8.5.1. Incubation period frequency distribution analysis findings.
Table 8.5.1(i) summarises the fld analyses for the full datasets.
Table 8.5.1(i) Experimental TSE in primates; full dataset, descriptions of lid.
Group	 N	 Description
Marmoset	 50	 Compatible with log-normality
Capuchin	 71	 Right skew too elongated even for log-nonnality
SquirrelM.	 322
Spider M.
	
57	 Right skew between normal & log-normal
African green	 20	 Left skew too elongated even for normality
Cynomolgus	 12	 Compatible with normality and log-normality; small data set
Rhesus	 30	 Not compatible with log-normality (kurtosis?)
Chimp	 73	 Right skew too elongated even for log-normality
Two possible associations are present; one between skew and dataset size, the other between skew
and whether categorisation is by species (members within a species being closely related
genetically) or genus (greater genetic heterogeneity, if different species involved). However, the
five largest datasets are also the five groups categorised by genera, making investigation difficult.
In addition, three different superfamilies are involved (see appendix 21), and these segregate with
the genus/species categorisation, further complicating interpretation.
Table 8.5. 1(u) summarises the f/d analysis for subgroup 6.
Table 8.5.1(u) Experimental CJD in primates; subgroup 6; descriptions of fid.
Group	 N	 Description
Marmoset	 S	 Right skew too elongated even for log-normality
Capuchin	 28
Squirrel m.	 129	 N
Spider m.	 20	 Compatible with both normality & log-normality
Africangreen	 13	 N
Cynomolgus	 4	 N
Rhesus	 17	 Compatible with normality
Chimp	 24	 Not compatible with log-normality (kurtosis?)
More homogenous experimental conditions did not result in a similar i/p fld across primate
categories, but subgroup sizes are veiy dissimilar, some are extremely small. More subgroup i/p
fYd's are compatible with the hypothesis of normality and log-normality than for full groups. Since
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numbers have also been reduced, it will, due to lack of power, be more difficult to reject these
hypotheses, therefore this may be the effect of reduction of sample size. Table 8.5. 1(iii)
compares the Ud skew for the full datasets of primates with that for the 'homogenous' subgroup 6
Table S.5.1(iii) Experimental TSE in
Group	 Full set
N	 Skew
Marmoset	 50
	
R
Capuchin	 71
	
R
Squirrel m.	 322
	
R
Spider m.	 57
	
R
African green	 20
	
L
Cynomolgus	 12
	
None
Rhesus	 30
	
None
73
	
R
y, size and f/s
Subgroup 6
N	 Skew
8	 R
28	 R
129	 R
20	 None
13	 None
4	 None
17	 L
24	 R
comparisons.
All datasets with over 30 cases are right skewed. There tis a tendency for a loss of right skew as
the datasets reduce in size. It is therefore surprising that the marmoset (N=8) f/d is still right
skewed, but this is heavily influenced by one case (histogram not shown). If a decrease of right
skewness results from reduction in case numbers, and thus on the probability of observing
particular values rather than on a biological phenomenon, one would occasionally expect such
results.
Subdivision of squirrel monkeys into two inoculation route groups confirms the occasional veiy
long i/p for both inoculation routes. Although both routes included a CNS component, multiple
site inoculation shortened the mean i/p by about 4 months. Possible explanations include
confounding, for example by dose, and the possibility that the non-CNS component produces
disease more rapidly than CNS inoculation.
Analysis of association between dataset size and c/s gave statistical significance for both the full
datasets and for subgroup 6, with an increase for c/s of 0021 and 0.051 units per additional case
in the respective datasets.
Therefore, and as with sheep and goats, 'large' datasets are often more right skewed than log-
normality, and there is an association between right skewness with dataset size. It is not possible
to confirm an underlying i/p f/d pattern for primates, neither has its existence been disproved.
Difficulties lie in the disparate and often small sizes of thtasets.
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8.5.2 Association of incubation period with certain life history measures.
Some of the primate groups represent genera, and some species (see appendix 21); group genetic
diversity will therefore vaiy. The African green monkey is a single species mth no sub-species,
therefore it may be the most genetically homogenous group examined. However other groups
may, although described by their generic name, comprise only one experimental species or
subspecies.
In examination of the i/p Lid, the relationship between age at inoculation and longevity is clearly
relevant. Death from other causes during incubation will effect the observed f/d. Little
information is available on the mean lifespan for these primates, therefore maximum recorded
lifespan was used.
The right skewness of the i/p f/d increases with an increase in maximum recorded i/p as a
percentage of maximum recorded lifespan. Although the mean lifespan may be much less, if all
animals were young when inoculated this suggests there was no lack of natural lifespan
remaining in which to exhibit an i/p fYd right skewness.
However, age at inoculation was unknown. If inoculation in a large proportion of the animals was
towards the end of their natural lifespan, truncation of the maximum observed i/p values would
be predicted. Although using elderly-looking animals to investigate disease with known
likelihood of long i/p is unlikely, using even 'middle-aged' animals might artificially truncate the
results, resulting in a reduced right L/d skew. The possibility of truncation cannot be eliminated.
Variation in most life histoiy measures, including longevity, is highly correlated with variation in
body size (Harvey and Clutton-Brock; 1985). For captive primates, since the age of a captured
animal is generally unknown, adult weight is more reliably estimated. The weight (and probably
therefore longevity) ranges for some genera are wide, and for some genera sex also makes a large
difference. Genus pan (chimps) are much heavier than any other genera used. The mid-point of
the given genus weight range was arbitrarily taken for analyses. It was therefore surprising to
find, excluding chimps, a graphically visible and statistically significant increase of over 3
months in the mean (and modal) i/p per additional kilogram weight.
Although not statistically significant, there was a tendency for a lower body weight to result in a
greater Lid right skew but this also correlated with sample size. As small primates are cheaper to
keep (less space, less food etc.), they may be used more extensively, resulting in larger samples.
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Sacher and Staffeldt (1974, cited by Harvey & Clutton-Brock, 1987) argue that species
differences are better predicted by absolute brain size than body size. They describe a 'postnatal
brain growth index' and primate subfamilies with relatively large brains at birth have relatively
less postnatal brain growth. This is an exception to the usual pattern whereby growth rates are
positively correlated with birth weight across species. It is conceivable that brain growth rates
may be relevant to TSE i/p's in primates.
Examination of life-measures led to the observation that, although not statistically significant, the
f/d right skewness decreased with increasing modal (and mean) i/p. This may be related to
longevity; if all infection occurs at a similar proportion of species lifespan, then the longer the
duration to modal i/p. the less subsequent mean lifespan remains in which to observe a right
skew. However, interpretation is difficult; different species/genera are involved, which affects
mean (and modal) up; age at infection may vary, and (as for all relationships) there may be
confounding by sample size.
Examination of the l/d c/s for diseases with different mean i/p's. but the same age at infection (or
initiating-event, for non-infectious disease), in a single species using 'large' samples, might be
informative.
8.5.3 Comparison with Sartwell's conclusions.
As for sheep and goats, the i/p lid for experimental TSE datasets in primates often gives a more
extended right-skewed distribution than is compatible with log-normality, particularly if the
sample size is over 30. SartwelPs hypothesis is not confirmed.
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RODENTS: DATA ANALYSIS AND DISCUSSION: Experimental
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CHAPTER 9
RODENTS: DATA ANALYSIS AND DISCUSSION.
Experimental TSE/prion disease.
Summary
For both experimental BSE in mice, and CJD in
guinea-pigs, with one strain of host and a reduced
number of other variables, an incubation period (up)
frequency distribution (f/d) with right skew more
extensive than that compatible with log-normality
was found; Sartwell's hypothesis is therefore not
confirmed. For BSE, skewness is associated with
mean inoculation age, right skewness decreasing as
mean inoculation age increases.
With experimental scrapie in mice, two highly stable
scrapie agent strains were used, inoculated into two
strains of host mouse, plus their crosses (giving three
sets of mice with known 'sine' gene alleles; s7s7,
s7p7 and p7p7); so that both host and agent were
tightly defined, giving six possible combinations.
Overall i/p f/d appearance was multi-modal; within
this, the i/p f/d of each combination was tightly
clustered, giving rise to the possibility of prediction
of the host genotype, if agent strain and i/p are
known. Clusters were compatible with normality
and log-normality, but sample sizes were all fewer
than 50. C/s decreases exponentially with increasing
modal (and mean) i/p.
Age at inoculation and passage number have
significant effects on i/p.
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9.1 Experimental BSE in mice.
9.1.1 Full dataset.
9.1.1.1 Analysis of incubation period for full dataset.
Rifi mice were used (see appendix 10 for details). 1/p details (in days) for 196 cases :-
Mean Up:
	
323
SD:	 21
Range:	 265-438
Mode:	 323
Median:	 321
There is no difference in mean i/p by sex (females, 325 days; males, 320; P= 0.303, non-
parametric test). The i/p f/d histogram is shown in figure 9.1.1.1.
Figure 9.1.1.1 BSE In nc.; full dat.set; I/p fld.
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Only one 'early' case is present, in comparison with several 'late' cases distant from the mode
which contribute to a right skewed appearance. 1/p f/d analysis results, table 9.1.1.1.
Table 9.1.1.1 BSE in mice; full dataset; i/p fld
F/dunder	 CC	 C/vatP
analysis	 0.05
Nonnality	 0.94 1	 0.992
)g-normality	 0.960	 0.992
Data are incompatible with both normality and log-normality. The right skew is too extensive.
9.1.1.2 Analysis of incubation period by age at inoculation.
The mean inoculation age of the mice is 62.7 days (SD 29.2, range 21-124). Regression analysis
gives an i/p reduction of 0.16 days per additional day of age at inoculation (r=-0.22, F=9.79,
P=O.002), plotted in figure 9 1.1.2.
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9.1.2 Analysis by oriinatin BSE case ('BSE Eroup').
9.1.2.1 Analysis of incubation period.
Table 9.1.2.1(i) gives details for each 'BSE group' (see appendix 10, data used, for details), one
group having been inoculated from each of the 7 cattle donors.
Table 9.1.2.1(i) BSE in mice: inoculation age and i/p data (in 	 ) by BSE group.
BSE N	 Mean	 Age Mean SD	 Range Mode Median
group	 infection	 range	 i/p
As apparent from the table, there is a difference in mean i/p by BSE group (P = 0.009, non-
parametric test). From inspection of individual histograms (not shown), f/d differences are
apparent Groups 2 and 7 have marked right skews, whilst the remainder appear more
symmetrical. Although group sizes vary all are small, but groups 2 and 7 are at opposite ends of
the range, with sizes of 32 and 23 respectively. I/p f/d analyses are given in table 9.1.2.1 (ii).
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Table 9.1.2.1(u). BSE in mice; i/p f/d analysis by BSE group.
	
BSE N F/d under	 CC	 C/v at P=	C/s	 P for Skew
group	 analysis	 0.05	 c,s
1	 35 Normality	 0.983	 0 968	 0.607	 0.107	 NS
2	 32	 N	 0.898*	 0 996	 1.951	 <0.001	 R
3	 30	 0.975	 0.964	 -0.588	 0.140	 NS
4	 31	 0.984	 0.958	 0.655	 0.099	 NS
5	 23	 0.985	 0.955	 -0.155	 0.716	 NS
6	 22	 N	 0.989	 0.954	 -0.219	 0.612	 NS
7	 23	 N	 0.898*	 0955	 1.763	 0.001	 R
1	 35	 Log-	 0.988	 0.968	 0.484	 0.192	 NS
2	 32	 normality	 0.922*	 0.996	 1.638	 <0.001	 R
3	 30	 N	 0.968	 0.964	 -0.781	 0.057	 NS
4	 31	 N	 0.988	 0.958	 0.539	 0.168	 NS
5	 23	 N	 0.983	 0.955	 -0.291	 0.495	 NS
6	 22	 N	 0.987	 0.954	 -0.295	 0.496	 NS
7	 23	 N	 0.920*	 0.955	 1.545	 0.002	 R
BSE groups 2 and 7 () are too right skewed even for compatibility with log-normality. All other
groups are compatible with both normality and log-normality. Regression analysis gives no
evidence for a relationship between group size and c/s (r=0.02, F=0. 18, P0.687).
9.1.2.2 Analysis of incubation period by age at inoculation.
Particularly with skewed f/d's, mean i/p is sensitive to extremes, and so dependant on range of
observed data, whilst modal i/p is not. Regression of modal i/p on BSE group mean inoculation
age gives a slight, non-significant reduction of 0.05 days per additional day of age at inoculation
(r=0.18, F=0.17, P=0.695). For mean i/p. the equivalent estimate gives a decrease of 0.16 days
per additional day of age at inoculation (r0.65, F3.58, P0.117).
Regression analysis gives a c/s reduction in of 0.03 units for each day's increase in BSE group
mean inoculation age (r=0.85, F= 12.83, P = 0.0 16). However, two way ANOVA gives
significance to the effect of BSE group (F=2.03, P=0.063) on i/p. but not to inoculation age once
BSE group is taken into account (F=O 48, P=0.490). Data was rearranged into groups A to H (see
appendix 10 for details) to partially separate effects of inoculation age from BSE group; table
9.1.2.2 gives inoculation age details, plus c/s data.
Tal ile 9.1.2.2 BSE in mice; inoculation age data (in days) and (/d c/s analysis; groups A t
	
Group N	 Mean	 Inoculat-	 Range	 C/s	 P for c/s Skew
inoculat-	 ion age	 span
ion age
	
range	 (days)
A	 71	 34.6	 21-46	 26	 2.186	 <0.001	 R
B	 69	 57.8	 47-72	 26	 0.597	 0.038	 R
C	 27	 96.1	 73-98	 26	 -0.144	 0.718	 NS
D	 29	 111.9	 99-124	 26	 -0.652	 0.109	 NS
E	 47	 31.1	 21-38	 18	 1.752	 <0.001	 R
F	 54	 46.9	 39-52	 14	 2.713	 <0.001	 R
G	 52	 70.7	 54-96	 43	 0.687	 0.038	 R
II	 43	 107.3	 97-124	 28	 -0.457	 0.180	 NS
IL
103
RODENTS: Data analysi. & discuuion
For both regrouping methods, there is a tendency for c/s to decrease as group mean inoculation
age increases (see figure 9.1.2.2). This is similar to that in analysis by BSE group.
Figur. 9.1.2.2 BSE In nice; c/s .g. at lnf.ctlon for groups A to II
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Regression analyses for groups A to D gives a decrease in c/s of 0.04 units per 'group mean day
older' at inoculation (r-0.96, F=24. 17, P=O.039), and for groups E to H similarly a decrease of
004 units per day (r=-0.88, F=6.71, P=O.122).
9.2 Experimental scrapie in mice.
9.2.1 Analysis of full dataset.
Appendix 10 gives details of scrapie strains and mouse genotypes used. 1/p data (in days) for all
407 cases:-
Mean Up:	 400
SD:	 157
Range:	 165-645
Mode:	 215
Median:	 455
By inspection of the histogram (not shown; similar to figure 9.2.2 shown later) neither normality
nor log-normality is applicable; there is no obvious single peak. Appearance is of multi-modality.
9.2.2 Analysis by agent strain.
Table 9.2.2 gives i/p data by agent strain.
Table 9.2.2 Scrapie in mice:
Strain	 N	 Mean
22A	 326	 438
ME7	 81	 248
p data (in days)
SD	 Range
150	 185-645
63	 165-355
:rapie agent strain.
Mode	 Median
215	 485
175	 245
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Mean i/ps are veiy different, that of strain 22A being almost 200 days more than that of strain
ME7 (P<0.001, non-parametric test). The i/p fYd histogram is given below (figure 9.2.2).
Figix. 9.2.2 Scrap). in nic.; ful dataset: l/p f/d by agent strain
40
2O
.— . . C4	 C1 rd	 ('	 ) () C') C') * * *	 ID ID ID ID ID ID ID
lip (days)
Although strain MEl has fewer cases, and is compacted into a smaller range, both strains appear
tri-modal. Neither normality nor log-normality is applicable.
9.2.3 Analysis of Strain 22A by 'sinc' aenotvpe.
Table 9.2.3(i)gives i/p details by 'sinc' genotype.
Table 9.2.31
'Sinc' type
recorded
s7s7
s7p7
p7p7
Unrecorded
pie in mice; strain 22A: i/p data (in days) by 'sinc' genoty
N	 Mean	 SD	 Range	 Mode	 Median
27	 462	 17	 415-495
	
455	 465
47	 568
	
37	 485-635
	
585	 575
29	 210
	
14	 185-245
	
205	 205
223	 438
	
149	 195-645
	
215	 485
Mean i/ps for the three 'sine' genotypes are very different, ranging from 210 days to 568 days
(P<0.O01, non-parametric test); the mean for unrecorded genotypes is within this range. Figure
9 2.3 (a)-(b) illustrates the data.
105
I- - - I
RODENTS Data analysis & discussion
9.2.3(a) Scraps. In mice; strain 22A; i/p fld by sinc genotyp.
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Flgur. 9.2.3(b). Sciapi. In mice; strain 22A; I/p fld. genotyp. unrecorded
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The three genotypes are each closely grouped. The unrecorded genotype appears to be a mixture
of all three. The i/p fld analysis is given in table 9.2.2(u).
Table 9.2.3(u) Scrapie in mice; strain 22A; i/p f/d analysis by 'sinc' genotype.
'Sinc'	 N	 Fid under	 CC	 C/v at P=	 C/s	 P for Skew
genotype	 analysis	 0.05	 c/s
recorded
s7s7	 27	 Normality	 0.982	 0.960	 -0.408	 0.317	 NS
s7p7	 47	 0.991	 0.974	 -0.454	 0.168	 NS
p7p7	 29	 0.993	 0.962	 0.508	 0.203	 NS
s7s7	 27	 Log-	 0.979	 0.960	 -0.559	 0.175	 NS
s7p7	 47	 normality	 0.985	 0.974	 -0.607	 0.071	 NS
p7p7	 29	 0.9%	 0.962	 0.364	 0.355	 NS
All genotype datasets are compatible with both normality and log-normality; none has a
significant skew.
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9.2.4 Analysis of strain ME7 b y 'sinc' 2enotype.
Table 9.2.4(i), i/p data by 'sinc' genotype. One unrecorded genotype case had an i/p of 215 days.
Table 9.2.4(i). Scrapie in mice; strain ME7; i/p data (in days) by 'sinc' genotype.
'Sinc' genotype N	 Mean	 SD	 Range	 Mode	 Median
recorded	 i/p
s7s7	 28	 176	 9	 165-205	 175	 175
s7p7	 28	 251	 16	 225-285	 255	 255
p7p7	 24	 329	 16	 295-355	 345	 330
Mean i/ps for the three genotypes are again veiy different (P<0.0O1, non-parametric test). There
is also a different order of increasing mean i/p magnitude. Histogram, figure 9.2.4.
Figs 9.2.4.Scrapi. in n*e; strain MEl; i/p fld by since ganotyp.
Again all genotypes are closely grouped and the different sequence is clear. 1/p fYd analysis is
given in table 9.2.4 (ii).
Table 9.2.4(u). Scrapie in mice; strain ME7; i/p l/d analysis by 'sinc' genotype
'Sinc'	 N	 F/d under	 CC	 C/v at P=	C/s	 P for Skew
genotype	 analysis	 0.05	 c/s
recorded
s7s7	 28	 Normality	 0.956*	 0.962	 1.659	 0.001	 R
s7p7	 28	 0.995	 0.962	 0.376	 0.346	 NS
p7p7	 24	 0.991	 0.957	 -0.381	 0.367	 NS
s7s7	 28	 Log-	 0.967	 0.962	 1.447	 0.002	 R
s7p7	 28	 nonnality	 0.998	 0.962	 0.23 1
	
0.559	 NS
p7p7	 24	 0.989	 0.957	 -0.452	 0.288	 NS
The s7s7 group is incompatible with normality (*), but just compatible with log-normality. Both
raw and log-transformed data are right skewed, the extent of which is not immediately apparent
visually. The analysis result may be influenced by the exaggerated mode. Both other genotypes
are compatible with both normality and log-normality, with no significant skew present.
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9.2.5 Interaction of 'sinc' Lenotype and agent strain.
Mean i/ps by genotype valy differentially with agent strain as shown in figure 9.2.5.
Figx. 9.2.5 Scr.pl. ki nc.: man i/p by ainc genotyp. and atraln
•	 $Iiln22A
—O•-- Sàn MEl
•	 $V.In 22A
—0--- Sv.n MEl
.7.7	 s7p7	 p7p7	 Urwecorded
•SInc • g.notyp ,.cord.d
Results of ANOVA for i/p using variables strain and 'sinc' genotype are given in table 9.2.5;
cases with unrecorded genotype are not included. No data transformation was necessaiy.
Table 9.2.5 Scrapie in mice; analysis of strain & 'sinc' genotype by ANOVA.
Variable	 Stratum	 N	 F	 P	 Mean 95% CI
i/p(adj)
Strain	 22A	 103 2223.56 <0.001	 413	 408-418
ME7	 80	 252	 247-257
'Sinc' genotype	 s7s7	 55	 616.29 <0.001	 319	 313-325
s7p7	 75	 410	 405-415
p7p7	 53	 269	 263-275
Interaction term Strain & 'sinc'	 -	 1618.96 <0.001	 -	 -
Strain 22A,	 s7s7	 27	 462	 453-471
by genotype	 s7p7	 47	 568	 562-574
p7p7	 29	 210	 202-218
Strain ME7,	 s7s7	 28	 176	 168-184
by genotype	 s7p7	 28	 251	 243-259
p7p7	 24	 329	 320-338
Strain and genotype are both statistically highly significant, as is the interaction between them.
The adjusted mean i/p for strain 22A is 161 days longer than that for ME7, and the adjusted
mean i/p for the heterozygous allele genotype s7p7 is around 100 or more days longer than for
either homozygous genotype. The mean i/p categorised by strain and genotype is as plotted
earlier.
9.2.6 Association of mean and modal incubation period with frequency distribution
coefficient of skewness.
Figure 9.2.6 is a plot of modal i/p and c/s for each 'sinc' genefagent strain combination. Mean
i/p's (not shown) give veiy similar results.
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Figur. 9.2.8 ScrapI. in mice: association b.tw..n f/d c/s and modal I/p
Mod l/p (days)
Regression analysis gives a c/s reduction 010.04 Units per additional 10 days for modal i/p (r
0.81, F=7.72, P=0.050). Comparable results for mean i/p are 0.04 c/s units (r=0.81, F7.48,
P=0.52). However, both plots appear curved; equations fitted (by R Sayers) to take this into
account give the following relationships:-
For modal up:- 	C/s = -(0.4307) + [(35.1452) x exp(-O.0 164 x up)] (r=0.97)
For mean up:- 	c/s = -(0.4446) + [(38.9451) x exp(-O.0 167 x i/p)I (r'O.98)
9.3 Experimental CJD in guinea-pies.
9.3.1 Analysis of full dataset.
1/p data (in days), for 79 cases:-
Mean:
SD:
Range:
Mode:
Median:
214
52
153-512
223
215
A histogram of i/p lId is given (figure 9.3.1) with the only two 'first passage' cases (see appendix
10) indicated.
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Range
422, 512
187-259
193 -2 56
192-27 1
177-215
153-168
154-162
166-185
160-163
154-196
Mode
226
241
223
182
185
160
number.
Median
467
220
233
218
185
160
159
185
160
179
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Figur. 9.3.1 CJD Ii guln.e-pige; fuN datasot; lip f/d.
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Right skewness appears to result from the extended i/p of the two first passage cases; the
remainder are relatively clustered. Table 9.3.1 gives the i/p ffd analysis.
Table 9.3.1 CJD in guinea-pigs; full dataset; f/d analysis.
N	 F/d under	 CC	 C/v at P=	 C/s	 P for
analysis	 0.05	 c/s
79	 Normality	 0.840	 0.984	 3.133	 <0.001
79	 Log-normality	0.935	 0.984	 1.355	 <0.001
The data is incompatible with both normality and log-normality, with an extensive right skew.
9.3.2 Effect of passage number on incubation period.
l/p data (in days) by passage number is given in table 9.3.2 (1).
Table 9.3.2(i) CJD in guinea-pi
Passage	 N	 Mean SD
1	 2	 467
	
64
2	 10	 217
	
21
3	 27	 231
	
16
4	 14	 222
	
24
5	 6	 189
	
14
6	 5	 160
	
6
7	 3	 158
	
4
8	 3	 179
	
11
9	 3	 161
	
2
10	 6	 179
	
15
(For some passage numbers, no mode was
First passage cases have much longer i/p's than other 'passage number' cases. Regression analysis
gives a reduction in mean i/p of 12.4 days per passage (r=-0.58 F=39.60, P<0.001). Much of this
occurs at first passage, although a lesser decrease is apparent over subsequent passages. Table
9.3.2(u) gives regression analysis results sequentially omitting one passage, up to passage 5.
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Table 9.3.2
Passage
from
number:
2
3
4
5
CJD in guine
Mean i/p
decrease per
passage (days:
9.0
10.1
8.0
0.8
;_effect of passa
r	 F
	-0.6 	 69.76
	
-0.74	 77.44
	- . 	 21.03
	
-0.10	 0.25
er on i/p.
<0.001
<0.001
<0.001
0.621
Passage of agent continues to reduce the subsequent mean i/p up to and including inoculation into
the fourth experimental animal; after this, mean up appears to stabilise.
Analysis of incubation period frequency distribution for passage numbers with 10 or
more cases.
From the fld histograms (not shown), no marked skew is apparent for any set. Table 9.3.3 gives
the i/p L/d analysis.
Table 9.3.3 CJD in guinea-pigs; f/d analyses for passage numbers 2-4.
	
Passage N FId under	 CC	 C/v at P=	 C/s	 P for Skew
No	 analysis	 0.05	 c/s
2	 10	 Normality	 0.955	 0.918	 0.324	 0.564	 NS
3	 27	 0.986	 0.961	 -0.488	 0.233	 NS
4	 14	 0.973	 0.934	 0.737	 0.158	 NS
2	 10	 Log-	 0.959	 0.918	 0.092	 0.869	 NS
3	 27	 normality	 0.980	 0.961	 -0.629	 0.130	 NS
4	 14	 0.982	 0.934	 0.568	 0.269	 NS
These small data sets are all compatible with both normality and log-normality.
9.4 Discussion.
9.4.1 BSE in mice.
9.4.1.1 Incubation period frequency distribution analysis findings.
Table 9.4.1.1(1) gives f/d analyses findings, table 9.4.1.1(11). the fld description.
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BSE in mice: descri ptions of rid.
Right skew too elongated even for log-normality
Compatible with both normality and log-normality
Right skew too extensive even for log-normality
Compatible with both normality and log-normality
N
N
skew too extensive even for
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Ta
Dataset
Full dataset
BSE group 1
BSE group 2
BSE group 3
BSE group 4
BSE group 5
BSE group 6
BSEgroup7
[Noc:. All signific
Table
Data set
Full dataset
BSE group 1
BSE group 2
BSEgroup3
BSE group 4
BSE group 5
BSE group 6
BSEgroup7
1(i). BSE in mice; summar
F/d compatible with:-
Normality	 Log-
normality
No	 No
Yes	 Yes
No	 No
Yes	 Yes
Yes	 Yes
Yes	 Yes
Yes	 Yes
No	 No
Ut at P=O.05J
Skew for.-
Raw	 Transfor-
data	 med data
R	 R
NS	 NS
R	 R
NS	 NS
NS	 NS
NS	 NS
NS	 NS
R	 R
The full dataset demonstrates that an i/p f/d more right skewed than log-normality is possible for
BSE in mice. When categorised by BSE group, i/p fYd for 5 of 7 groups are compatible with both
normality and log-normality, probably reflecting lack of statistical power at small sample sizes;
for these groups there was no correlation between c/s and sample size, but all comprise 35 or
fewer cases.
9.4.1.2 Association between inoculation age and incubation period.
Increase of inoculation age results in an i/p reduction of 0.16 days per day; this is of broadly
similar order to estimated i/p decrease of 0.05 +1- 0.01 days per day for inoculation of nuce using
a scrapie agent strain (Dickinson & Mieckle, 1971).
However, both inoculation age and i/p are associated with BSE group. As group mean inoculation
age increases, so group mean i/p (dependant on observed data range) tends to decrease, whereas
for modal i/p (not dependant on observed range) the effect is much less marked (although neither
associations are statistically significant). Brain titre of agent may differ considerably resulting in
different mean i/p's by BSE group, but this is unlikely to correlate with inoculation age, and
Bruce ci al (1994) conclude that only a single 'strain' of BSE agent exists. It therefore seems
likely that observed effects are due to inoculation age rather than BSE group.
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Since BSE groups 2 and 7 (the most right skewed groups) have youngest mean inoculation ages,
data was regrouped to examine the association between inoculation age and i/p fld with reduced
BSE group effect (although complete removal is impossible). Both regrouping by similar
inoculation age range (A-D) and by similar sample size (E-H) confinns that younger mean
inoculation age in a particular group results in a tendency for i/p lid to be more right skewed.
One explanation is that groups inoculated at younger mean ages are able to manifest a much
greater range of lip's, whereas for groups inoculated at later ages, too little time remains to
observe the longest possible i/p's. This might imply that incubating mice, inoculated later in life,
will die from other causes but, although 17 (8%) mice did die from other causes, these were
generally shortly after inoculation, implicating trauma or bacterial infection at inoculation.
Additionally, the mean lifespan of RI!! mice at the laboratoiy concerned is considerably longer
than the oldest age at death in this data (H Fraser, personal communication). Totalling the
longest i/p and oldest inoculation age gives 562 days whereas, in one survival analysis, mean age
at 'natural' death for 78 mice was approximately 590 days (SD = 222; range approx 175-1025).
One 'normal' RI!! mouse survived to over 1100 days of age.
It therefore seems unlikely that not enough 'time' was left for older-inoculated mice to manifest an
i/p lid which was more right-skewed. Perhaps infection later in life speeds the incubation process
in some way, but there is no evidence that the modal i/p is shortened; maybe interaction between
inoculation age and host-response shortens i/p in only a particular subset of cases.
9.4.2 Scrap ie in mice.
9.4.2.1 Incubation period frequency distribution analysis findings.
Table 9.4.2.1(i)gives the lid analyses findings, table 9.4.2. 1(u), the lid description.
ie in mice: summary of lid anaTable 9.4.2.1(i). Scra
Dataset	 N
Strain 22A: s7s7
	
27
Strain 22A: s7p7
	
47
Strain 22A: p7p7
	
29
Strain ME7: s7s7
	
28
Strain ME7: s7p7
	
28
Strain ME7: D7D	 24
Ffd compatible with:-
Normality	 Log-
normalit3
Yes	 Yes
Yes	 Yes
Yes	 Yes
No	 Yes
Yes	 Yes
Yes	 Yes
Skew for,-
Raw	 Transfor-
data	 med data
NS	 NS
NS	 NS
NS	 NS
R	 R
NS	 NS
NS	 NS
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Table
Dataset
Strain 22A: s7s7
Strain 22A: s7p7
Strain 22A: p7p7
Strain ME7: s7s7
Strain ME7: s7pl
Strain ME7: p7p7
1(u). Scrapie in mice; descriptions of lid.
Description
Compatible with both normality and log-normality
Exaggerated mode; right skewed
Compatible with both normality and log-normality
Of the ten datasets examined, all four which are not single-agent and single-mouse strain
combined appear tn-modal; clearly they are neither normal nor log-normal.
The remaining 6 single-agent plus single-mouse strain datasets all have fewer than 50 cases. All
except one are compatible with both normality and log-normality. For that which is not, although
analysis gives a right skew, there are no distant right outliers in the fid; this right skewness is
therefore likely to be a reflection of the effect of the very exaggerated mode. In summaiy, there
are no datasets with very extended right 'tails'.
9.4.2.2 Association between incubation period, agent strain, and mouse strain.
Scrapie agent strains are 'isolated' and stabilised by passage through experimental animals until
reproducibility of i/p is achieved.
With such well characterised agent strains, inoculated into two genetically different but highly
inbred strains of mice and their crosses, the six combinations give charactenstic, tightly-
clustered, urn-modal i/p ranges; mixed datasets reflect this by assuming multi-modality. The
unrecorded genotype, 22A strain combination, has an appearance of tn-modality from which
probable genotype can be predicted, using cluster characteristics.
Overall genetic uniformity, as well as specific 'sinc' genotype may be important in development of
characteristic clustered i/p ranges. If other variables (e.g. age at inoculation) are also
standardised, it may be that clustering would be tightened further. Perhaps when multiple values
per variable exist (generally so in 'natural' situations), characteristic i/p clustering is lost resulting
in a wide i/p range, with occasional extremely long i/p's giving an f/d more right-skewed than
log-normality. However, even in genetically mixed populations, an appropriate equivalent of the
'sinc' gene might result in less readily apparent clustering tendencies about various modal values.
However, although all six combinations showed compactness of i/p range, all were small samples.
Large samples for each specific combination might result in occasional extreme right outliers, as
in other datasets, which would alter mean, but not modal i/p.
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9.4.2.3 Association between modal and mean incubation period and coefficient of skewness.
Although the c/s was not statistically significant for five of the six mouse/agent combinations,
there was a statistically significant reduction in c/s with increasing modal lip, and almost so for
mean i/p. However, inoculation age was stated to vaiy from 22-152 days, therefore this result
cannot be directly equated to a reduction of c/s with increasing mean a/o, unless mean inoculation
age was similar for each group, and this is not known. (Since sample sizes are all small and firly
similar, any effect of sample size on c/s would be expected to affect each group similarly.)
9.4.3 CJD in Euinea-pigs
9.4.3.1 Incubation period frequency distribution analysis findings.
Table 9.4.3.1(i) gives the l/d analyses findings, table 9.4.3.1(u) the lid description.
Table 9.4.3.1 CJD in guinea-pigs; summa
Dataset	 N	 FId compatible with:-
Normality	 Log-
Full set
	
79	 No	 No
Passage 2	 10	 Yes
	 Yes
Passage 3	 27	 Yes	 Yes
Passage 4	 14	 Yes
	 Yes
of f/d analyses.
Skew for:-
Raw	 Transfor-
data	 med data
R	 R
NS	 NS
NS	 NS
NS	 NS
Table 9.4.
Dataset
Full set
Passage number 2
Passage number 3
Passage number 4
CJD in uinea-ni!s: descrintions of f/d.
Right skew too extensive even for log-normality
Compatible with both normality and log-normality
I,
The full dataset was vety right skewed, due almost entirely to the two 'first passage' cases. These
are also different from each other, at 422 and 512 days; it is assumed that one is derived from
each of the two human cases mentioned in the source paper. On subsequent guinea-pig to guinea-
pig passage the three small dataset lid's were all compatible with both normality and log-
normality.
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9.4.3.2 Effect of passage on incubation period.
Passage of CJD agent reduces the subsequent mean i/p up to and including inoculation into the
fourth guinea-pig and after this it appears to stabilise. The greatest reduction is on passage from
first to second guinea-pig (46.5%), after which reduction per passage is much less marked,
reaching 40.5% of original i/p by the fifth guinea-pig.
9.4.4 Comparison with Sartwell's conclusions.
Both mice inoculated with BSE agent, and guinea-pigs inoculated with CJD agent demonstrate
that, with experimental variation present (age at inoculation, and passage number respectively), a
dataset with a right skew too extended for compatibility with log-normality is possible.
Reduction of variability by using highly characterised mouse and scrapie agent strains resulted in
substantial narrowing of i/p ranges, which were then generally compatible both with normality
and log-normality. However, these data sets were also small; although they do not conflict with
Sartwell's hypothesis, it is not confirmed.
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CHAPTER 10
HUMANS: DATA ANALYSIS AND DISCUSSION: Natural and iatrogenic
TSE/prion disease.
10. Summary.
10.1 Analyses of sporadic cases of TSE.
10.2 Analyses of cases of TSE with familial history or PrP gene mutation;
Nifi and GLS data.
10.2.1 Analysis of all cases with known familial history.
10.2.2 Analysis of cases with known PrP gene mutation, either in the case or
another affected family member.
10.2.2.1 Mean age at onset by genetic mutation recorded.
10.2.2.2 Analysis of age at onset frequency distribution by genetic
mutation.
10.2.2.3 Association between coefficient of skewness, and mean and modal
age at onset.
10.2.2.4 The 'met'val' heterogeneity factor.
10.3 Analysis of transmitted cases.
10.3.1 Kuru.
10.3.2 Analysis of pituitary hormone injection cases.
10.3.2.1 Analysis of data supplied by Dr R Will.
10.3.2.2 Analysis of data on French cases supplied by Dr P Brown.
10.3.3. Analysis of other iatrogenic cases.
10.4 Discussion
10.4.1 Age at onset and incubation period frequency distribution analysis findings.
10.4.1.1 Comparison of age at onset frequency distribution in sporadic and
familial TSE datasets.
10.4.1.2 Cases with recognised transmission routes: age at onset frequency
distribution findings.
10.4.1.3 Cases with recognised transmission routes: incubation period
frequency distribution findings.
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10.4.1.4 Cases with mutation of PrP gene recorded: association between
age at onset frequency distribution, and mean and modal age at
onset.
10.4.2 Summary of the findings from the analysis of the other variables.
10.4.3 Comparison with Sartwell's conclusions.
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CHAPTER 10
HUMANS: DATA ANALYSIS AND DISCUSSION.
Natural and iatrogenic TSE/prion disease.
Sn mmarv.
The frequency distribution (f/d) of age at onset (a/o)
for cases with no known risk factor (sporadic
disease) has an extended left skew incompatible with
normality, and mean a/o of around 60 years. For
non-sporadic cases (those with identified risk factors
of familiarity or PrP gene mutation) a/o f/d is also
left skewed, although mean a/o reduces to 45-50
years. If a/o approximates to incubation period (lip),
Sartwell's hypothesis of log-normality does not
apply.
Cases grouped by PrP gene mutation have
characteristic alo means and modal regions; mean
aio varies from 33 to 55 years. There is evidence that
fld coefficient of skewness (cls) is associated with
modal (and mean) alo, right skewness decreasing as
modal a/o increases. The complete non-sporadic f/d
thus comprises discrete modal regions and f/d's, each
associated with a particular mutation. Further
genetic analysis should allow further discrimination
into individual lid's.
Datasets for recognised infectious transmission route
cases (kuru, iatrogenic) are small, but both i/p f/d
and a/o lid tend to right skewness; modal a/o's are
earlier than for other groups and again may be
associated with c/s. Small sample sizes makes
confirmation of Sartwell's hypothesis impossible.
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10.1 Analyses of sporadic cases of TSE.
The a/o data (in years) for alo for the three data sources (see appendix 10 for all human data
source and categorisation details, unless otherwise indicated):-
Mean i/o:
SD:
Range:
Mode/modal region:
Median:
N:
UK data
62.0
9.2
29-82
65
63
376
NIH data
61.6
9.3
16-83
59-67
62
501
GLS data
56.3
10.7
23-80
5 3-70
57
97
There is no difference in mean i/o by sex for any dataset (UK data, P = 0.162; NIH data, P =
0 499; GLS data, P= 0.706; non-parametric test). The mean GLS i/o is younger than the other
two dataset i/o's. The histogram for i/o l/d for UK dataset is shown (figure 10.1). The l/d
histograms for NIH and GLS data (not shown) are broadly similar.
Figure 10.1 Sporadic CJD rn humans; UK dataset sb f/d.
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A left skew is apparent, the mode being at 65 years. There maybe a suggestion of bi-modality, at
around 35 to 37 years. Results of the i/o lid analysis for all three datasets are given (table 10.1).
Table 10.1 Sporadic TSE in humans: i/o l/d anal
Dataset N	 FId under	 CC	 C/v at P
analysis	 0.05
UK	 376 Normality	 0.984	 0.995
NIH	 501	 0.985	 0.997
GLS	 97	 •	 0.984	 0.986
UK	 376	 Log-	 0.954	 0.995
NIH	 501 normality	 0.930	 0.997
GLS	 97	 •	 0.948	 0.986
data source.
C/s	 P for c/s
	-0. 2 	 <0.001
	
-0.754	 <0.001
	
-0.676	 0.007
	
-1.372	 <0.001
	
-2.205	 <0.001
	
-1.394	 <0.001
As predicted from the histograms, none of these datasets have an lid compatible with log-
normality. In each dataset there is a marked left skew too extended even for compatibility with
normality.
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10.2 Anal yses of cases of TSE with familial histor y or PrP gene mutation; NIH and GLS
data.
10.2.1 Analysis of all cases with known familial history.
The a/o data (in years) for alo for the two datasets is given in table 10 2.1(i).
Table 10.2.1(i). Familial TSE in humans: a/o data (in years) by data source.
Data source	 N Mean a/o SD Range Mode Median
NIH	 218	 48.8	 12.6	 19-83	 46	 50
GLS	 159	 44.5	 12.5	 20-73	 40	 43
Within neither dataset is there any difference in the mean a/o categorised by parent-positive
disease status, whether for mother, father, or both parents (P values ranged from 0.118 to 0.436,
non-parametric tests). However, there is a difference in mean a/o between the two datasets
(P=0.001, non-parametric test). The histogram of a/o f/d by data source is shown (figure 10.2.1).
Figur. 10.2.1 Familial TSE I humans; sb fid by data sourc•
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The f/d's are not markedly dissimilar and no particular skew is obvious. The a/o fld analysis
results are given in table 10.2.1(u).
Table 10.2.1 (ii) Familial TSE in humans: a/o f/d an
Dataset	 N	 F/d under	 CC	 C/v at P=
analysis	 0.05
NIH	 218	 Normality	 0.994	 0.993
GLS	 159	 •	 0.995	 0.989
NIH	 218	 Log-	 0.964	 0.993
GLS	 159	 normality	0.986	 0.989
s by data source.
C/s	 Pfor
c/s
	-0. 7	 0.202
	
0.102	 0.585
	
-1.012	 <0.001
	
-0.517	 0.008
Both datasets are compatible with normality, but not log-normality. There is no statistically
significant skew in the raw data.
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10.2.2 Anal ysis of cases with known PrP gene mutation, either in the case or another
affected family member.
10.2.2.1 Mean age at onset by genetic mutation recorded.
The mean a/o for each codon (Cn) mutation by data source is plotted (figure 10.2.2 1).
Flgia. 10.2.2.1 FamIlial TSE in humans: mean alo by PiP gene mutation and
data source.
The two data sources give very similar mean a/o's. Other values for the two data sources (not
shown) are also similar (see appendix 23 for method of estimating amount of data overlap by
source). Because the pairs are so similar, only the larger dataset in each pair is used in further
analysis. The a/o data (in years) by mutation recorded is given in table 10.2.2.1.
Table 10.2.2.1 TSE in humans: a/o data (in years) by PrP gene mutation.
Mutation	 Dataset N Mean a/a SD Range Mode/al Median
Codon 217 GLS
	
1
	
65
Codon 200 NIH
	
69
	
55.1
	
9.4
	
28-73
	
59
	
58
Codon 198 GLS
	
19
	 51.6
	
9.6
	
34-71
	
40-60
	
50
Codon 178 NIH
	
73
	
47.2
	
9.2
	
19-72
	
46
	
48
Codon 145 GLS
	
1
	
38
Codon 117 GLS
	
25
	 39.1
	
11.3 20-64
	
23-42
	
38
Codon 102 GLS
	
29
	
45.8
	
12.0 22-66
	
39
	
48
Insert
	 GLS
	
29
	 34.7
	
7_ 9	 22-5 3
	
32
	
35
10.2.2.2 Analysis of age at onset frequency distribution by genetic mutation.
The histograms of the a/o £'d for the six mutations with more than one case are shown (figure
10.2.2.2 (a)-(c)).
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Figure 10.2.2.2 TSE in humans; nb f/d by PrP gene mutation.
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Inspection of the histograms suggests an association between the mean afo and f/d skewness,
particularly for the larger samples. Table 10.2.2.2 gives a/o f/d analysis results.
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at
Table 10.2.2.2 TSE in humans; a/o f/d at
Mutation	 N F/d under	 CC
analysis
Codon 200 69 Nonnality 	 0.962
Codon 198	 19	 N	 0.993
Codon 178	 73	 N	 0.971
Codon 102 29	 0.987
Codon 117	 25	 N	 0.992
Insert	 29	 N	 0.986
byPrP
C/v at
P= 0.05
0.982
0.948
0.983
0.963
0.958
0.963
mutation
C/s
-0.955
0.209
-0.643
-0.327
0.304
0.164
-1.49 1
-0.198
-1.783
-0.880
-0.319
-0351
Codon 200 69	 Log-	 0.925	 0.982
Codon 198	 19	 normality	 0.994	 0.948
Codon 178	 73	 N	 0.915	 0.983
Codon 102	 29	 0.960*	 0.963
Codon 117	 25	 0.991	 0.958
Insert	 29	 0.979	 0.963
[Note: asterisks indicate rejection of the hypothesis of normality or log-norma
Analysis confirms the visual impression that for codon 200 mutations, a comparatively large
dataset, the a/o f/d is left skewed and incompatible with both normality and log-normality.
Codon 198 data, a very small dataset, is compatible with both.
For codon 178 mutations, also a large sample, the a/o f7d is again left skewed and incompatible
with both normality and log-normality. Codon 102 mutation data is compatible with normality,
but not log-normality.
For codon 117 mutations, and the group of inserts, both of which are small clatasets, results are
compatible with both normality and log-normality.
10.2.2.3 Association between coefficient of skewness and mean and modal age at onset.
Figure 10.2.2.3 is a plot of the mean a/o by the c/s for each mutation.
Flgur. 10.2.23 TSE in humans; fid cia by m.an sb and PrP gsn. .,utstisna.
N... .1. y..r.I
Regression analysis gives a non-significant reduction in c/s of 0.043 units for each 'additional
year to mean a/o' (r=0.64; F=2.85, P=0 166). Although for small samples, mode identification
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proved difficult, the mode, or mid-point of the observed 'modal region' is compared with c/s. The
plot (not shown) is similar to that shown above. Regression analysis again gives a non-significant
reduction, 0.035 units per additional year (r0.70, F =3.91, P0.119).
10.2.2.4 The 'met/val' heterogeneity factor.
For 36 cases, codon 129 met/val status was known. Table 10.2.2.4 gives a comparison of the a/o
for these cases with the overall a/o for the primaiy mutation. Case numbers are given in brackets.
Table 10.2.2.4 TSE in humans: effect of met/val
heterogeneity on mean a/o (data in years).
Primary	 Mean a/o	 Codon 129 alleles; mean a/o plus
mutation	 for primary	 case numbers
mutation
met/met	 met/val	 val/val
Codon 178	 47.2	 46.3 (3)	 48.2 (10)	 41.0 (7)
Codon 200	 54.9	 63.5 (2)	 -	 -
Codon 198	 51.6	 -	 56.0 (1)	 44.0 (2)
Codon 117	 39.1	 -	 40.4 (11)	 -
With such small samples, further analysis is not indicated.
10.3 Analysis of transmitted cases.
10.3.1 Kuru.
The a/o details (in years) for 18 cases:-
Mean a/o:	 24.1
SD:	 12.1
Range:	 10-45
Mode:	 16
Median:	 21
There is no difference in the mean a/o by sex (9 of each; P= 0 859, non-parametric test). The a/o
ffd histogram is shown (figure 10.3.1).
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Figur. 10.3.1 Kuru in humans; aIo f/d.
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The modal alo, at 16 years, is much younger than for previous human datasets. The histogram
appears right skewed. The f/d analysis are given in table 10.3.1.
Table 10.3.1 Kuru in humans: a/o l/d an
N
	
F/d under	 CC	 C/v at P=	 C/s	 P for
analysis	 0.05	 c/s
18
	
Normality	 0.952	 0.946
	
0.573
	
0.223
18	 ,g-normality 	0.978	 0.946
	
0.123
	
0.790
Neither the hypotheses of normality nor log-normality can be rejected. There is a statistically
insignificant right skew, however the dataset is small.
10.3.2 Analysis of pituitary hormone injection cases.
10.3.2.1 Analysis of data supplied by Dr R WilL
No significant differences were found by sex, for a/o or i/p analyses. The histogram for the a/o
(not shown) has no obvious asymmetzy. The modal region is 20-3 2 and the median is at 22. The
fld is compatible both with normality and log-normality, and is thus compatible with the visual
impression of symmetry (c/s=0. 178; P=0.675).
The i/p (estimated as years from first treatment to disease onset) data for 23 cases:-
Mean:	 15.7
SD:	 6.9
Range:	 6-35
Modal region: 9-16
Median:	 15
The i/p fid histogram (not shown) has a right skewed appearance. The i/p f/d analysis results are
given in table 10.3.2.1.
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tion cases in humans, first set: i/p f/d analysis.
	
CC	 C/vatP=	 C/s	 Pfor
0.05	 c/s
	
0.965	 0.955	 1.010	 0.029
	
0.998	 0.955	 -0.050	 0.906
The i/p lid is compatible with both normality and log-normality. However, the CC value for the
log-normal transformation is much larger than for the raw data, and the raw data is right skewed.
No association is apparent between the age at first injection and the estimated i/p. Regression
analysis gives an i/p increase of 0.05 years, per additional year of age at commencement of
treatment (r=0.05, F=0.05, P=0.821).
10.3.2.2 Analysis of data on French cases supplied by Dr P Brown.
The i/p is estimated both from first treatment (maximum possible) and from 1985 (probable
contamination date; see appendix 10). The i/p (estimated as years from 1985 to disease onset)
data for 21 cases:-
Mean:	 6.1
SD:	 1.0
Range:	 4-7
Modal region:	 7
Median:	 7
The i/p lid histogram, showing i/p estimate from 1985, plus time from first treatment is shown
(figure 10.3.2.2).
Figur. 10.3.2.2 Pituitary injection casea in humans. French dataset: I/p f/d
assuming infection in 1985, pIus f/d ot time from first treatment (maximum
Up').
—	 so so	 so so o —	 e. so so	 so so
l/p lye.")
Assuming infection occurred in 1985, the lid appears left skewed, with a veiy marked mode and a
maximum at 7 years. However, data was collected up to mid-1993, eight years after 1985.
Allowing for a reporting lag, 7 years is probably the longest observable i/p duration under tius
assumption. Table 10.3.2.2 gives i/p lid analysis, using the i/p estimated from 1985.
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Ic 10.3.2.2 Pituitar
N	 Fid under
analysis
21	 Normality
21	 Log-normali
injection cases in humans,
CC	 C/vat
P= 0.05
0.997	 0.952
0.997	 0.952
French set: i/p l/d anal
C/s	 Pfor
	
-0.583	 0.197
	
-0.782	 0.09 1
Neither the hypotheses of normality nor log-normality can be rejected, although the left skew
approaches significance in the log-transformed data.
10.3.3. Analysis of other iatro2enic cases.
The data comprises 9 dura mata grafts, one comeal graft (i/p 18 months), and one transmission
by contaminated electrode (i/p 20 months). Table 10.3.3 gives the 9 dura graft details.
Table 10.3.3 Dura graft cases in humans; i/p and a/o data.
Factor examined	 Mean	 SD	 Range Modal Median
lip (months**)	 63.1	 36.1	 19-120	 30-96	 45
Age at graft (years)	 26.1	 9.5	 10-44	 23	 23
AIo (years	 31.3	 10.1	 18-51	 26	 28
The minimum i/p is less than 2 years, the maximum 10. The f/d histograms for both age at graft
and a/o (not shown) appear right skewed. Six (66%) of the grafts occur from ages 22-26. For the
i/p fYd histogram (not shown) for dura grafts alone, no particular skew is apparent. However,
inclusion of corneal and electrode transmission visually suggests the possibility of a right skew
(c/s = 0.577; P=0.296) for iatrogenic CNS infection route cases.
10.4 Discussion
10.4.1 A2e at onset and incubation period frequency distribution anal ysis findin2s.
10.4.1.1 Comparison of age at onset frequency distribution in sporadic and familial TSE
datasets.
Table 10.4.1.1(i) gives the a/o f/d analyses summaiy.
Table 10.4.1.1(i) Sporadic and familial TSE in hums
Dataset	 N	 F/d compatible with:-
Normality	 Log-
normallt
Sporadic:
UK	 376	 No	 No
NIH	 501	 No	 No
GLS	 97	 No	 No
Familial:
NIH	 218	 Yes	 No
GLS	 159	 Yes	 No
[Note:- Significance level for all analyses is at the PO.O5 level.J
summary of a/o f/d analysis.
Skew for.-
Raw	 Transfor-
data	 med data
L	 L
L	 L
L	 L
NS	 L
NS	 L
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Dataset
Sporadic:
UK
NIH
GLS
Familial:
NIH
GLS
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Table 10.4.1.1(11) gives the fYd description for each dataset, plus the mean a/o.
ic and familial TSE in humans; mean
Description
Left skew too extended for normality
Compatible with normality
and f/d descriptions.
Mean a/o I
62.0
61.6
56.3
48.8
44.5
No dataset is particularly small, the size ranging from 97 to 501. The a/o ranges observed might
therefore be expected to be representative, and were certainly wide for all datasets, from around
20 to 80 years. In both categories (sporadic and familial) GLS data has the youngest mean alo.
This may reflect a publication bias, which may also include 'time bias'; i.e. older publications
classifying cases as non-familial due to lack of evidence to the contraiy, plus a possible bias
introduced by deletion of known duplications.
There is a clear difference in the 'd for the two categories, sporadic and familial, as well as a
separation of mean a/o values.
Sporadic datasets all have modal regions around 60-70 years, followed by a sharp frequency drop,
which may be partly explained by death from competing causes, and partly by older case under-
ascertainment (Cii) SU Report, 1994) and all have veiy extended, low frequency left 'tails'
incompatible with normality.
Both fmilial datasets have earlier modal regions, around 40-50 years, and both are compatible
with normality, with a higher frequency than sporadic cases in the 20-30 age group.
Figure 10.4.1.1 is a composite (stacked) of NIH sporadic and non-sporadic (defined as having
any known risk factor, familial, ethnic, or a known genetic mutation) cases, showing the tendency
to earlier onset in cases with a known risk factor, and the overall f/d left skew for TSE/prion
disease in humans.
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Figix. 10.4.1.1 Sporadic and non-sporadic TSE in humans; NIH data; ala
f/d; stacked composite.
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None of these datasets demonstrates a right skew, in contrast to the situation with natural scrapie
in sheep and goats, and many experimental datasets.
10.4.1.2 Cases with recognised transmission routes: age at onset frequency distribution
findings.
Data on a/o was available for three of these datasets. Table 10.4.1.2(i) summanses the a/o f/d
analysis findings for the two larger datasets.
Table 10.4.1.2(i) Recognised transmission route cases in humans;
summary of a/o fld analyses.
Dataset	 N	 FId compatible with:-	 Skew for.-
Normality	 Log-	 Raw	 Transfor-
normality	 data	 med data
Kuru	 18	 Yes	 Yes	 NS	 NS
Pituitary cases
	
23	 Yes	 Yes	 NS	 NS
INota:- Signilicance level for all analyses i .1 the P=O.05 kvel.J
These are both small datasets, and from statistical analysis, compatible with both normality and
log normality. However, all have much younger mean and modal a/o's than both sporadic and
fiunilial TSE's, and, although not statistically significant, all are right skewed. Table 10.4. 1.2(u)
sununarises this finding.
Table 10.4.1.2(11) Recol
Dataset
Kuru
Pituitary cases
Dura mats cases
transmission route cases in hu
C/s	 Mode/al re
	
0.573
	
16
	
0.178
	
20-32
Not analysed: right	 23
skewed aoearance
i; a/o f/d descri
alo Mean aJo
24.1
25.0
31.3
Whilst the actual a/o for any particular case obviously depends, at least partly, on infection age, it
is suggested that the a/o f/d is dependant both on the mean, and particularly the modal a/o of a
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given dataset, with an increase in modal and mean a/o associated with a decrease in c/s. With
such small samples, this is difficult to demonstrate conclusively.
The oldest-onset case of kuru, at about 45 years, may approach the extent of natural lifespan for
remote dwelling natives of Papua New Guinea at the time these cases occurred, in the 1950's.
10.4.1.3 Cases with recognised transmission routes: incubation period frequency distribution
findings.
Three such datasets have i/p information. Two comprise pituitaly injection cases, treatment
generally being given subcutaneously. The third comprises cases where infection site closely
involves the CNS; dura grafts, comeal grafts, and brain implantation of contaminated electrodes.
For the first (international) set of pituitary hormone cases (N =23), the estimated i/p fYd is right
skewed, and the CC suggests closer compatible with log-normality than normality.
The small dataset of iatrogenic CNS-proximate transmissions (N =1 1) is also right skewed,
though non-significantly. The modal up, around 1-2 years, is much shorter than peripherally-
inoculated pituitaly cases.
The i/p lid in those cases known to be transmitted therefore appears to resemble experimental
datasets, in that the tendency is to right skewness, and an association is suggested between
infection route, particularly proximity to the CNS, and mean i/p. which would also be compatible
with experimental evidence.
For the second (French) pituitary dataset (N=2 1) the relevant f7d is probably that estimated from
1985. The rapid frequency increase and sharp truncation at 7 years suggests an epidemic only
part-way through. If the l/d is similar to that of many experimental datasets, a marked right
skewness is to be expected. If total numbers treated in 1985 were large, such an lid indicates that
many more cases are likely to develop.
10.4.1.4 Cases with mutation of PrP gene recorded: association between age at onset
frequency distribution, and mean and modal age at onset.
Table 10.4.1.4(i) gives a summary of the a/o lid analyses.
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TSE with known PrP gene mutatk
N	 Fid compatible with:-
Normality	 Log-
normalit
Codon 200
	
69	 No	 No
Codon 198
	
19	 Yes	 Yes
Codon 178
	
73	 No	 No
Codon 102
	
29	 Yes	 No
Codon 117
	
25	 Yes	 Yes
Inserts	 29	 Yes	 Yes
mmary of a/a l/d ar
Skew for.-
Raw	 Transfor-
data	 med data
L	 L
NS	 NS
L	 L
NS	 L
NS	 NS
NS	 NS
Table 10.4.1.4
I Dataset
Each of the six main PrP mutations described have a different mean a/o ranging from around 33
to 55 years. Table 10.4.1.4(u) describes the fld for each dataset (divided into 3 arbitrary groups,
'late', 'intermediate' and 'early' mean a/o), and gives the modal and mean alo values.
Table 10.4. 1.4(u) TSE with known PrP gene mutation;
modal and mean a/o (in years), and lid descriptions.
Dataset	 Description	 Mod/al Mean
region	 a/o
a/a
Codon 200	 Left skew too elongated for normality 	 59
	
55.1
Codon 198	 Compatible with normality and log-normality 	 40-60	 51.6
Codon 178	 Left skew too elongated for normality	 46
	
47.2
Codon 102
	 Compatible with normality 	 39-52	 45.8
Codon 117	 Compatible with normality and log-normality 	 23-42
	
39.1
Inserts	 Compatible with normality and lo g-normality	32
	
34.7
Even using the largest dataset for each mutation, only two have sample sizes over 30, and of
those smaller than this, three are compatible with both normality and log-normality, most
probably a reflection of small sample size. The two largest sets, one 'late' and one 'intermediate'
mean a/o both have a left skew too elongated for normality, and the remaining set, of
'intermediate' alo, is compatible with normality only.
Allowing for the difficulties of interpretation with variable size datasets, both this analysis, and
the non-significant reduction of the c/s with increasing modal and mean aio (section 10.2.2.3)
suggest that modal and mean aio's are associated with fld skewness, an hypothesis already put
forward in sections 10.4.1.1 and 10.4.1.2. Figure 10.4.1.4 demonstrates this for three mutation
groups with well separated modal a/os.
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Flgur. 10.4.1.4 TSE In humans; lid skawn.ss and modal aio; a comparison
of thr.. PrP gen. mutations.
Mutation
Different modal regions are clear. Dataset size variation may affect mean a/o results - the a/o
range observed (and thus the mean a/o) may be linked with sample size - but sample mode should
not be. Theoretically, a 'late' modal a/o implies enough time to observe unusually early cases, and
an 'early' modal a/o gives time for unusually late cases, resulting in left and right skews
respectively, and this tendency is apparent. Mean lifespan, and competing causes of death are also
relevant factors, particularly for 'late' modal a/o groups. A similar pattern exists for the remaining
mutation groups (not shown), but less clearly; case numbers are much smaller.
There is some indication that mean a/o is affected by codon 129 metival combination. If so, the
extent of this effect will depend on the proportions of each combination present in the sample.
If case numbers allowed, further subdivision for example by this classification, and separation of
inserts by type, might enable further multi-modality to be recognised. The total set of
genetic/familial cases, whilst appearing originally as a uni-modal continuum with a wide a/o
range, appears to comprise many groups, each with a characteristic a/o mode and fYd. In addition,
further PrP gene mutations have now been found (Prusiner, 1993).
Whether PrP gene mutation is sufficient cause for disease, or merely increases susceptibility, it
seems probable that the final prion protein shape will differ, dependant upon the particular
genetic mutation involved. With an extensive genetic insert, the final protein conformation may
be disrupted more than with a single codon change. Assuming protein conformation is significant
in disease aetiology, then the more abnormal it is, the less likely that particular protein is,
perhaps, to be enzymatically degraded, resulting in accelerated accumulation of an abnormal
protein and an associated earlier alo. This suggestion, that insert mutations might be the most
damaging, is supported by this data; such cases do have the earliest modal a/o.
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10.4.2 Summary of the findin2s from the anal ysis of the other vanables.
No differences were found by gender. For familial cases, there was no evidence of a difference in
the a/o between cases where the mother was also a case, and those where the father was also a
case. This may argue against maternal transmission of infectious agent (possibly concurrent with
a genetic susceptibility factor). However, case numbers with known parent disease-status were
small.
For NIH sporadic data, the mean a/o for experimentally transmitted cases (data not shown) is
younger than that with other diagnostic methods. This may reflect bias in selecting cases for
experimental transmission. Atypical cases, including younger cases, are more likely to have been
selected, particularly in later years, partly as a method of confirming diagnosis. Eight iatrogenic
cases were successfully transmitted.
For pituitary hormone cases, there is no association between i/p and age at first treatment;
however, actual infection date is unknown.
10.4.3 Com p arison with Sartwcll's conclusions.
Both sporadic and familial datasets were left skewed. If a/o is taken as an estimate of lip, these
were clearly incompatible with Sartwell's hypothesis. For fld by specific PrP gene mutation, those
mutations associated with an 'early' modal a/o tended to be more right skewed than those with a
later modal a/o. However, small sample sizes made discrimination between normality and log-
normality (or even perhaps a more extended right skew) impossible.
For transmitted cases, datasets were small but the i/p f/d were right skewed, and for one set of
pituitaiy injection cases at least, compatible with log-normality. For all such datasets where both
the i/p and the mean a/o was known, mean a/o was considerably less than for sporadic, familial,
or even individual PrP gene mutation gToups.
For many categories of human TSE/prion disease, taking the a/o as an estimate of the i/p. the
large left skew present means that Sartwell's hypothesis of log-normality does not apply. Even in
the iatrogenic transmission dataset where i/p f/d is log-normal, the small sample size makes
confirmation of this hypothesis impossible.
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CHAPTER 11
CATtLE: DATA ANALYSIS AND DISCUSSION: BSE.
11 Summary.
11.1 Age at onset frequency distribution.
11.1.1 Age at onset frequency distribution by group.
11.1.2 The effect of censoring.
11.1.3 Comparison of left censoring in groups 1 and 3Y.
11.2 Association of other variables with age at onset.
11.2.1 Analysis of age at onset by maximum possible age of exposure: Group 2.
11.2.2 Analysis of age at onset by feedflag status: Group 3
11.3 Effect of Culling.
11.4 Application of AIDS methodology to these datasets: Back-calculation to
overcome censoring.
11.5 Discussion.
11.5.1 Age at onset frequency distribution analysis findings.
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CHAPTER 11
CATFLE: DATA ANALYSIS AND DISCUSSION
BSE.
Summary.
Large datasets extending in time over the whole of
the BSE epidemic have an age at onset (a/o)
frequency distribution (f/d) which is too right
skewed for compatibility with Jog-normality.
The effect of censoring over the duration of the
epidemic is marked, resulting in a decrease in mean
alo in successive birth cohorts, with a concurrent
decrease in coefficient of skewness (cls); lid of
successive cohorts changes from right skewness,
through symmetry, to left skewness.
Back-calculation (as used in AIDS analysis) utilises
an assumed incubation period (lip) lid in analysis; of
the three distributions tested (Weibull, gamma, log-
normal), log-normal gave the best fit to observed
data.
It is suggested that, for BSE, log-normality may be a
reasonable approximation to alo f/d over much of
the alo range. However, even if alo is a good estimate
of lip, Sartwell's hypothesis is not confirmed; low
probability, long i/p (alo) cases may make large
datasets too right skewed.
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11.1 Ae at onset frequency distribution.
11.1.1 A!e at onset frequency distribution b y !roup.
The aio data (in months) by group (see appendix 10 for group definitions) is given in table
11.1.1(i).
Table 11.1.1(i) BSE in cattle; a/o data (in months) by group.
Group N	 Mean SD Range Modal Median
region
1	 488	 60.9	 12.0 33-113	 59-60	 60
2	 204	 61.8	 11.1 38-122	 55	 61
3	 5810	 60.8	 12.9 21-133	 49-65	 59
At just over five years (i.e. 61 months), there is no difference between the mean a/o by group (P =
0 143, non-parametric test). Group 3, the largest sample, has the widest range. Figure 11.1.1
illustrates a/o lid for group 3; all groups were similar.
Figure 11.1.1 BSE ki cattle; group 3; nb fid.
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A right skew is apparent. Table 11.1. 1(u) gives results of a/o lid analyses for all groups.
Table 11.1.1(u) BSE in cattle; a/o l/d analysis by group.
Group	 N	 FId under	 CC	 C/v at P= 	C/s	 P for
analysis	 0.05	 c/s
1	 488	 Normality	 0.975	 0.997	 0.973	 <0.001
2	 204	 N	 0.973	 0.992	 1.040	 <0.001
3	 5801	 0.973	 0.999	 1.066	 <0.001
1	 488	 Log-	 0.996	 0.997	 0.289	 0.0 10
2	 204	 normality	 0.995	 0.992	 0.231	 0.169
3	 5801	 •	 0.997	 0.999	 0.309	 <0.001
None are comparable with normality; all are right skewed. The two larger groups, 1 and 3, are
also too right skewed for compatibility with log-normality whereas group 2, the smallest group, is
compatible with log-normality.
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59
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55
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52
52
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SD
16.8
14.1
14.2
12.6
11.8
10.8
8.8
6.2
4.3
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Median
88
77
67
62
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59
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47
68-132
55-125
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39-105
32-98
31-87
34-76
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11.1.2 The effect of censoring.
Groups 1 and 3Y were examined and gave similar results. Results for group 3Y results are
shown. Table 11.1.2 (1) gives a/o data (in months) by calving cohort.
Table 11.1.2(i) BSE in cattle; group 3Y;
Calving cohort	 N	 Mean a/o
81	 29	 92.6
82	 185	 78.6
83	 454	 69.9
84	 713	 63.7
85	 712	 61.5
86	 932	 60.2
87	 1281	 56.1
88	 306	 52.8
89	 65	 46.2
90	 1	 21.0
Sample size varies (1 to 1281), the 87 cohort directly before the 'feedban' (on 18th July, 1988)
being largest. Mean a/o reduces significantly (P<0.0O1, non-parametric test) with cohort, as do
medians. The a/o appears stable for cohorts 8 5-86 (P =0. 106, non-parametric test). Inclusion of
either cohort 84 or 87 alters this (P<0.0Ol in both cases, non-parametric test). Medians for 84-86
are the same. Regression of a/o on calving cohort gives a reduction of 3.6 months per cohort (r =
-0.48, F=1384.80, P<0.001). Figure 11.1.2 shows a/a histograms by calving cohort (90 excluded).
Figure 11.1.2 BSE in cattle; group 3Y: effect of censoring on a/o range by calving cohort.
(Vertical axes are mlnlmlsed and not to scale)
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The one case for cohort 90 is atypically early. Excluding this, left censoring is only marked for
cohorts 81-82. Right censoring occurs through the whole period. Table 11.1.2. (ii) gives a/o fld
analyses by calving cohori
Table 11.1.2(u) BSE in cattle; group 3Y; a/o f/d analysis by calving cohort.
	
Calving N F/d under	 CC	 C/v at	 C/s	 P for Skew
cohort	 analysis	 P= 0.05	 c/s
81	 29	 Normality	 0 . 931*	 0.964	 1.178	 0.008	 R
82	 185	 N	 0.969*	 0.991	 1.004	 <0.001	 R
83	 454	 0.964*	 0.997	 1.117	 <0.001	 R
84	 713	 0.980*	 0.998	 0.755	 <0.001	 R
85	 712	 0.987*	 0.998	 0.616	 <0.001	 R
86	 932	 N	 0.994*	 0.998	 0.249	 0.002	 R
87	 1281	 N	 0.994*	 0.999	 0.049	 0.472	 NS
88	 306	 0.992*	 0.995	 -0.362	 0.010	 L
89	 65	 N	 0.962	 0.981	 -1.000	 0.002	 L
81	 29	 Log-	 0.960*	 0.964	 0.812	 0.051	 R
82	 185	 normality	 0.990*	 0.991	 0.505	 0.006	 R
83	 454	 N	 0.989*	 0.997	 0.534	 <0.001	 R
84	 713	 N	 0.996*	 0.998	 0.289	 0.002	 R
85	 712	 N	 0.998	 0.998	 0.125	 0.171	 NS
86	 932	 N	 0.996*	 0.998	 -0.130	 0.104	 NS
87	 1281	 N	 0.993*	 0.999	 -0.260	 <0.001	 L
88	 306	 N	 0.983*	 0.995	 -0.686	 <0.001	 L
89	 65	 N	 0.945*	 0.981	 -1.271	 <0001	 L
[Note: Asterisks indicate incompatibility with normalityllog-nonnality.
significance of aitew is at U.0 level, propamme will not calculate probability for NJ
With large sample sizes, the trend from right to left skewness with successive cohorts is clear.
None are compatible with normality. Only cohort 85, with demonstrated right censoring, is
compatible with log-normality. Cohorts 88-89 have left skews.
Regression of the c/s on calving cohort gives a reduction of 0.26 units per cohort (r=0.96,
F76.50, P<0/001). Conversely, in the presence of censoring, regression of c/s an mean a/o gives
an increase of 0.05 units per additional month (r=0.86, F=19.94, P=0.003).
11.1.3 Comparison of left censoring in groups 1 and 3Y.
Comparison of the histograms (not shown) suggests that left censoring may be slightly less in
group 3Y than in group 1. Differences in the amount of left censoring in a cohort would be
expected to alter minimum and mean a/o. For group 1, for cohorts 8 1-82 and 89, small sample
size makes comparisons unrewarding. The remaining cohorts are compared (table 11.1.3).
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Table 11.1.3 BSE in cattle; groups 1 and 3Y; comparison of minimum
and mean sb's (in months) per cohort.
Group Measurement	 83	 84	 85	 86	 87	 88
1	 Msnunuma/o	 51	 43	 40	 33	 37	 36
3y	 -	 41	 39	 32	 31	 34	 31
1-3Y	 Difference	 10	 4	 8	 2	 3	 5
1	 Mean./o
	 70.3	 65.0	 63.6	 61.7	 57.9	 54.3
3Y
	 69.9	 63.7	 61.5	 60.2	 56.1	 528
1-3Y	 Difference
	 0.4	 1.3	 2.1	 1.5	 1.8	 1.5
P for difference	 0.841 0.941 0.192 0.162 0008 0.123
For all cohorts, the mean a/o is less for group 3Y than 1, but only statistically significantly so for
87, the largest cohort. Minimum a/o is again less for all 3Y cohorts, more markedly so in the
early cohorts. Data are consistent with the hypothesis that there is less left censoring in group 3Y.
11.2 Association of other variables with ae at onset.
11.2.1 Analysis of ae at onset by maximum possible ae of exposure: Grou p 2.
Maximum possible age of exposure is estimated as age at purchase (a/p). Details (in days):-
Mean a/p:	 152
SD:	 111
Range:	 0-365
Mode:	 0
Median:	 151
A minimum a/p of zero implies transfer to the new farm on the day of birth; this is also the modal
a/p (9 cases). Figure 11.2.1 plots a/p (in days) against alo (in months).
Pgws 11.2.1 BSE hs cMlte; sb (month.) by sip (days).
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No marked association is apparent. Regression analysis gives a reduction of 0.01 months in the
a/o per additional day of possible exposure (r=0.01 1, F=2.29, P=0. 132). The mean a/p does not
vaiy with cohort (P=0.225, non-parametric test), and no correlation is apparent (r=-O.03),
therefore confounding by calving cohort is unlikely.
11.2.2 Anal ysis of age at onset by feedfla g status: group 3
The large 87 cohort is used to examine the a/o by feedflag status (see appendix 10 for feedulag
definition). Table 11.2.2(i) gives a/o data (in months) by feedflag status.
	
Table 11.2.2(i). BSE in	 tie; group 3/87; a/o data (in months) by feedflag status.
Feedflag N Mean a/o SD Range Mode Median
Y	 1281
	
56.1	 8.8	 34-76	 52	 56
N	 99
	 58.4	 8.0	 38-75	 55	 59
Although the mean a/o by feedflag is different (P0.006, non-parametric test), a/o ranges are
broadly similar. Figure 11.2.2 compares a/o f/d by feedflag Status.
FIgure 11.2.2 BSE in catde: Group 3/87: sb f/d by feedfiag status
There is an impression that, for feedflag N, f/d may be slightly left skewed. Feedflag Y appears
roughly symmetrical. Table 1 1.2.2(u) gives fld analysis results by feedfiag status.
Table 11.
	
Feed	 N
-flag
	Y	 1281
	
N	 99
	
Y	 1281
	
N	 99
(ii). BSE in cattle; gro
F/d under CC
analysis
Normality	 0.994
N	 0.995
Log-	 0.993
normality	0.986
3/87; afo f/d by feedflag status.
C/v at
	 C/s	 P for
P= 0.05	 c/s
0.998	 0.049	 0.472
0.987	 -0.278	 0.236
0.998	 -0.260	 0.002
0.987	 -0.622	 0.012
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Feedfiag Y f/d, although symmetrical, is incompatible with both normality and log-normality.
Rejection of normality is therefore on other grounds, for example kurtosis; large sample size
makes compatibility more difficult to achieve. For feedflag N, a much smaller sample, data is
compatible with normality; left skewness is not marked.
11.3 Effect of Cullina.
Figure 11.3 shows observed the a/o fYd (in years) for group 3 as observed, compared with the
same group adjusted for culling (method, appendix 24). Results for group 1(not shown) were
similar.
Figur. 11.3 BSE In cattle: group 3: effect of cuUing correction on a/a fld
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The culling correction has increased the sample size by 20% to 6962 cases. The 'unculled' mean
a/o is 4.7 years (SD 1.17), as against 4.6 years (SD 1.11), for the observed, culled sample. The a/o
fYd appears similarly right skewed for both datasets, and a/o 17d analysis conclusions are similar
(see section 11.1.1). Both have a right skew which persists even in log transformed data. No
values for cull adjustment are calculable for ages 12 and 13.
11.4 Application of AIDS methodolo y to these datasets: Back-calculation to overcome
censoring.
Back-calculation (kindly undertaken by R Sayers; see appendix 25) was performed for three
different a/o fYd assumptions, Weibull, gamma and log-normal, each for groups 1, 2, 3 and 3Y.
All groups gave similar results. Table 11.4 gives results for group 3, both unadjusted and adjusted
(in brackets) for culling (excluding the 1 case < 2 years old); N5809.
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Table 11.4 BSE in cattle; group 3; estimates of a/o data (in months) from back-calculation:
unadjusted and (adjusted) for culling.
Distribution	 Percentiles
1%	 50%	 95%	 99%
Gamma	 39(40)	 62(68)	 91 (104)	 107 (124)
Weibull	 37 (38)	 63(68)	 89 (97)	 100 (109)
Log-normal	 41(41)	 65(68)	 99(113)	 121 (143)
Mean	 Mode	 Max log likelihood
Gamma	 64.0 (69.9)	 58 (62)	 -3405.32 (-3419.53)
Weibull	 63.9 (69.0)	 61 (66)	 -3585.76 (-3482.38)
Log-normal	 67.5 (72.3)	 60 (61)	 -3378.39 (-3390.47)
The maximum log-likelihood is the largest for the log-normal distribution. For this distribution,
the mean a/o is around 6 years, an increase on all previous estimates, and the 99% value is
around 10 (unadjusted) to 12 (adjusted) years.
11.5 Discussion.
11.5.1 A ge at onset frequency distribution analysis findings.
11.5.1.1 Frequency distribution for complete groups.
Table 11.5.1.1(i) gives the a/o f/d analyses summaries for the three complete groups.
of a/o lid analyses.
Skew for:-
Raw	 Transfor-
data	 med data
R	 R
R	 NS
R	 R
Table 11.5.1.1(i) BSE in cattle; summar
Group	 N	 Fid com patible with:-
Normality	 Log-
normality
1	 488	 No	 No
2	 204	 Yes
3	 5801	 No
Table 11.5.1.1(u) gives the L/d description for the 3 groups.
Table 11.5.1.1(u). BSE in cattle; alo lid descriptions.
Group	 Description
I	 Right skew too elongated even for log-normality
2	 Compatible with log-normality
3	 Right skew too elongated even for log-normality
The two larger samples are too right skewed to be compatible with log-normality; the smaller set
is nol Sample size has already been implicated as important in observed skewness but, here, all
samples are relatively large.
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11.5.1.2 Effect of censoring on frequency distribution.
When examined by birth cohort, groups I (not shown) and 3Y both demonstrate a trend for the
a/o lid skewness to move gradually from right to left over time. Table 11.5.1.2 describes lid
skewness, by cohort, for the larger set 3Y.
Table 11.5. 1.2 BSE in	 f/d skewness description by cohort.
cntjtion	 1
81	 Right skew too elongated even for log-normality
82
83
84
85
	
Skew compatible with log-normality
86
87
	
Skew compatible with normality
88
	
Left skew too elongated for normality
89
Although for the cohorts 85-86 the a/o skewness is compatible with log-normality, for the
remaining 7 of the 9 cohorts it is not.
When subdivided by feedflag status, (an indicator of probable exposure in the first year of life),
both 'Y' and 'N' subsets from group 3/cohort 87 had skews which were compatible with normality,
as did the complete 87 cohort. However, the smaller group ('N'; N = 99) was compatible with
normality, whilst the larger group ('Y'; N=1281) was not. This may reflect the discriminant
ability of the tests, when applied to different sample sizes.
11.5.2 Censoring: association of birth cohort with ae at onset and coefficient of skewness.
During an epidemic of a disease with a long up, if the 'true' i/p lid is not changing over time, then
censoring results in the reduction of mean i/p in subsequent infection cohorts (Petennan, 1987).
Clearly, if the 'true' i/p is changing with time, the pattern observed will become even more
complex, however censoring will still be present, and constitute an important component of any
observed i/p change over time. In addition, if a/o is used to estimate up, then if infection is not
close to birth, apparent i/p will be affected.
Effective exposure to the BSE agent is thought to have commenced in the winter of 198 1/82 (i.e.
the 81 birth cohort) (Wilesmith et al, 1988). Therefore, in order to give at least the possibility of
exposure from birth (and thus increase the probability of a/o as a valid estimate of up) this is the
first cohort included in the in the BSE groups analysed here.
144
CATrLE: Data analysis and discuu ion.
It is possible, for BSE, that the 'true' i/p changed over time, perhaps due to early low doses, or
post-passage adaptation of agent in cattle after recycling. Any major flrstpassage change in 'true'
i/p Ud due to these effects might be expected to cause a sudden, rather than a gradual change in
the pattern of a/o f/d by cohort observed. However, the gradual pattern of a/o change observed fits
vety closely to the theoretical pattern which would be caused by censoring, and in particular right
censoring. Although it is therefore unproven that censoring is the only influence on the observed
a/o, it seems reasonable to conclude that it is a major influence, which even by itself renders the
observed a/o lid unreliable.
Using the a/o to estimate the up, considered valid since early exposure is likely, both groups 1
(not shown) and 3Y demonstrate an average reduction of 3.6 months in mean a/o per birth cohort
through the epidemic.
If 'true' i/p is stable, once the theoretical maximum i/p for any infected cohort has passed,
assuming good case ascertainment, right censoring will be eliminated for that cohort. if, due to
good case ascertainment, left censoring is also eliminated and adequate case numbers exist, then
observed i/p mean and range should reflect the underlying theoretically possible values. For
subsequent cohorts where maximum i/p has also been passed, the observed mean, maximum and
minimum values should stabilise. Right censoring will again be apparent in later cohorts where
this maximum has not yet occurred. The modal i/p should be more stable than the mean, and be
affected by censoring only when outside the observed i/p range. A gradual reduction of 'true' i/p
would cause modal instability, whilst a sudden, sizeable reduction in 'true' i/p should, eventually
be apparent as a second region of mean and modal a/o stability, given adequate later cohort sizes.
For both groups, the a/o for cohorts 85-86 appears relatively stable, in the region of 60-63 months
(and have a skewness compatible with log-normality). Due to the rather flattened f/d for most
cohorts (possibly, partly, a reflection of spread of infection age through the first year) a modal
region may be more appropriate than a specific point. The mode for group 1 is relatively stable
from 83 onwards, at around 60 months whilst for group 3Y it is less stable; it is possible that this
is an indication of a 'true' i/p change superimposed upon the censoring effect.
The calculated c/s reduces with successive cohorts, as skewness changes from right to left;
therefore as mean a/o reduces, so does c/s. Thus, in the presence of epidemic censoring, and for
analysis by cohort, association between mean a/o and c/s is (artifactually) reversed from that
suggested by other data, where a younger mean a/o is generally associated with larger c/s.
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Group 3, the 'pre-order' herds, might be expected to suffer less left censoring than other herds.
The data is not inconsistent with this, but impossible to confirm due to the small size of
comparison groups.
11.5.3 Effect of ae at infection on mean ae at onset.
Using the a/p to estimate the maximum age of exposure (group 2), increasing a/p resulted in a
(non-significant) reduction in a/o of 0.01 months per day (equivalent to 3.7 months per year).
However, if first exposure is generally soon after birth, and if infection by the agent generally
occurs at the first exposure, maximum age of exposure may be unimportant.
The increase in the mean a/o for animals recorded as not fed suspect foods in the first year of life
(group 3N) is statistically significant, at 2.3 months. Even allowing for a potential age at
infection effect of i/p reduction of 3.7 months per year (see section 11.2.1), a greater increase
might be anticipated. Possible explanations include recording errors, incorrect assumptions about
infection age, poor infection efficiency at first exposure (group 3Y), access to concentrates
intended for other age groups, general farm and pasture contamination and lateral transfer,
resulting in unrecorded earlier exposure and infection. In addition, i/p may be dependant upon
additional unknown biological factors resulting in a tendency for overt disease to develop at a
particular modal age (assuming infection had occurred prior to that age).
11.5.4 Culling.
Cattle are culled for many reasons, including ill health and poor productivity. Culling patterns
may be different in BSE-negative herds, although earlier investigations into other diseases found
a similar pattern (J Wilesmith, personal communication). In addition, herds with high BSE
attack rates may suffer heavy culling at particular ages. The culling pattern derived will,
therefore, be only approximate.
Although culling reduces cases of overt BSE, the modal and mean a/o and a/o f7d appear
relatively unaffected. However, no adjustment can be applied for ages when no case was observed.
Therefore the maximum a/o for an unculled sample can only be estimated by extrapolation,
giving a right tail extension and increased skew. This would only be observed if, due to a
different culling pattern, sufficient cattle lived longer. Since in practice, culling patterns are
thought to have remained relatively stable over time, the observed f/d is more likely to be useful
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in predicting overt disease. Culling adjustment will only affect the observed a/o f/d if dairy herd
management alters to the extent that the culling pattern changes on many farms.
This culling adjustment gives an estimate of the numbers of adult daiiy cows culled whilst
incubating disease; here, approximately 17% of the total potential cases. Some may be
slaughtered for food.
11.5.5 Back-calculation applied to BSE data.
Under the assumptions given (see appendix 25), log-normal distribution fitted the data better than
either Weibull or ganuna distributions. Using this distribution, comparison of group 3 data,
unadjusted for culling, gives a mean a/o of 60.8 months for observed data (with or without the
atypical 21 month case), and 67.5 months by the back-calculation method (which excluded that
case). The minimum observed a/o (excluding the 21 month case) of 31 months is less than the 41
months for back-calculation 1st percentile, whilst the maximum observed a/o (133 months) is
greater than the 121 months for the back-calculation 99th percentile. The mode, by back-
calculation estimated as 60 months, is within the modal region of 49-65 for observed data.
If log-normality is an appropriate distribution to use, then this method gives no evidence for
censoring of the a/o extremities in this dataset, although increase in the mean a/o suggests a
shortfall in observed numbers with older a/o's, possibly due to right censoring in recent cohorts.
Alternatively, this discrepancy may arise because log-normality is not the most appropriate
distribution, and/or that the working assumptions were incorrect
11.5.6 Com parison with Sartwell's conclusions.
There is some indication, both from the 85/86 cohorts of group 3Y (over most of their range,
probably the least distorted by censoring) and from the maximum log-likelihood results for
distributions used in back-calculation, that log-normality may, for BSE, be a reasonably close
approximation to a/o fYd over much of the alo range.
Nevertheless, even if the a/o is a good estimate of the up, these results do not confirm Sartwell's
hypothesis. The a/o fld's for the largest two complete groups are too right skewed for log-
normality, although the smallest one is compatible. Previous results indicate an association
between sample size and skewness, most probably due to low probability, long i/p (a/o) cases.
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CHAPTER 12
ASSOCIATION BETWEEN SAMPLE SIZE, STANDARD DEVIATION,
AND COEFFICIENT OF SKEWNESS FOR A LOG-NORMAL
FREQUENCY DISTRIBUTION.
12.1 Theoretical values for coefficient of skewness for a log-normal frequency
distribution.
12.2 Observed values from random number generation.
12.3 Frequency distribution of observed coefficient of skewness values.
12.4 Discussion.
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CHAPTER 12
ASSOCIATION BETWEEN SAMPLE SIZE, STANDARD DEVIATION,
AND COEFFICIENT OF SKEWNESS FOR A LOG-NORMAL
FREQUENCY DISTRIBUTION.
12.1 Theoretical values for coefficient of skewness for a bE-normal frequency distribution.
Theoretical c/s were calculated for a range of SD values (method; appendix 26). Examples of
results are as follows:-
SD	 C/s	 SD
	
C/s
	
0.005	 0.0 15
	
0.05
	
0.15
	
0.0 10	 0.030
	
0.10
	
0.30
	
0.015	 0.045
	
0.50
	
1.75
	
0.020	 0.060
	
1.00
	
6.19
	
0.025	 0.075
	
1.50
	
33.5
	0.030	 0.090
	
2.00
	
414.4
	 . 4 	 0.120
	
2.50
	
11,824
Results shown suggest that as SD decreases, c/s also decreases; intuitively this makes sense, since
an SD of zero would mean that all values were identical, and no skew would exist. Further
analyses will involve only SD values of 0.05 and larger.
12.2 Observed values from random number Eeneration.
Initial investigation of the association between sample size and c/s when the underlying
distribution is log-normal was undertaken by random number generation (method: appendix 27),
for many combinations of SD and sample size, with 10 random-generation repeats for each.
Figure 12.2(a)-(d) gives examples of results; each graph plots, for a particular SD, and sample
sizes from 5 to 500, the 10 individual c/s values per combination.
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Figure 12.2(a)-(d) Association between sample size and c/s for different SD values:
log-normal distribution.
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For SD = 0.05, for sample sizes below 50, c/s is unstable, with values both above and below the
theoretical c/s, after which it converges around theoretical c/s value.
For larger SD values it is apparent that as sample size increases, observed c/s tends to increase
until the theoretical c/s value is approached; however, as SD increases, so does the sample size
needed in order to attain theoretical c/s.
Table 12.2(1) gives mean c/s (and SD of the c/s values) values for the ten observations, for sample
sizes 5, 40, 100, and 500 for each SD of underlying distribution used to generate the random
numbers.
Table 12.2(i) Comparison of observed and theoretical c/s by sample size and SD;
10 observations ner combination
Mean (and SD) for 10 observed c/s values for.-	 Theoretical
SD	 N =5	 N=40	 N=100	 N=500	 c/s
0.05	 0.31 (0.47)	 0.11 (0.28)	 0.04 (0.27)	 0.16 (0.14)	 0.15
0.5	 0.10 (0.73)	 1.15 (0.57)	 1.43 (0.32)	 1.66 (0.24)	 1.75
1.0	 0.58 (0.56)	 2.03 (0.93)	 3.16 (0.89)	 4.18 (1.30)	 6.19
2.5	 1.02 (0.40)	 4.13 (1.49)	 5.92 (1.39)	 13.24 (4.32)	 11.824
Increase in mean c/s with increasing sample size confirms graphical interpretation. Even for an
underlying SD of only 0.5, mean observed c/s with sample size of 500 does not quite match
theoretical c/s (95%), and for SD of 2.5, it is only 0.1%
For further analysis, numbers of repeats per SD/sample size combination was increased from 10
to 5000. Table 12.2(u) gives examples of results.
Table 12.2(u) Comparison of observed and theoretical c/s by sample
size and SD; 5000 observations ner combination.
Mean (and SD) for 5000 observed c/s values	 Theoretical
c/s
SD	 N=5	 N=500	 N=1 million
0.05
	
0.04 (0.62)	 0.15 (0.11)	 0.15 (<0.00)	 0.15
1.5
	
0.84 (0.57)	 7.96 (3.49)	 29.77 (20.20)	 33.5
With 5000 random-generations per set of conditions, SD of 0.05 has a similar pattern to larger
SD's. Even with a sample size of! million, with a large SD of 1.5, observed mean c/s only
reaches 89% of theoretical.
12.3 Frequency distribution of observed coefficient of skewness values.
Figure 12.3 (a)-(b) shows c/s f/d for 5000 random-generations for SD = 1.5, for sample sizes of 5
and 1 million.
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Figure 12.3(a)-(b) Coefficient of skewness frequency distribution for 5000 random-
generations; SD of theoretical distribution - 1.5.
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Range and c/s distribution both vazy greatly with sample size, even though samples were
randomly generated from the same theoretical distribution.
C/s for the distribution of the individual c/s's are as follows:-
N= 5:	 C/s for c/s f/d = -0.736 (P<0.001)
N=1 million:	 C/s for c/s f/d = 7.009 (P<0.001)
C/s f7d for N=lmillion is also incompatible with both normality and log-normality (correlation
coefficients: 0.665 and 0.901 respectively, critical value 0.999), and log-transformed data is still
markedly right skewed (c/s = 2.257, P<0.0O1).
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12.4 Discussion.
Results from previous chapters indicate that sample size and fYd c/s (and hence compatibility with
any particular distribution) may be associated.
Results presented in this chapter demonstrate that for a theoretical log-normal distribution, when
observed sample size is small, mean observed c/s tends to be much less than theoretical c/s; as
sample size increases, mean observed c/s tends to increase towards theoretical c/s. Theoretical c/s
increases with increasing SD of the theoretical distribution from which the random numbers are
drawn. The sample size at which mean observed c/s reaches theoretical c/s depends upon the SD
of this theoretical distribution; with a small SD (e.g. 0.05) , theoretical c/s is reached with a
smaller sample size than with a large SD (e.g. 1.5).
There is also a dependency upon the numbers of separate sample observations used to calculate
the mean c/s. The distribution of the c/s values, both for N=5 and N1 million with SD=1.5 both
show a wide range of values; although the mean observed c/s for N=lmillion is actually
reasonably close to the theoretical value, at 89%, range of the 5000 separate c/s values is from just
over 10 to over 320 units; 69 (1.4%) c/s estimations are over 100, and only 76% are within the
range 20-<40. A singe observation even of a sample this large could well give a highly
misleading result.
Although this analysis applies to log-normal distributions, and the distributions from which
samples in earlier chapters are taken are unknown, it is apparent that the calculated c/s of a small
observed sample cannot be equated to that of the theoretical distribution from which it is
generated and since the SD of the underlying distribution is unknown, minimum sample size
required cannot reliably be estimated. In addition, one observation of any sample size is prone to
wide errors.
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CHAPTER 13
OVERVIEW OF MAJOR FINDINGS AND CONCLUSIONS.
13.1 Evaluation of Sartwell's hypothesis as applied to TSE/prion disease.
13.1.1 Datasets with incubation period measurements.
13.1.2 Datasets with age at onset measurements.
13.2 Association of modal age at onset with incubation period and age at
onset frequency distribution and frequency distribution coefficient of
skewness.
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CHAPTER 13
OVERVIEW OF MAJOR FINDINGS AND CONCLUSIONS.
13.1 Evaluation of SartweU's h ypothesis as applied to TSE/prion disease.
The main aim of this study was to evaluate Sartwell's hypothesis in relation to TSE/pnon disease,
with the underlying objective of validating or otherwise the incorporation of a log-normal i/p (or
alo) term into BSE epidemic modelling.
The major finding from the project is that Sartwell's hypothesis is not confirmed in this group of
diseases, for a number of reasons which will now be summarised. Datasets analysed comprise
those where i/p is known, and those where a/o is used as a 'proxy' i/p. They will be reviewed
separately.
13.1.1 Datasets with incubation period measurements.
Of 43 datasets tested for compatibility with log-normality, and summarised in earlier discussion
sections, 14 (33%) had a right skew too extensive for compatibility with log-normality; 21(49%)
mostly small datasets were compatible with both normality and log-normality; 2 (5%) had left
skews; 1 (2%) was compatible with normality only; 4 (9%) were incompatible with log-normality
for other reasons, and only one (2%) was compatible with log-normality only.
However, there are many problems in the interpretation of these results. The first is the variation
in sample size, from 4 to 447. Appendix 14 indicates the loss of discriminatoiy power, with small
sample sizes, for the tests used to evaluate compatibility with normality and log-normality, and
chapter 12 shows the association of c/s with sample size. Both of these effects would tend to mask
an extreme right skew, the former by loss of discrimination, the latter by usually underestimating
the c/s. The 14 datasets with a right skew too extensive for log-normality are therefore the most
persuasive evidence of non-confirmation of Sartwell's hypothesis as the underlying theoretical fYd
in TSE prion disease.
The second major problem is that of variability in the cases within each dataset, most of which
were experimental results. Taking the 'full experimental set' datasets for each species generally
means an amalgamation of results with differences in age, environment and genetic constitution
for both donor and host, different infection routes, infecting materials, doses, agent 'strains' and
passage histories, plus many other variables. However, Sartwell's hypothesis is based on
observation of a 'mixed' situation, even if not quite so extreme. In his datasets, each case was
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genetically different, each living in their own particular way and environment. Age, health,
dosage, and many other factors for each case were also different. Armenian (1995) stresses the
robustness of this model. The Tull' datasets for goats, several primates, BSE in mice, and CJD in
guinea-pigs are veiy right skewed suggesting that, in a situation of great variability, this is not
uncommon.
In addition, there is the problem of which variables to use to categorise experimental data.
Information varies with data source, splitting reduces the sample size (e.g. the 4 case dataset),
and many variables are by their nature, unknowable. In general, in those examples where
subdivision into categories by known variables has been performed, the main effect is to reduce
right skewness, and to reduce the tests discriminatory powers, without markedly changing the
overall appearance of the lid histogram. This suggests that observed extreme right skewness is
associated with dataset size rather than exclusively with the mixed nature of the full set.
The 'full' sheep experimental set suggests that sample size is not always the skewness-
determinant however, and the effect of a reduction of variables may be dependant on the
proportions of the different categories present. One particularly marked exception is that of the
highly inbred strains of mice inoculated with the highly stabilised and characterised 'strains' of
scrapie agent. Here, reduction of variables to the practical minimum produces sets of cases which
appear to be more clustered, with a narrower i/p range, and less 'tailing'. It is hypothesised that
reducing variation even further (for example, mice at the same age at inoculation) would further
tighten the i/p range around a particular modal i/p.
Thus, it may be that from a dataset with many variables (such as might be encountered in the
natural situation for a TSE), and with an lid with a right skew too extensive for log-normality,
stepwise reduction of the number of variables reduces the right skewness through a stage of log-
normality to result in a tightly clustered i/p.
13.1.2 Datasets with ae at onset measurements.
Excluding cattle, complicated by the censoring involved in the epidemic, a total of 24 datasets
with a/o measurements were tested. Of these, 3 (13%) had a right skew too extensive for
compatibility with log-normality; 7 (29%) mostly small datasets were compatible with both
normality and log-normality; 5 (21%) had left skews; 4 (17%) were compatible with normality
only; 2 (8%) were incompatible with log-normality for other reasons, and 3 (13%) were
compatible with log-normality only.
156
OVERVIEW: Major findings & conclusions.
Excluding cattle, sample size varied from 15 to 1334. Those datasets with extensive right skew
tended to be large, and all were suspected of having a mainly or entirely infectious aetiology
(although this may be misleading; see section 13.2). In addition, they may have been associated
with less culling or other artificial data truncation. Culling would tend to reduce right skewness.
As well as the problems of sample size and extreme data variability (which, for natural data is far
less easily controlled or categorised), there is here the additional problem of the validity of using
a/o as a proxy for i/p.
For those cases believed to be mainly or wholly infectious, for example natural scrapie in sheep
and goats and BSE in cattle, a/o is a valid proxy if infection occurs close to the time of birth.
Actual infection time is unknown and thus no other measurement available, and in the presence
of exposure to an infected flock or herd or contaminated food from birth, it is at least possible. It
is therefore assumed (but not proven) that a/o is a close estimate of i/p for the majority of cases.
For those cases believed to be the result, either directly or indirectly, of a congenital abnormality
(here, in the form of a genetic mutation), for example familial human cases and possibly some
cases in sheep, then a/o can be seen as equivalent to the i/p of infectious disease. For those cases
where aetiology is as yet unknown (mainly sporadic Cm), the assumption that an as yet
undiscovered congenital abnormality (possibly an unidentified genetic mutation, not necessarily
of the PrP gene, predisposing to susceptibility in some way) is involved, again may render a/o
equivalent to i/p. In practice, it is the only relevant information that is generally available.
The use of the alo as a proxy for the i/p is therefore considered to be a valid procedure but, for
particular individual cases, it may not always be appropriate. Whilst this is perhaps unlikely to
affect modal a/o values, it may be relevant to the extremes of the f/d range. In particular vely
large a/o values may be the result of later infection or disease initiation; it is possible that this is
at least partly responsible for extensively right skewed Lid's.
In sheep, three datasets were compatible with only log-normality, one of which at least was
subject to culling. Two other datasets classed as incompatible for other reasons were very close to
log-normality. Although overall, Sartwell's hypothesis cannot be confirmed for a variety of
reasons as the underlying theoretical Lid in TSE/prion disease, it may be that in sheep, in the
natural situation, and particularly if culling removes very old animals, log-normality is a
reasonable approximation to the observed situation.
Due to the effects of censoring in an epidemic, results taken directly from the cattle data analyses
may be misleading, as discussed in chapter 11. Sartwell's hypothesis has not been confinned as
the underlying theoretical i/p in TSE/pnon disease, and it is not certain that a/o is an exact
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representation of i/p in BSE. In addition, results of analysis of AIDS data for compatibility with
Sartwells's hypothesis as an example of another infectious disease with a long i/p were
inconclusive, again due to the problems of epidemic censoiing.
Nevertheless, of those distributions used in applying back-calculation methods adapted from
AIDS modelling to BSE data, a log-normal distribution gave the best fit to the data, although it is
possible that some other uncommonly used distribution might be even more appropriate. In
addition, data from sheep suggests that log-normality might be a reasonably good distribution for
practical use in that species. From these two findings, and if the disease in cattle behaves
similarly to that in sheep, it appears that for practical purposes the use of log-normality to
describe aio f/d in the modelling of cattle with BSE is the most appropriate of the commonly used
distributions to use in the first instance, as was done (Wilesmith et al, 1988), further evaluation
being dependant on the continued closeness of fit with the observed data.
13.2 Association of modal aae at onset with incubation period and ae at onset freguency
distribution and fre guency distribution coefficient of skewness.
It became apparent from these analyses that the observed disease onset fYd, whether measured as
an i/p or a/o Lid, may be dependant upon the modal a/o. Several of these correlations are based on
evaluation of the observed c/s, and it has already been demonstrated that this is, in isolation, an
unreliable estimator of the true c/s for a log-normal Lid. Extrapolating, it seems reasonable to
expect that any type of skewed distribution may suffer from similar effects, particularly if close to
a log-normal distribution. From this, it might be concluded that c/s estimation is of little use.
However, it is suggested that if a group of otherwise comparable datasets show a trend in c/s
values, then provided that the actual c/s values are used only as a guide, some inference might
reasonably be drawn from them.
That such an association existed was first suggested by primate data analysis, when the i/p was
evaluated with respect to life-history measures. It was observed that, although not statistically
significant, the Lid right skewness decreased with increasing modal (and mean) i/p (see sections
8 4 and 8.5.2). With BSE in mice, increasing mean age at infection (and thus increasing modal
alo) was associated with a decrease in the c/s (see sections 9.1.2.2 and 9.4.1.2), and for scrapie in
mice, the association between increasing modal i/p and decreasing c/s was clearly shown
(sections 9.2.6 and 9.4.2.3).
However, the association becomes vely apparent with the examination of human data. Looking
first at all cases without a known infectious aetiological mechanism, examination of the a/o lid
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for cases with recorded genetic mutations is discussed at length (section 10.4.1.4). Mutations with
an early modal a/o (from around 30 years of age for inserts) tend to be right skewed, whereas
mutations with a late modal a/o (around 60 years for codon 200 mutations) tend to be left skewed.
Not surprisingly therefore, analysis of all cases with a known familial histoiy (an amalgam of all
cases with genetic mutations) tends to have a mode (at around 45-50 years), roughly mid-way
between the extremes of those for individual mutation types, and an f7d compatible with
normality. For sporadic Cii) cases, with a late modal a/o (in the region of 65 years), lid is left
skewed
All human datasets with a known infectious aetiology are small, with a resultant lack of
discnminatoiy power between different distributions and a probable underestimation of the true
c/s. Nevertheless, for all three sets with a recorded a/o, the modal alo is early (from 16 to around
30 years of age) and all appear right skewed. Clearly, this early modal a/o is in turn dependant
upon a prior, and therefore also early, age at infection, which is documented for iatrogenic
infection and assumed for kuru cases.
Examination of the i/p for the two relevant iatrogenic datasets gives a veiy short mean and modal
i/p particularly for the 'CNS-inoculated' group. In addition, data values for 'maximum up' for the
pituitaiy hormone cases described in section 10.3.2.1 are in general a few years less than the a/o
data for the comparably sized set of kuni cases, perhaps indicating similarities in pathology
dwing incubation. For both these datasets analysis indicates a tendency to right skewness for the
i/p lid, as for the a/o lid. Comparison with experimentally infected datasets, for example BSE in
mice, suggests that if a large enough group of patients for some reason suffered iatrogenic
infection at a late age (resulting co-incidentally in a late modal a/o), they would exhibit a much
reduced right 'tail' to the i/p f/d, possibly, but not necessarily, associated with death from other
causes, as well as a less right skewed nb lid.
In summaly, it is suggested that the i/p lid c/s is determined by the difference between the modal
a/o and either the mean or modal age at death, and that a right skewed i/p lid (whether more or
less skewed than log-normality) will only occur when this margin is wide enough to
accommodate that skew. The modal a/o will depend upon time/s of infection, plus the modal i/p.
Ultimately, therefore, this margin depends also upon modal i/p. For congenital disease, i/p
equates to alo. Skewness will then depend directly on the modal a/o.
It is therefore hypothesised that for TSE/prion disease in humans, the modal a/o, whether
dependant upon a congenital abnormality or prior infection, is inversely associated with the
observed a/o c/s. Examination of much larger datasets, particularly for specific mutations, and for
known, recorded infection amongst different age groups (unlikely to be easily accomplished), is
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required to fully evaluate this hypothesis, and especially to estimate whether the degree of any
association is similar for both mutation group datasets and known infectious datasets. Any
difference may be indicative of differing aetiologies.
if this hypothesis is correct, it may extend to other classes of disease. Huntingdon's chorea, an
hereditary disease of humans, has a mid-life modal a/o of 38.3 years (SD 11.5) and an overall a/o
fld which is very close to normality, based on an examination of3153 cases (Ridley et al, 1992).
The differences in sample size makes comparison difficult, but the Ud does appear to be much
more symmetrical than the marked left skew of the sporadic CJD datasets vith their mean alo's at
around 60 years.
Returning to Sartwell's hypothesis, his data was based on diseases with short i/p's. the longest
being for 'serum hepatitis' with a modal value of three months, the majority measured in days.
With such short mean and modal lip's, unless an outbreak of one of the diseases which he
examined occurs in a close-to-death population, such as might be found in a hospice, or during
active combat in war, mean duration of time left to death from other causes will generally be so
large in comparison with the lip of the disease in question that a right skewed f/d is probably
inevitable. Its compatibility with log-normality may depend on for example sample size, case
ascertainment, and duration of observation, as well as power of the statistical method being used
to reject this (or any other) hypothesis. This would fit with his observations regarding
experimental datasets, where observation and case ascertainment is generally more complete.
And finally, with respect to human TSElprion disease, if this hypothesis is correct, the question
now is not 'why is the alo fYd as it is?', but rather 'what determines the modal a/o7.
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Appendix I
APPENDIX 1
EXAMPLES OF HISTOGRAMS OF INCUBATION PERIOD FREQUENCY
DISTRIBUTIONS, PLUS OTHER DETAILS, FOR DISEASES WITH SHORT
INCUBATION PERIODS AS DISCUSSED IN CHAPTER 1.
Figure A1.1 Frequency distribution: Serial interval for measles as an estimation of i/p (after
Stillerman & Thalheimer, 1944).
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Figure A1.2 Frequency distributions for incubation periods for S outbreaks of 'Typhoid
Fever' reviewed by Miner (1922).
Outbreak 1; N=93; Mean = 9.5 days
Outbreak 2; N=23; Mean = 7.0 days
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Figure Al.3 Details of i/p for 'Serum Jaundice'; Camp Polk series (after Parr, 1945)
o
Days from Vaccination to Disease Onset.
Vaccinated at Camp Polk, Feb 27th 1942.
Remained at Camp Polk through the outbreak.
Vaccination lot: Number 369.
Mean Incubation Period: 96.4 days
Standard Deviation:16.1 days
Mode: 93 days (52 cases)
Range: l5to 147 days
(It was suggested that the case on day 15 may have been coincidenctal)
Number of Cases: 1004
Estimated Attack Rate: 18.4 cases per 100 soldiers vaccinated
with this vaccine lot.
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Figure A1.4 Frequency distributions: Reported cases of GBS by period between vaccination
and onset in 1-week periods and 2-day periods (after Schonberger et al, 1979)
1-Week Periods
Cu..
IN
041
120
IN
N
N
'a
20
1 2 7 4 1 S 7 S 0 10 11 12 12 14 15 IS 17
P.dod b.twunv.ccklsICn & arsst (ii wSSI'a)
2-Day Periods
PUrtur a( Ca...
5.I3 57511 13•117157l flfl7Ifl3I30l?394I
Period bctw.sn vocarNian & o'ast (Si 2-y gar4ss)
Figure Al.5 Frequency distribution: Experimental gonorrhoea using human volunteers; i/p
f/d (after Mahoney Ct al, 1946)
Mean: 5.6 days; SD:5.3 days
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APPENDIX 2
DETAILS OF SARTWELL'S METHOD FOR THE EXAMINATION OF THE
FRIQUENCY DISTRIBUTION OF AN INCUBATION PERIOD.
Procedure Undertaken.
The frequencies (number of cases with disease onset within a given time) are
grouped in time intervals appropriate to the disease (hours, days or weeks).
* Cumulative frequencies, and corresponding cumulative percentages are
calculated.
* The time intervals are transformed into logarithms.
* Cumulative percentages are plotted against log time on normal probability
paper.
* if the points arc nearly linear, a straight line is fitted by inspection.
* "Estimated median": the logarithm of the point at which this line intercepts the
50% frequency line (50 percentile) is read off. Its antilogarithm is the "estimated median"
of the frequency distribution, in the original time units.
* "Dispersion factor": the logarithms corresponding to the 16 percentile and 84
percentile are read off (corresponding to +1 and -1 standard deviations). The difference
between the 2 logarithms is found by subtraction, and this value divided by 2. The
antilogarithm of the resultant figure is the "dispersion factor", in the original time units.
Notes:-
These 2 parameters coerespond to the geometric mean, and geometric standard deviation, when calculated
andinetically.
The incubation period range given by "estimated median/dispersion factor" to "estimated median x dispersion
factor" should encompass approximately 68% of observed mcubation periods for that disease, for a log-
noemally distributed disease.
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APPENDIX 3
EXAMPLES FROM SARTWELL'S TABLE OF FREQUENCY DISTRIBUTION
RESULTS FOR OUTBREAKS IN WHICH HE FOUND A 'LOGARITHMIC NORMAL'
DISTRIBUTION.
Disease	 Number of	 Estimated	 Dispersion
cases	 median	 factor
Strentococcal	 51	 56 hours	 1.53
sore throat (1)
Salmonellosis (2)
(S. typhimurium)
Measles (3)
Common cold (4)
(experimental)
Amoebic dysenteiy (5)
Induced malaria (6)
	
227
	
2.4 days	 1.47
	
25
	
12.4 days	 1.32
	
92
	
2.4 days	 1.50
	
215
	
21.4 days	 2.11
	
24
	
6.4 days	 1.33
Sources of Data.
(1) Ingraham, personal communication to Sartwell.
(2) Mosher et al, 1941.
(3)Goodall, 1931.
(4) Andrewes, 1949.
(5) National Institute of Health, 1936.
(6) Greig, 1939.
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APPENDIX 4
PRACTICAL DEMONSTRATION OF SARTWELL'S METHOD USING TWO SETS
OF OUTBRIAK DATA ALSO EXAMINED BY SARTWELL
a) Measles Data from Stillerman & Thalheimer, 1944.
- serial interval used as best measure of incubation period
- grouped into 2 day intervals for plotting
Day	 Log Cases Cum.	 Cum.	 Day	 Log Cases Cum. Cum.
day	 cases	 day	 cases
	8	 .90	 3	 3	 1.5	 14	 1.15	 30	 171	 85.9
	9	 .95	 9	 12	 6.0	 15	 1.18	 11	 182	 91.5
	10	 1.00	 28	 40	 30.2	 16	 1.20	 5	 187	 94.0
	
11	 1.04	 28	 68	 34.2	 17	 1.23	 9	 196	 98.5
	12	 1.08	 44	 112	 56.3	 18	 1.26	 2	 198	 98.5
	 3	 1.11	 29	 141	 70.9	 19	 1.28	 1	 199	 100
Results from Graph (figure A4.1, next page).
Sartwell	 This Plot
Estimated median:	 12.2 days	 11.8 days
Dispersion factor:	 1.18	 1.19
Calculated results for "estimated median" and "dispersion factor" here differ slightly from SaitwelFa results since this method
depends upon the fitting of the line by eye, with associated observer bias. Alternative methods, such as fitting the line by
regression, would remove this observer bias, but this was not done by Saitwell; neither were any 'goodness of fit' tests to see
whether observed distiibution differed from h,othesised distnbution.
b) 'Typhoid Fever' Data from Saw yer, 1914.
- grouped into 2 day intervals for plotting
	
Day	 Log	 Cases	 Cum.	 Cum.	 Day	 Log Cases Cum.	 Cum.
	
day	 cases	 day	 cases
	3	 .48	 1	 1	 1.1	 17	 1.23	 1	 82	 88.2
	
4	 .60	 4	 5	 5.9	 18	 1.26	 1	 83	 89.2
	
5	 .70	 12	 17	 18.3	 19	 1.28	 3	 86	 92.5
	
6	 .78	 19	 36	 38.7	 20	 1.30	 0	 86	 92.5
	7	 .85	 13	 49	 52.7	 21	 1.32	 2	 88	 94.6
	
8	 .90	 10	 59	 63.4	 22	 1.34	 0	 88	 94.6
	
9	 .95	 5	 64	 68.8	 23	 1.36	 1	 89	 95.7
	
10	 1.00	 2	 66	 70.8	 24	 1.38	 1	 90	 96.8
	
11	 1.04	 5	 71	 76.3	 25	 1.40	 1	 91	 97.8
	
12	 1.08	 2	 73	 78.5	 26	 1.41	 1	 92	 98.9
	
13	 1.11	 1	 74	 79.6	 27	 1.43	 0	 92	 98.9
	
14	 1.15	 2	 76	 81.7	 28	 1.45	 0	 92	 98.9
	
15	 1.18	 3	 79	 84.9	 29	 1.46	 1	 93	 100
	
16	 1.20	 2	 81	 87.1
Inspection of Graph (figure A4.2, next page): - points not on a straight line
- therefore not a log normal distribution
- Sartwell obtained similar result.
[Note: Cum. cumulativej
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Figure A4.I Sartwell's method plot for measles; data from Stillerman & Thalheimer, 1944
- - - _.	 _____. -
Sartwell's method for calculations from Eraph:-
a) Estimated median = antilog of 1.07 = 1k75 days
b) Dispersion factor (log 84 percentile - log 16 percentile)/2
= (1.143 -0.995)12
= 0.148/2 = 0.074
Antilog 0.074 Li2
Figure A4.2 Sartwell's method plot for 'typhoid fever'; data from Sawyer, 1914
- - --	 ---• -
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APPENDIX 5
REVISED CASE DEFINITION OF AIDS (CDC, 1987).
A. With definitive diagnosis of indicator disease (with or without definitive
diagnosis of 11W infection).
1) Candidiasis - oesophagus.
2) Czyptococcosis - extrapulmonary.
3) Cryptosporidiosis; diarrhoea> 1 month.
4) Cytomegalovirus infection (other than liver, spleen or lymph node) in patient> 1
month old.
5) Herpes simplex -> pneumonitis, oesophagitis, mucocutaneous ulceration for>
1 month.
6) Kaposi's sarcoma; patient < 60 years.
7) One cerebral lymphoma; patient <60 years.
8) Lymphoid interstitial pneumonia; patient < 13 years.
9) Mycobacterium avium-intracellulare or M. kansasii (disseminated).
10) Pneumocysfis carinii pneumonia.
11) Progressive multifocal leucoencephalopathy.
12) Toxoplasmosis of brain; patient> 1 month.
B. With definitive diagnosis of indicator disease PLUS definitive diagnosis of
fflV infection.
1) Recurrent bacterial infection in a child.
2) Coccidioidomycosis - disseminated.
3) HIV encephalopathy.
4) Histoplasmosis - disseminated.
5) Isosporo diarrhoea> 1 month.
6) Kaposi's sarcoma; any age.
7) One cerebral Iyznphoma; any age.
8) Non-Hodgkin's lymphoma.
9) Any disseminated mycobactenal disease (not lvi. tuberculosis).
10)M. tuberculosis - extrapulmonary.
11) Recurrent Salmonella septicaemia (not S. typhi)
12) HLV wasting syndrome.
C. With definitive diagnosis of 11W infection, and presumptive diagnosis of
indicator disease.
1) Oesophageal candidiasis.
2) Cytomegalovirus retinitis with visual loss.
3) Kaposi's sarcoma.
4) Lymphoid interstitial pneumonia; patient < 13 years.
5) Disseminated mycobacterial disease (species not defined).
6) Pneumocystis carinhi pneumonia.
7) Toxoplasmosis of brain.
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APPENDIX 6
A BRIEF OUTLINE OF THE BACK-CALCULATION METHOD USED (AFTER
BROOKMEYER AND GAIL, 1988) TO OVERCOME THE PROBLEM OF LEFT AND
RIGHT CENSORING IN AIDS MODELLING.
A stable i/p over time is generally assumed, and the fYd assigned a function, usually from the
Weibull or gamma fumilies of curves; occasionally normal or log-normal functions are used.
Changes in infection rate from time T (start of infection) are assigned a further function,
frequently exponential. A function for the convolution of these two curves is then evaluated.
Thus, for an epidemic with infection commencing at time T, expected case numbers at time
(T+t1), (T+t2) etc. can be calculated for any time X after T, as the product of the number
infected at each time up to X and the proportion of all those infected at each time which would
have disease onset at timeX, estimated from the i/p fYd. Hence the total number of cases in a
given period of time, from say (T+X') to (T+X2), is described by the integral of the convoluted
form, between those times.
If X1 and X2 are taken as the time-window of case observations during which case ascertainment
was considered reliable, then numbers observed can be compared with numbers predicted.
Since the number given by the equation depends upon certain parameters in the equation, those
parameters are found (using maximum likelihood methods) which give best fit to the observed
data, for X1 to X The complete integral can then be evaluated using those parameters, and the
epidemic's total size estimated.
The reliability of observational data used from X 1
 to X2 depends on the dates chosen for X1 and
X2. If X1 is too early in the epidemic, ascertainment bias is again likely. If X 2 is too late,
reporting-lag leads to under-representation of later cases. Assumptions are made about the time T
(start of infection) and changes in infection rate. These will be based on incomplete information,
possibly compounded by secrecy; possibly different for different risk-groups.
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APPENDIX 7
DIAGRAMMATIC REPRESENTATION OF THE PRINCIPLES OF BACK.
CALCULATION AND COMPARTMENTAL MODELS ILLUSTRATED FOR ONE
INFECTION TIME POINT.
Back Calculation
- allows for censoring
Number
of Cases
I	 i	 i/pf/d
N
Cases	 Time
seen
Key:
n incidence (cases seen) over
time observed
N - total (unknown) number of
cases
Ratio n/N = ratio of the
integrals
Integral of N (Vp f/d) = 1
Therefore can calculate N
Compartmental Models
- simulates transmission
pathways etc
With: rates RI - R6,
at time t
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EXAMPLES OF ThE ESTIMATES OF THE INCUBATION PERIOD FOR AIDS
Reference	 Group studied Function used	 Resultant i/p (years)
for i/p lId
Andreani et al, 1983	 Tx in Haiti	 Smgle case	 4
Currin dii, 1984	 TA-AIDS	 Direct calculation	 Mcd. 2.3 (1.3-4.8)
Curran Ct ii, 1985b	 TA-AIDS; pied. 	 Direct calculation	 Med. 1.2 (0.3-3.8)
Lui dii, 1986
	
TA-AIDS; adult 	 Weibull i/p lid	 Mean 4.5 (90% Cl; 2 6-14.2)
Rees, 1987	 TA-AIDS	 Normal i/p lid	 Mean 15 (SD; 5)
Rodgers dii, 1987	 TA-AIDS; pact	 Direct calculation	 Mean 2.0 (0.3-6.8)
Perinatal infeCtion	 -	 Mean 1.4 (0.1-7.2)
Medley ciii, 1987	 TA-AIDS; >60 y
	
Weibull /p lid	 Mean 5.5, met 5.4
TA-AIDS; adult	 Mean 8.2, med. 8.0
-	 TA-AIDS; pact	 Mean 2.0, med. 1.9
Medley dii, 1988*	 TA-AIDS; adult 	 Gamma i/p lid	 Mean 27.4 (SD 17.5)
-	 TA-AIDS; pied. 	 Mean 2.4 (SD 1.5)
Medley dal, 1988b	 TA-AIDS	 Gamma i/p lid	 Mean 24.1, med. 20.8
-	
-	 Weibull i/p lid	 Mean 7.6, med. 7.3
Lifon clii, 1988	 TA-AIDS; adults	 Method unknown	 Met 3.8
TA-AIDS; pact	 Med. 2.8
Liii dii, 1988*	 TA-AIDS; pied.	 Weibull i/p lid	 Mean 2.4(90% CI; 1.5-7.2)
Lui ciii, 1988b	 Gay men	 Weibull i/p lid	 Mean 7.8(90% CI; 4.2-15)
Lamp ciii, 1988	 Gay men	 Non-parametric 	 Met 10.8
Frosner, 1988	 Haemophiliacs	 Normal i/p lid	 Mean 9 (SD 3)
Kalbfleisli & Lawless, 1988 	 TA-AIDS	 Parametric	 Met 7.3(95% CI; 4.6-hit)
Bacchetti & Moss, 1989	 Gay men	 Non-parametric	 Med. 9.8(95% CI; 9.4-hit)
Dayetal, 1989	 UKcascs	 Gacnmai/pfYd	 Med.>12
Weibull i/p lid
	
Met 7-8
Longini & Clark, 1989 	 Mixed	 Complex	 Mean 9.8(95% CI; 8.4-11.2)
Munozdal, 1989
	
Gay men	 Non-parametric 	 Met 11
BlaXhUIt ciii, 1990
	
TA-AIDS	 Non-parametric 	 29% by 5
Giesedte ciii, 1990	 Gay men	 Non-parametric 	 MeanS
Ta)lor dii, 1990	 Gay men	 Complex	 36% by 7(95% Cl; 26-47%)
Erioc et ii, 1991
	
Transplantees	 Direct calculation	 Mean 2.7
Henthiks dii, 1993	 Gay men	 Gamma i/p lid	 Mean 10.2, med 9.2
Robinson ci al, 1993.	 Ugandan cases	 Complex	 Mean 5-6
Alcabea dii, 1994	 Injecting dnig users 	 Non-parametric	 Med. 10.2(95% Cl; 7.9-123)
Volkov clii, 1994	 TA-AIDS; Mexico	 Direct calculation	 Med 2.4 (max. 4)
Ward, 1994
	 TA-AIDS	 Direct calculation	 Med 4.8 (0.1-12.8)
[Notes on table: Tx - transfusion; med median; pact paediatnc inf infinityj
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APPENDIX 9
INFORMATION SUPPLIED WiTH TILE TA-AIDS DATASET DISCS.
Transfusion-Associated AIDS Datas.t
AIDS Program
Csnt.r for Inf.ctious Diseases
Centers for Disease Control
This dataset contains information on transfusion-associated AIDS (TA-AIDS) ci...
r.port.d to tb. C through D.c.ab.r 31, 1990. Tb... data have been voluntarily
reported to C by Stats and local. h.aJ.th  departments, and are prot.ct.d under
an Assurance of Confidentiality (B.ctiona 306 and 308 (d) of th. Public Esaith
Service Act, 42 u.s.c. 242k and 242.) which pr.v.at. disclosure of any
informat ion that could b. used to sitber dirsctly or indir.ctly identify
individual, patients or ..tablishm.nts. Tb. statistical data contained on this
dataset are being r.leas.d for sci.ntific us. solely for the purpose of
estimating th. incubation tie, for AIDS. Thai. data should not b. published or
rersl.ased in any form which would .ith.r directly or indirectly Ld.ntify the
month and year of transfusion or diagnosis of individual patients. Person. with
transfusion-associated AIDS who are later found to have other risks for flY
infection are reclassified into th. appropriate transmission category. Thus, the
number of transfusion-associated AIDS cases on the datasat say not be the sam.
is that found on the Deconb.r, 1989 Monthly Surveillance sport.
The BIV-antibody test was licensed in March 1985 and in th. following months was
implemented by blood banks to screen blood donations • TA-AIDS cases reported
with dates of trin.fuuion after this ti.. period hive a high likelihood of having
other risks for ElY-infection; of the first 34 TA-AIDS cues investigated with
transfusion dates after June 1965, approximately 90% had other risks for
fly-mi action or had also received unscreened blood donations before the recorded
dates of transfusion. Tb. TA-AIDS cases found en reinvestigation to hays been
infected with HIV after receiving antibody negative blood components are noted
on the dataset.
Th. Centers f or Disease Control and local health departments cannot verify that
all of the TA-AIDS case. r.port.d to have received blood before June 1985
actually received a blood transfusion or if the reported transfusions were
donated by persons infected with fly. Although misclassified cases are believed
to represent a meall proportion of reported TA-AIDS cases, the users of this data
set should consider that some person with other risks for ElY infection may be
incorrectly classified as TA-AIDS cases. As persons with TA-AIDS tend to be
older than parsons infected by other routes, this po.sthl. misclassification say
be most likely for men in the 20-40 year old age group.
Sees TA-AIDS cases are reported with th. transfusion(s) having occurred very
shortly before or at the ti.. of the diagnosis of AIDS. As the shortest verified
incubation period after parenterally-acquired SW infection is 2 months, reported
TA-AIDS cases reported with very short incubation periods may hav, received other
transfusions or aay have had other risks for ElY infection. Thus, all cases with
a reported interval of time from transfusion to diagnosis of AIDS of 2 months or
lees ar, investigated again and, if new information i. found, the reports for
these cases are revised.
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Page 2 - TA-AIDS D.t...t
Rppcoxlattaly	 of adult TA-AIDS cases are eprt.d to C to have di.d the
,ses	 th seth. .oath of diagnosis, compared to about 12% for all otb.r
report.d adult AIDS ca.... )tucb of this difference can be explained by the age
distribution of TA-AIDS cases cs.r.d to other ca-sea. Within moat risk
death in the mouth of diagnosis i .  more coa for pationts age 50+ then for
younger patients, and 641 of TA-AIDS pat Lent. are sq. 10+ *t dS 'q.ia ye, 9% for
ather adults. Possible explanations for this higher early mortality are a poorer
prognosis for TA-AIDS cases b.caus. of host or viral factor. uniqoa to this
group, and delayed r.00gnition by physicians of opportunistic Lithe.... L.
par.oas with transfuaien-wociat.d lilY in.f.ctiota. Turth.r information can be
obtained from the coc surveillance public use data sat, which contains risk
group, age at diagnosis, month of diagnosis, s.nd calendar quarter of death for
each AIDS case. Users of th. data t should consider that th. period b.tw.n
the dat. of transfusion and diagnosis may be proloog.d.b.can.. of thi. possible
delay in diagnosis.
The diskette specifications ares
Density
Format
d.
rile X.
Record •i.Le
Record Terminator
Total o.r of records
Total bytes
Double sided/Double Dens ity
IlK PC Dos/Ks DOS
ASCII
TD9OQ4. DAT
36 byte. (34 bytes of data
and lie, feed)
cR/LI
4010
250783
plus carriage control
the diskette contain, exactly cc. record for each reported transfusion-as.ociat.d
AIDS case, coded a. followss
Variable	 Columns	 Deicriot ion
Age	 01	 Age at diagnosis of first
opportunistic dis.as., coded as
1- lass than on year
2 - 1-12 years
3 13-29 year.
4 - 30-39 years
S - 40-49 years
6 - 50-69 years
7 - 70 year. or older
9 - Unknown
AIDS-rulat.d
SAX	 02	 Sex of patient, coded as
1. - Kale
2 - 7ena1a
RAPOATA	 03-06	 lear and month (YflO() the AIDS cas. report was
received at the COC. Ca...
	 reported during 1981 are coded as 819'
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Page 3 - T2-5IJ)5 Dataset
Variable	 colmn. Descrivtion
DZDM'X	 07-10	 Year and month (Zt)) during which the first
AIDS as.ociat.d opportunistic disease was
diagnosed.	 Cases with Ok—"t
diseases diagnosed before 1982 are coded as
'8199'.
TXDATS1 11-14 Year and month (YflQ() Of either the first
transfusion or the on. most likely to have
resulted in infection it that can be
d.t.rmin.d (5.. 1USDOR). £ code ot
indicat.. that at least one transfusion was
received soest in. before that indicated on
TIDATt2, but that the month and y are
unknown.
TXDATE2	 15-18	 Yanr and month (YYXX) of the second
tran.fusion.
TXDATZ3	 19-22	 Year and month (YVO(} of th. third
transfusion.
Sp.cial not. regarding transfusion dat..t every effort has bean mad, in the
oaa• of aultipi. transfusions to d.t.zmin the month during which infection was
most likely to have occurred. Uowsver, information on patients varies
con. Ldsrably so that this can sot always be done. If SU800I!OR.i then it La
likely that the transfusion(s) on th. first date listed resulted in
If not, the nzb.r of units transfused (if available) say be used to Suggest
which dat. is moat likely. Also, U.S. blood banks began screening donat.d blood
in March, 1985, so that transfusions rsc.Lv.d after this date ars less likely to
have result.d in infection than prior transfusions. Currently the C collect.
only the date of the first transfusion and last transfusion prior to an AIDS
diagnosi. as part of routine AIDS surveillance.
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Pegs 4 - T1-PID5 Dateset
UBITS1
IT
UNITS3
BUSDONOR
AZTX1
VERIPIED
BAC
BURXL
AXDESOP
WLUBG
ow
OWT
via ion)
mcci
sxtrapulsona.ry
TO
PTOSP
23-25	 Total nueber of blood mit. rec.Lv.d duringfirst transfusion, if known.	 Blank
26-28 Total nusb.r of blood units rec.iv.d during
the s.cocd transfusion, if known. Blank
otherwise.
29-31 Total nueb.r of blood units r.c.iv.d during
th. third transfusion, if known. Blank
otherwise.
32 d.d ii '1' if a eisa investigationidentified a donor with .Lth.r diagnosed
AIDS, a posit iv. EIV tset, an sbnor.alimaunologic finding, g.n.ralia.dlysuphad.nopatby, or a known history of being
at risk for AIDS. Blank oth.rwis..
33
	
	
Ag. at first transfusion, cod.d the sase a.
AGE.
34 Cod.d as '1' if all transfusion dat.. are
after March, 1985, and eisa investigation
identified MIV •transaissioa from blood
screened for H]V antibody. Blank otherwise.
35 Bact.rial infections, altipLe or recurrent(including Sal.non.11a s.peicit) (pediatric
cases only)
36	 Burkitt's Lymphocia
37	 Candidia.ais, esophageal
38	 Candidiasis, bronchi, trachea, or Lungs
39	 Cytom.galoviru. inf.ct ion
40	 Cytoesgalovirus retinitis (with loss of
41	 Coccidioido.ycosi.,	 d.suatnat.d or
42	 Cryptococco.i., sictrapuleory
43	 cryptosporidiosis, chronic intestinal
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Pag. S - TA-lIDS Datatat
DTIA
RISTO
US
IBL
'so
duration)
LIP
)cAVIUX
PC
PLE
plc.
SLS
TB
TP
TIBG
44	 HIV snc.pbalopatby
45	 ffLatcpla.Ls. dia.inat.4 or .xtrapal.onary
46	 iro@Lc woocu'ou harps.	 Lnf.ction
47	 Lymphot, iunoblaitic
48	 Xso.poria.Ls. chronic Lnt. gtinal (>1 onth
49	 Tapo.Ls .arca
50 Lymphoid intarutitial pn.oais and/or
pulmonary lymphoid hypsrplas La (p.diatric
cassi only)
Si	 Mvcobactsriui avium complu
52	 Mvcpbactsriuii, of oth.r .psciss or
uzzidantif Lad sp.ci.s
53	 pneumocvitis carthii pn.umonia
54	 Primary iyuiiphoma of th. brain
55	 Progrss.ivs &ltifocal L.tiko.nc.phalopathy
56	 Saiwonulla ..pticLa (adult cuss only)
57	 Mycobacterium tub.rcu]osi.
58	 Toxoplasmosis
59	 Wasting syndrcms this to SW
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Page 6 - TA-AIDS Datasst
LIDS-indicator opportunistic di...... (colus.. 35 through 59)
Co1s 35 through 59 contain infornatico sack of the LIDS-indicator di..aa..
listed on the LIDS confidential can• report fore. Sack of th...vsriablss is on.
character long and is coded as follows,
0 - AIDS-indicator opportunistic di..... was not diagno..d
1 - AIDS-indicator opportunistic disease was diagnosed d.finitiv.ly .
2 - AIDS-indicator opportunistic di..,.. was d 4iiii#isd pranuiiptiv.ly.
Cat.g (colusn 60)
1 - Cams nests tb. prs-1925 survsillancs definition
2 - Cans a..ts tbs 1985 surveUlanos definition
3 ii Case nests tb. 1987 .urv.Ulanc. definition and was diagno..d 4sf initivaly
4 - Ca.. nests the 1987 survaillanc. definition and wa. diagnosed prs.iwjtivsly
RaCe (coluen 61)
1 - Whit. (not Hispanic)
2 - Black (not Hispanic)
3 - _______
4 - Asian/Pacific Islander, Aserican Indian/Alaskan Native, or unknown
Updated versions of tb. Transfusion-associated AIDS case datas.t will be
avaUabl. sack quarter upon r.qusst. Land your r.qu.st along with a blank
doubl.-sid.d/doubl. -density di.k.tts toi
Gloria Gavin
Statistic. and Data Managonent Branch
Division of NW/AIDS CID
Centers for Disease Control
Xailstop N48
1600 Clifton Road
Atlanta, Georgia 30333
[Note: Race (column 61); Asian/Pacilic Islander, etc. are coded as group 4 on the information
sheet but are actually coded as group 9 on the disc. J
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APPENDIX 10
DETAILS OF DATA USED FOR TSE/PRION DISEASE EXAMINATION, INCLUDING
SOURCE, VARIABLES, AND EXPERIMENTAL METHOD (WHERE APPLICABLE)
SHEEP.
Natural scrapie.
Two sources of data were used; a literature search (references; table AlO. 1, below), and VIDA.
Stringent efforts were made to avoid case duplication. The database was checked visually, by
comparison with source, for errors. In these analyses, natural scrapie in sheep includes cases of
disease where the animals were kept in direct or indirect contact with experimentally induced
cases of scrapie, either by chance or in a deliberate effort to investigate the possibility of contact
as a natural transmission method.
Table A10.l Data references: natural sc pie in sheep.
Greig (1940b)	 Brotherston et al (1968) Houmgan et al (1979)
Party (1962)	 Gordon (1966)	 Wooldndge (1991)
Dickinson et al (1965)
Since age at onset (alo) was recorded in different ways in different papers, data from Party (1962)
and from Wooldridge (1991), papers detailing large numbers of cases, are analysed separately.
VIDA data is also analysed separately. The remainder (108 cases) comprise the general literature
search (GLS) described in the analyses. Additional details on these datasets are given below.
Data from Parry (1962).
Party (1962) gives a/o details of 1008 cases by sex, in graphical form in 6-monthly increments,
starting with 12-18 months. The increment mid-point is used in analyses, giving fifteen months
as the first age point.
Party collected data between 1952 and 1960 from approximately 50 pedigree sheep flocks of ten
breeds, plus some commercial flocks, dispersed over 17 counties of Great Britain, giving variable
local conditions. Most farms were in the 'Oxford flock health scheme'. They were visited
regularly, and had good identification and recording systems. Diagnosis was based on
'unequivocal' clinical signs plus fatal outcome, and sometimes histopathology. Party suggests that
the number of diagnostic errors is likely to be small.
In these flocks, only one ram is kept for every 20-40 ewes, and most are culled before three years
of age as normal management practice. For ewes, generally 15 to 20 % are between 4.5 and 11
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years, with no marked difference between flocks; prior to this there is probably a large cull at
around four years of age.
Data from Wooldridge (1991).
Wooldridge (1991) reported a postal questionnaire survey of scrapie in sheep spanning the years
1930 to 1990 inclusive, comprising data from 167 farms. The survey was not random and many
biases were identified. The a/o was unrecorded for 591 (3 1%) cases; estimates were given in some
cases. Cases comprise both those clinically diagnosed (with possible misclassification), and VIC
diagnosed cases with histopathological confirmation. Some indication of the alo was obtained for
1334 cases, 160 being VIC confirmed. For animals over five years old, questionnaire design
allowed only one categoly ('five or more years') and the full extent of the right tail is thus lost.
Therefore no means or ranges are calculated.
Data from VIDA.
The VIDA database records all scrapie in sheep confirmed histopathologically by the VIC's, from
1975 onwards. Data used here comprises 2361 such cases recorded by 7/10/1993. There are
many biases in VJDA data (see Wooldridge, 1991), and no way of reliably estimating the
situation regarding the culling of older animals in the population from which VIDA data comes.
Data from the GLS.
A total of 108 additional cases were found from the GLS. For 1 case, i/p but not a/o was given.
For 107 sheep a/o was given, either in months or years. For 55 cases, it was known that the dam
was herself either a case, or had been exposed to a source of infection.
In order to analyse cases as one group, data given in years was converted to months
(multiplication by 12), resulting in converted data being 'bunched' at twelve month intervals.
Smoothing was therefore carried out by redistribution of those cases converted from 'years' to
'months' equally throughout the year, as two separate groups, as account was taken of the
exposure status of the dam. It is recognised that this may introduce bias, particularly for any year
which spans a steep part of the lid curve.
Even if scrapie is always the result of infection (unproven), there is no way of knowing when
infection occurred. If infection from the dam is possible, infection may be perinatal, or possibly
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intrauterine. Two groups are identified; cases where the dam either was known to have contacted
an infection source during pregnancy, or became a case herself (pregcode = 1; 55 cases), and
cases where no such factors were recorded (pregcode =0; 57 cases).
For ten cases, including nine with a known alo, the sheep were positively recorded as grazing
pasture previously grazed by scrapie infected sheep, a potential infection source which was
actually being investigated using these sheep (Greig, 1940). The period of grazing was recorded,
as was the time of disease onset. Two of these cases were born whilst their dams grazed this
pasture and they were thus exposed from the time of birth. The remaining eight sheep were
believed to have had no exposure prior to grazing this pasture, which was therefore assumed to be
their source of infection. Truncation of the right tail by culling or flock dispersal is probable
(Greig, 1940). For one additional case, both a/o and time from start of exposure to infection was
given. Prior to recorded exposure, this animal was also believed to be from a scrapie-free source.
Thus there was a total of 11 cases with a documented exposure window. Actual infection time
during this 'window is unknown (if transmission was the aetiological mechanism). The i/p is
therefore arbitrarily estimated as time from first recorded exposure until disease onset, the
maximum possible value.
Experimental TSE in sheep,
Data was mainly obtained from a literature search (references; table A 10.2). Experimental BSE
data was obtained from M Dawson (personal communication). Stringent efforts were made to
avoid case duplication; the database was checked visually by comparison with source, for errors.
Details given for both experimental methods and results vaiy, and this is relevant when
interpreting results.
Table A1O.2 Data references: 	 TSE in S
Cuille & Chelle (1936)	 Pattison & Millson (1960)	 Dickinson et al (1968)
Greig (1950)	 Pattison & Millson (1961a) Pattison et al (1972)
Wilson et al (1950)	 Dickinson et al (1966)	 Pattison et al (1974)
Pattison et al (1959) 	 Gordon (1966)
A total of 447 cases of experimental sheep TSE was recorded in the database. The variables with
some information recorded for most cases are passage status (either directly from a natural TSE
case, or from a previous experimental TSE case, or from dam inoculation with TSE agent),
munediately preceding donor species, original disease, infection route and infecting substance
(i.e. tissue) used. Original disease segregated with immediately preceding donor. Sex, dose, agent
strain or original source (e.g. SSBPI) and breed were, overall, poorly recorded. Two cases were
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female, and for the remainder, sex was unspecified; this factor could not therefore be examined.
Dose was recorded in different ways making comparisons difficult or impossible.
Subgroup 1.
Definition. Sheep with experimental scrapie, where the immediately preceding donor was a
sheep, inoculation was into the CNS, and the infecting substance used was CNS material only.
There were 77 such cases.
For some of these cases, additional information was available on passage status or number, breed,
age at infection, or dosage. Thirty of the 77 sheep were infected from a natural case of scrapie
(i.e. passage 1), and the remaining 47 from a previous experimental case. One experimental
group had passage number given for seventeen cases, from passage 2 up to passage 9, but
numbers are too small to investigate in any formal way. For 38 cases, age at infection was given.
Of these, 21 were direct from natural cases and infected at 7 months
For all 77 cases, the breed of case was given, and for 54 cases, the breed of donor was given.
Case breeds are as follows: Cheviot; 61; Greyface, 5; Welsh Mountain, 5: Halfbred, 2; Blackface,
2 Figures for donors are: Cheviot, 19; Greyface, 7; Welsh Mountain, 18; Halfbred, 3; Swaledale,
7 Since numbers were small for many donor/case breed combinations, breeds were regrouped as
either 'donor and case = the same breed', or 'donor and case = different or unknown breeds' for
analysis.
Seventy-five of the 77 cases had information on dosage. For all this was 1 ml of a 10% dilution of
brain preparation. However, donor brains may have contained widely vazying amounts of agent.
Subgroup 2.
Definition. Sheep with experimental scrapie, where the immediately preceding donor was a
sheep with experimentally derived scrapie, infection was by s/c inoculation, and the infecting
substance was CNS material only. There were 97 such cases.
Sex was unknown for any case. All were infected using a 10% dilution of brain material, all bar
two being from the same preparation, the 23rd passage of a particular agent preparation; the two
other cases were the 24th passage. Dose was given as volume of brain extract, 89 receiving the
same 2 ml volume.
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GOATS.
Natural scrapie.
Two sources of data were used; a literature search (references; table A 10.3, below), and VIDA.
Stringent efforts were made to avoid case duplication. However, it was impossible to avoid all
overlap between cases from the literature search and VIDA, therefore they are analysed
separately. The database was checked visually by comparison with source, for errors. In these
analyses, natural scrapie in goats includes cases of disease where animals were kept in direct or
indirect contact with experimentally induced cases of scrapie, either by chance, or in a deliberate
effort to investigate the possibility of contact infection as a natural transmission method.
Table A10.3 Data references: natural
	
ie in goats.
Mackay & Smith (1961) Harcourt & Anderson (1974) Toumazos & Alley (1989)
Brotherston et al (1968) Stemshorn (1975)	 Wood et al (1992)
Hourrigan et at (1969)	 Flourrigan et al (1979)
Culling of goats occurs, particularly for males, but it is difficult to assess quantitatively due to
lack of data, as is the 'natural' lifespan of a goat.
Data from the GLS.
A total of 66 cases was found. For 37, sex was recorded, 32 being female, 5 male. The alo was
given in months for 47 cases, the remainder were given in years or six-month intervals. In order
to analyse cases as one group, data was converted to months, the method depending on
information available. For example two cases reported together as eight years, and four and a half
years respectively, were converted as (8x12=96) and (4x12 + 6 = 54) months, whereas 'between
three and four years' was converted to (36 + 6 months = 42 months). Conversion is thus a
possible source of error. Small numbers and mixed recording methods meant that 'smoothing' was
not feasible.
Three contact groups were identified. Fifteen cases where the dam also became a case, 36 cases
where flock or herd contact with scrapie was recorded, and 15 cases with no contact recorded.
However, for the group with no contact recorded, unrecorded contact may have occurred. In only
one case was it stated categorically that there had been no contact with either sheep or goat,
directly or via pasture. Similarly, where flock/herd contact is recorded, this does not exclude
absolutely the possibility of the dam being scrapie positive.
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For 9 cases, the latest possible age by which removal from known exposure had occurred was
recorded; all were exposed from birth. It is difficult to be certain that such removal was effective.
Some of these goats may have been kept together subsequently, with possible lateral spread.
Data from YLDA.
The VIDA database records all scrapie cases in goats confirmed histopathologically by VIC's,
from 1989 onwards. Data comprises 28 such cases recorded by 7/10/1993. Bias and other aspects
of VIDA data are as for sheep.
Experimental TSE in coats.
Data was mainly obtained from a literature search (references; table Al0.4 below). Experimental
BSE data was obtained from M Dawson (j)ersonal communication). Stringent efforts were made
to avoid case duplication; the database was checked visually by comparison with source, for
errors. Although approximately 75% of the cases originate from the same group of investigators,
at the same research establishment, details given both for experimental methods and results vazy,
as they do for sheep. This is relevant when interpreting results.
Table A10.4 Data references; experimental TSE in goats.
Gordon et al (1957)	 Pattison & Millson (1961c) Marsh Ct al (1969)
Pattison et al (1959)	 Pattison & Millson (1962)	 Pattison et al (1972)
Gordon (1960)	 Pattison (1964)	 Hadlow et al (1974)
Pattison & Millson (1960) 	 Pattison (1965a)	 Gajdusek (1977)
Pattison & Millson (1961a) Pattison (1965b) 	 Gibbs et al (1979)
Pattison & Milison (196 1b
A total of 400 cases of experimental TSE's in goats was recorded in the database. As for sheep,
and for the same reasons, the first i/p analysis utilises the complete dataset. Again, as for sheep,
variables with some information recorded for most cases are passage status (either directly from a
natural TSE case, or from a previous experimental TSE case), immediately preceding donor
species, original disease, infection route and infecting substance used. Again, original disease
segregated with immediately preceding donor. Dose was poorly recorded, and a large number of
preparation methods and pre-treatments were used. Forty cases were female, 126 were male. For
the remainder, sex was unspecified.
Subgroup 1
Definition. Goats with experimental scrapie, where the immediately preceding donor was a goat,
inoculation was into the CNS, and infecting substance used was CNS material only. There were
201 such cases, over 50% of the total.
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For some cases additional information was available on passage number, age at infection, dose,
and other manipulations. For 60 cases, the number of goat-to-goat passages was given. Passage 2
indicates the donor was a goat infected directly from a natural sheep case, that is, the donor was
itself a passage 1 case, and so on. All cases had similar experimental conditions and protocol.
For 71 cases age at infection was given, ranging from I to 9 months. Numbers infected at any age
were small, the maximum being 23 cases at 6 months, most age categories having ten or fewer
cases infected.
To examine the effect of dose, Pattison & Milison (1961b) describe a complete dilution
experiment starting with a single scrapie agent homogenate. Dilutions are described as 1/5 (i.e.
20%), 1/10, 1/20 and so on, down to 1/8 1920, in fourteen doubling steps; i.e. 15 strengths in all.
Either one, two or three goats were given 1 ml at each dilution (23 in all), and all but one goat (at
the most dilute level, observed for 19 months) developed disease; this goat is excluded from
analysis.
Ten other agent manipulations were identified; the majority had veiy few examples. 'Enzyme
treatment', freeze/thaw cycling, boiling for up to 3 hours, autoclaving, and ether extraction all
had 8 or fewer cases. There were 19 cases of formalin treatment, and 15 cases of host pre-
treatment by CNS inoculation with 100 mis of 'dense suspension of normal goat brain' carried
out 10 weeks (2.5 months) before agent inoculation.
Subgroup 2
Definition. All cases with a plausible 'natural' infection route; s/c (plus i/d) inoculation (27
cases) and oral dosing (7 cases).
There were 34 cases, of which 28 were s/c (or i/d) inoculated, and 6 oral infections
Subgroup 3
Definition. Passaged directlyfrom a 'natural' case of scrapie in sheep, the generally assumed
infection source in natural goat scrapie.
There were 14 cases. For 6, breed of donor sheep was known: 4 Welsh Mountain and 2
Swaledale; all six were CNS transmitted using CNS material, but different agent doses or goat
breeds may have been used.
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PRIMATES.
Two sources of data were used, a literature search and personal communications (references; table
AlO.5). These sources were amalgamated. Age at inoculation was generally unknown; other
details available varied from case to case. For data originating from the National Institutes of
Health (NIH) (over 90% of the 635 cases), animals were always observed until disease onset or
death from other causes (P Brown, personal communication). The proportion of inoculated
primates that die from TSE varies both th the primate species, and to some extent with the type
of inoculated material, i.e. sporadic, familial, iatrogenic, kuru etc. (P Brown, personal
communication). Therefore estimating the extent of right censoring is complex (see Brown et a!,
1994 for available information).
Table A1O.5 Data references and personal communications:
experimental TSE in primates
Gajdusek, 1977	 Masters et al, 1979 Baker et al, 1990 M Dawson, CVL (pc)
Peterson et a!, 1978	 Gibbs et a!, 1979	 P Brown, NIH (p.c.)
Primate classification used in analyses is as given in source data, since no further taxonomic
information is available; sometimes this refers to a species, sometimes a genus. As for goats and
sheep, experimental conditions varied. Again as for goats and sheep, and for the same reasons,
the first i/p analysis utilises each complete dataset. Many experimental variables are present, and
information available varies. Table Al0.6 gives information on some variables.
Table A1O.6 Experimental TSE in primates; some major variables by primate gr
Group	 Passage	 Original disease	 Info on
Pg-i Pp CJD CJDQ) Kuna Scraple BSE	 'dose'
I	 (ap)	 +GSS
Marmoset	 20 30	 12	 5	 31
Capuchin	 67	 4	 48	 15	 6
Squirrel m.	 306 16 266	 40	 9
Spiderm.	 54	 3	 36	 9	 11
African green	 18	 2	 19	 1	 0
Cynomolgus	 8	 4	 9	 0	 0
Rhesus	 25	 5	 25	 1	 2
Chimp	 63 10 49	 7	 17 __________
otea on table:- Pg-I: passage direct from natural case: Pg>1: passage
Information given on 'dose' varied in repoit method;
sporadic, f- familial.J
Data on additional variables, including infection route, infecting substance, formalinisation of
agent etc., is given for some cases. Relevant taxonomic details are given in appendix 21.
Datasets with greater homogeneity; Subgroups 1 to 6.
To better assess whether any consistent i/p f/d pattern exists for similarly treated sets of
experimental animals, more homogenous sets of experimental conditions were selected and
0	 2
	
15
2	 0
	
63
7	 0
	
296
1	 0
	
44
0	 0
	
20
3	 0
	
9
2	 0
	
26
0	 0
	 54
case
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applied to each primate group. In this process numbers within subgroups necessarily decreased.
The following subgroups were defined:-
Passage number
1
1
>1
Subgroup
1
2
3
4
5
6
Original disease
Kuru
CJD (all types) + GSS
CJD (sporadic only)
CJD (familial) + GSS
CJD (sporadic only) **
** Additional conditions for subgroup 6:- all from single laboratoiy (for a given primate); dose
given as '10% dilution of brain extract'; no 'manipulation' of extract by formalin, paraffin wax, or
fractionation recorded; inoculation route includes an intracerebral component, either alone or as
part of a mixed route infection. Subgroup 6 was therefore the most homogeneous.
Data for squirrel monkeys.
Numbers of cases for squirrel monkeys, the largest group, allowed examination in more detail.
However, they are a genus, not a species and it is not certain that all cases were from the same
species. Nevertheless, the majority were from one laboratory, therefore if different, possibly they
would have been categorised separately.
Many sources of variation are recorded. For most cases passage status (whether directly from a
natural TSE case, or from a previous experimental case), original disease, preceding donor,
infection route and substance were recorded. For some cases, a genetic mutation of PrP gene in
the originating case, or manipulation of the inoculum was recorded. Dose was recorded in a
variety of ways. Sex was unknown in all cases. For most variables, the majority of cases had the
same value, and i/p lId for that category would therefore have resembled the full set; others
comprised very small numbers of each of several variables.
For the 129 squirrel monkeys in subgroup 6, it was possible to further strati1' by inoculation
route: 53 cases had been CNS inoculated only, 76 had undergone multiple site inoculation (but
which included a component of CNS inoculation in all cases).
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RODENTS.
BSE in mice.
Data was kindly supplied by H Fraser, NPU, Edinburgh, and comprised BSE i/p in 196 RH!
(genotype 'sinc's7s7) mice, sex (females, 100; males, 320), infection age and date, and
originating BSE-case identity number.
All cases represent primary transmission (passage 1). Inocula originated from seven field cases of
cattle BSE. Other than this, and inoculation date, experimental protocol was unchanged. Mice
were injected intracerebrally (0.02 mIs) and intraperitoneally (0 1 ml) with a 10% brain
homogenate. All inoculations from a single case of BSE were performed on the same date. All
mice underwent daily examination for signs of BSE, and histopathological examination after
death or killing. Initially, 213 mice were inoculated; 17 (8%) died from other causes.
Inoculation age and BSE group tend to segregate together. Compared with overall inoculation
age range, within each BSE group range is tight, presumably due to age of mice available when
required, which is likely to be clustered by litter membership.
To attempt to reduce effects of BSE group on c/s, in order to further investigate any age effect,
data was regrouped as follows:-
Groups AB,C,D: Dataset divided into four age groups with equal age-range-spans of 26 days
for inoculation age.
Groups E,F,G,H: Dataset divided into four age groups as equally sized as possible without
splitting mice inoculated at the same age.
Scrapie in mice.
Data was extracted by measurement, from histograms (Dickinson & Miekie, 1971) where it was
grouped by 10 day intervals. Data comprised an i/p for 407 cases, plus scrapie agent 'strain'; for
some cases, mouse 'sinc' genotype was given.
Experimental design was complex, in order to investigate effects of host genotype and agent
strain interactions. All mice were inoculated intracerebrally with 0 02 mls of fluid, an estimated
agent dose of 104LD. Inoculation age range was 22-152 days; a decrease in i/p of 0.05 +1- 0.01
days per increased day of age had previously been found.
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Two fully inbred strains of mouse were used: C57BL (homozygous for the s7 'sinc' * allele) and
VM (homozygous for the p7 'sinc' allele); these were also crossed to produce s7p7 offspring.
Further crossed generations were also used; these comprise the 'unrecorded genotype' in the data.
All inoculated mice developed scrapie, except for 'a few' which died early of unrelated causes.
Two strains of scrapie agent were used, ME7 and 22A. Both had previously been passaged
several times through mice, most recently twice through VM mice.
[ The 'sinc' gene, a contraction of 'scrapie incubation period gene', was originally characterised
by the response of various strains of mice to infection with certain scrapie agents, including ME7;
s7 originally signified the 'short up' allele and p7 the 'prolonged lip' allele; the correlation of the
ME7 results with this designation is therefore expected; that strain 22A did not follow this
pattern was a major focus of interest of the authors.]
CJD in guinea-pigs.
Seventy-nine Hartley strain guinea-pigs were inoculated intracerebrally (Manuelidis &
Manuelidis, 1979), using 0.1 ml of a 10% dilution of brain material. All developed CJD, thus
there was no truncation. Passage number varied from 1 (directly from two human cases) to 10;
two first passage guinea-pig cases are described; it seems probable that one derived from each
human case.
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hUMANS.
For analysis, data is categorised initially into sporadic disease, non-sporadic disease, and
documented iatrogenic disease. Sporadic disease is defined here as non-recording of any known
risk factor for TSE/prion disease. Non-sporadic disease is defined as any case (other than
iatrogenic) with a recorded risk factor, and includes all cases with a recorded genetic mutation, as
well as those with a documented family history.
Data supplied by Dr R Will, National Creutzfeldt-Jacob Disease Surveillance Unit,
Edinburgh.
Data used comprised information on 376 cases of sporadic CJD with onset from 1969 to 1990,
supplied on disc as a database. Sex and diagnostic method (histopathology, or clinical plus
characteristic EEG) was recorded, plus age at death. For the period 1980 to 1990, where disease
duration was over one year (6%), a correction was made to give age at onset rather than age at
death; comparable information was unavailable for earlier cases.
Additionally a list of i/p data for iatrogenic cases (pituitary hormone injections, and dura mata
graft) of international origin was supplied.
For pituitary hormone injection aetiology, data comprises 23 cases (8 females, 15 males), from a
variety of countries. Treatment (tx) generally consisted of multiple injections, over widely
differing durations and occasionally continuing until disease onset. Treatment (tx) duration is
summarised as follows:-
Mean (years) Range (years)
Age at first treatment: 	 9.2	 1-30
Duration of treatment:	 7.6	 1-17
Age at onset:	 25.0	 10-44
Precise infection time during treatment is unknown, therefore the i/p was estimated in two ways:
from first treatment to disease onset (maximum possible), and from treatment mid-point to
disease onset. Since conclusions on the i/p 17d were similar, only the results from the first
(maximum possible i/p) estimate are shown in the thesis.
Eight of the 9 dura mata grafts cases were also from this source; presumed infection time is well
documented.
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Data supplied by Dr Paul Brown, National Institutes of Health, Bethesda Washington, USA.
I was allowed access to all records of TSE's/prion disease (i.e.; sporadic CJD, familial CJD, GSS,
FF1) recorded at NIH. There were several categories:-
Experimentally transmitted cases as of November, 1993, from USA, abroad, iatrogenic cases, and
kuru.
Cases in France from 1968 to 1982.
Additional observations by, and reports and referrals to NIH, often having particular features
including genetic mutations, familial history, or ethnicity of interest
There was category overlap, but cases were individually identified and duplication eliminated.
Data was abstracted from records, and after database entry, checked visually for errors.
Of 785 cases, 271 were experimentally transmitted; this is considered diagnostic. Transmission
criteria have altered with time. Early in investigations, transmission was routinely attempted.
Later it was undertaken only for particularly interesting cases, leading to selection bias. Most
cases without positive transmission were histopathologically confirmed, the remainder diagnosed
by clinical signs. However, for the French survey approximately 40% were diagnosed clinically.
There is no notification requirement to NIH; it occurs because of a clinicians interest, or a request
for material of a particular type, introducing a selection bias. However, the French survey (the
largest single component), a countrywide search for all clinical cases of CJD is less likely to
suffer this bias, although other clinical manifestations, for example GSS, were not included.
Eighteen kuru cases with recorded a/o (the accuracy of which is unknown) were obtained from
NIH data; the time of infection is unknown. All transmitted to laboratory animals.
Additionally a list of French pituitary hormone injection cases was supplied, comprising 21
cases. There is evidence to suggest that use of contaminated inoculum in France may have
occurred only in 1985 (P Brown, personal communication), therefore i/p was estimated from this
time.
Data from a general literature search (GLS).
The literature search for all clinical manifestations of TSE/prion disease was time delineated,
rather than exhaustive. Diagnostic method depends on the paper, and includes histopathology,
genetic mutation, and family history. There is a probable reporting bias; cases with particular
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features, whilst reported, may not be typical. Extensive cross-referencing within the GLS, to
eliminate duplication was believed to be successful. Checking of the data within the database was
done as for the previous dataset. Alter database entiy, data was error-checked visually.
Table A1O.7 Data references; TSE in humans; GLS.
Alema (1973)	 Nochlin et al (1989)	 Nakazato Ct al (1991)
Gajdusek (1977)	 Blisard et al (1990)	 Tranchant et al (1991)
Brown Ct al (1979) 	 Collinge Ct at (1990)	 Amano et al (1992)
Mayer et al (1979)	 Nakazato et al (1990) 	 Collinge et al (1992)
Neugut Ct al (1979)	 Nisipeanu et at (1990)	 Genthon Ct al (1992)
Galvez et al (1980)	 Sadeh et al (1990) 	 Hsiao et at (1992)
Foncin et al (1982)	 Tateishi Ct al (1990) 	 Kretzschmar et at (1992)
Manuelidis et al (1985) Brown et al (1991) 	 Terao et al (1992)
Vinters et al (1986)	 Hsiao et at (1991a) 	 Collinge et al (1993)
Peariman Ct al (1988)	 Hsiao Ct a! (1991b)	 Kitamoto et al (1993)
Farlow et a! (1989)	 Kretzschmar et at (1991) 	 Martinezlage et al (1993)
Hsiaoet at (1989)	 ________________________ ________________________
GLS data includes sporadic, familial, and iatrogenic TSE/prion disease cases, separated for
analysis.
Data duplication.
It proved impossible to cross-reference a considerable number of GLS cases with other data,
therefore not all case duplication could be eliminated. However, where identified, the case was
deleted from the GLS to reduce duplication as far as possible. The NIH dataset is known to
contains some duplicates of UK data. The exact extent of duplication is difficult to assess,
therefore individual analysis of the datasets, rather than combined analysis, was undertaken.
Genetic mutations recorded in data.
Mutations of PrP gene recorded in this data comprise codon substitutions, and base pair inserts.
Table A10.8 details the codon mutations. Insert mutation details recorded vazy, but comprised so
few of each that they are analysed together.
Table A1O.8 TSE in humans; codon substitutions recorded in data used
and resultant amino acid change.
Codon substituted Amino-acid chan ge in
217	 Glutamine -> Arginine
200	 Glutamic acid -> Lysine
198	 Phenylalanine -> Senne
178	 Aspartic acid -> Asparagine
145	 Tyrosine -> 'Stop'
117	 Alanine->Valine
102	 Proline -> Leucine
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For NIH data, 214 cases were recorded (189 with known family histoty); for GLS data, there were
123 cases (122 with family histoiy). Numbers from each data source are as follows:-
Mutation	 NIH data	 GLS data
217	 -	 1
200	 69	 19
198	 16	 19
178	 73	 -
145	 -	 1
117	 17	 25
102	 20	 29
Insert	 19	 29
For analyses, the larger set from each source was used (see appendix 23 for method of estimation
of overlap).
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CATrLE.
Using programmes specially written by A Mitchell, on 5/8/94 data was abstracted as files of fixed
field-length, from the BSE database maintained on the Sequent computer at CVL Epidemiology
Department, Addlestone, Weybridge, Surrey, KT15 3NB.
By 29/7/94, 132,538 histologically confirmed cases were recorded in this database, from 31,138
different farms, plus suspect cases undergoing investigation. Many records lack sufficiently
precise information on age, date of onset, and feeding history (recorded by the year) for these
analyses. The following criteria are used for all cases included in analyses:-
(a) Month and year of birth recorded; month and year of disease onset recorded.
(b) BSE confirmed by histopathology.
For all cases, date of infection is unknown; a/o is therefore used as an estimate of i/p. which
necessitates assuming infection close to birth. Therefore, cases born before 1/7/81 are excluded,
as exposure from birth was considered unlikely (Wilesmith et al, 1988). There is often a reporting
lag of several months duration, therefore cases with onset within six months prior to data
abstraction are excluded.
Cohorts are described by 'calving season of birth', from the 1st July until the subsequent 30th
June inclusive, to fit the usual pattern of cattle management and farm recording. For example,
cohort 81 indicates birth from 1/7/81 to 31/6/82 inclusive.
Three final cattle groups were obtained as follows:-
Cattle group 1: 488 cases.
In order to closely estimate i/p by a/o, cattle were all known or strongly suspected to have been
offered protein concentrates (potentially containing ruminant derived protein) from the first few
weeks of life, and none after their first year, achieved by selecting cattle recorded as being fed
suspect feeds only in their first year of life. In addition, to reduce potential recording errors, all
cases were homebred, in dairy herds, from a farm where all homebred cases were recorded as
having a similar feeding regime.
Cattle group 2: 204 cases.
In order to closely estimate i/p by a/o, cattle were all strongly suspected to have been offered
protein concentrates (potentially containing ruminant derived protein) from the first few weeks of
life, and none after their first year, achieved by selecting cases occurring on beef suckler farms,
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which were purchased onto those farms at 365 days old or less, with no record of being fed
suspect feeds subsequently.
Such purchased replacement calves are generally bred on dairy farms and surplus to
requirements; they will generally have had concentrates from weaning, around 3 weeks of age, as
for other dairy-farm calves; they are assumed infected by such feeding before purchase.
Cattle group 3: 5,810 cases.
Censoring (as for AIDS; see chapter 6 and Peterman, 1987) was anticipated in the BSE epidemic;
left censoring results in non-observation of early, short i/p cases. 'Pre-order' farms were
identifying and reporting cases before BSE became notifiable. Farmers on these farms may
therefore be more observant, and less likely to have missed early cases, thus possibly reducing
left censoring. Even on these farms, it was unlikely that left censoring was eliminated, and it is
known that histological samples were unobtainable for a number of cases with typical clinical
signs (J Wilesmith, personal communication). All 'pre-orde? farms were all selected. All cases
on these farms meeting the original criteria were then selected from these farms. In addition, each
case was assigned a 'feedflag' (F) as follows:-
F	 Feedin2 status in first year of life:-	 N
Y Recorded as fed suspect feeds in first year.	 4678
	
80.5
N Recorded as not fed suspect feeds in first year. 	 325
	
5.6
U Feeding in first year unknown/unrecorded.	 807
	
13.9
For examination of the effect of censoring, in order that all cattle in the analysis were exposed to
a possible infection source in their first year of life, and were therefore comparable to group 1,
only feedflag status '1' is used.
Typical cattle 'concentrate' feeding regimes.
Until the 'ban' on feeding ruminant protein to ruminants (18th July 1988) all concentrates
potentially contained ruminant derived meat and bone meal (MBM), and thus, possibly, the BSE
agent. Dairy-herd calves are generally weaned at a few days of age onto milk substitutes. In
addition, they are generally introduced to some form of 'concentrate', for example calf pellets,
either at the same time, or very soon after. The majority of daizy calves have had access to such
calf concentrates before one month of age, and are gradually weaned off the milk stbstitute. Soon,
roughage is added, and 'rearing' concentrate is generally substituted for calf concentrate. During
their second year, calves intended as replacement dairy heifers often receive no concentrate, their
diet comprising only grazing and conserved fodder. Once they have borne their first calf, at
around two years, they generally receive, in addition to grazing, some form of adult dairy ration
concentrates. Beef-herd calves and cows may well receive no concentrates at any stage.
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APPENDIX 11
FILIBEN'S METHOD FOR FREQUENCY DISTRIBUTION ANALYSIS FOR
COMPATIBILITY Will! NORMALITY AND LOG-NORMALITY USING MINITAB
STATISTICAL SOFFWARE.
Theoretical basis of method (Filiben, 1975).
Filiben's test statistic, the nonnal probability plot correlation coefficient r, is defined as the
product moment correlation coefficient between the ordered observations X 1
 and the order statistic
mediansMfromanormal (0,1) distribution.
r =Corr(X,M)
-
-(x1 —i)2(M1	 2
A normal frequency distribution will give near-linear normal probability plots, which will in turn
give near-unity values for the probability plot correlation coefficient r.
Filiben's paper provides a table of the percentage points of the normal probability plot correlation
coefficient r, for sample size values up to N=100, which the author states in a corrigendum to be
nearly equivalent to the Wilk-Shapiro statistic (Shapiro & Wilk, 1965). Additional values for
sample sizes up to N=2000 were kindly calculated by R Sayers.
Method as used in Minitab statistical software, release 7.2 (1989).
The method used is as described in Minitab reference manual (1989), release 7, section 4-8;
normal probability plots and correlation.
For estimation of compatibility with normality, the data used (Xi. in Filiben's method; column Cl
in the Minitab manual example) is the incubation period for each case. For estimation of
compatibility with log-normality, the data used is the logarithm (to base 10) of the incubation
period for each case. The command NSCORES produces, for each value of X, the corresponding
value forM
For each sample, a normal probability plot (X, plotted against Mi), and a correlation coefficient
(X1 correlated with M,) designated CC in this thesis (r in Filiben's method) is then produced.
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If the dataset f/d is close to normal, then the plot approaches linearity, and the CC approaches 1.
The Minitab manual also provides a table of 'critical values' (C/v's), which corresponds to, but is
much less extensive than, the table of the percentage points of the normal probability plot
correlation coefficient r given in Filiben's paper. The values are also not quite identical, with the
third decimal place generally being one integer different; they are actually the Wilk-Shapiro
statistic referred to by Filiben.
If the calculated CC falls below the C/v for a given percentage point then the hypothesis of
normality (or log-normality, when using the log-transformed data) is rejected with that level of
probability; the L/d is incompatible with that distribution. Due to the lack of percentage points
given in the Minitab C/v table, Filiben's table was used for samples with size greater than 20.
Unless otherwise stated, the percentage point level (P value) used for estimating compatibility
with normality (or log-normality) for all datasets is the 0.05 level.
Example of the normal probability plot produced by Minitab.
*
75+	 4
3 9 2
Cl
	
4669 2
+4+
9+47
50+	 4+4
+4
46+6
57
25+
	
652
5
0+	 +
4---------+---------4---------4
-2.0	 -1.0	 0.0	 1.0	 2.0	 3.0
Age at onset.
Estimation of compatibility with normality (or log-normality) of l/d for age at onset was
calculated by the same method.
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APPENDIX 12
THE METHOD DESCRIBED BY SNEDECOR AND COCHRAN (1967) FOR
ESTIMATION OF FREQUENCY DISTRIBUTION COEFFICIENT OF SKEWNESS
USING MINITAB STATISTICAL SOFFWARE.
Theoretical basis of method (Snedecor and Cochran, 1967).
Skewness of the frequency distribution (Lid) of a population can be measured by the average value
of (X -	 a quantity called the 'third moment about the mean'. An extended right tail gives a
positive value, and an extended left tail a negative value for the skewness. In order to make this
measurement independent of scale, it is divided by &. The resulting measurement is called the
coefficient of skewness, denoted by I3 i•
The coefficient of skewness (c/s) of a sample from that population is denoted by Ib 1 , and
calculated as follows:-
First, m3 and m2 are calculated.
1713
 = (x-)3 In
m
The coefficient of skewness Jb 1 is then calculated.
'Jb1 =m31(m21m2)
In calculating m2, the sample variance, division is by n rather than the more usual (n - 1),
making subsequent calculations slightly easier.
Method as used in Minitab statistical software, release 7.2 (1989).
The data, or X values, used for calculation of the coefficient of skewness ('lb 1 in the above
method; designated c/s in this thesis) are, for the f/d of the raw data, the incubation period values.
For the Lid of the log-transformed data, the logarithm (to base 10) of the incubation period values
are used.
A macro was used to compute the c/s values, as follows:-
198
Appendix 12
ci ki
1st cS.(cl.kl)**2
Let c6s(c1-k1)3
en c5 kZ
.swc6k3
1st k4xk3/(k2*sqrt(k2))
prInt ki k4
end
Where ci = X values and k4 = c/s.
The skewness probability (P) value was calculated by the method of Royston (1985), using a
FORTRAN programme (kindly written by R Sayers) on a Prime computer.
Age at onset.
Skewness of fYd for age at onset was calculated by the same method.
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APPENDIX 13
SHEPPARD'S METHOD FOR THE CORRECTION OF THE ESTIMATE OF THE
STANDARD DEVIATION FOR FREQUENCY DISTRIBUTIONS WITH GROUP
INTERVALS.
Theoretical basi3 of the method (Sheppard, 1897).
An error in the estimation of the variance (and thus the standard deviation) is introduced, when
grouping data, by the assumption that each observation takes the mid-value of the group. For
frequency distributions with equal group intervals, an allowance can be made for this error.
Method.
If C is the length of the group interval, then Sheppard's correction is made by reducing the
variance by (1/12)C2. Where observations x1, x2 ... x, have frequencies off1, f2, ... .f,,, the formula
for the standard deviation S (designated SD in this thesis) therefore becomes:-
s—.'41 
ft2(fr2i2
- LI Ui) 12
Age at onset.
Where appropriate, Sheppard's correction for SD for age at onset was calculated by the same
method.
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APPENDIX 14
DISCRIMINATORY POWER OF THE TESTS USED TO ESTIMATE COMPATIBILITY
WITH NORMALITY AND LOG-NORMALITY.
Figure A14. 1 compares normal and log-normal distributions. These vere produced by averaging
100 computerised random simulations (using Minitab statistical software, release 7.2, 1989). In
each case a sample size of 500 and an SD of 1.0 were used. Modes have been aligned for case of
comparison of the 'tails' of the distributions and the minimum x-value set to zero, thus altering
the means from those originally used for sampling (0 for both distributions).
Agite A14.1 Co.rpositicn of Nomnd id Log-nornd Distnbutions
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Only 93.8% of the log-normal distribution is shown, in order to use the same X-axis scale, as the
maximum value was close to 500 units.
Figures A14.2 and A 14.3 show the effect of sample size on the appearance, firstly for a normal,
and then for a log-normal distribution. The distributions were produced as above (except that only
10 simulations were performed for each sample), altering only the sample size, for comparison of
N=500, 50 and 5.
Figur. A14.2 Th. Normal Distribution: Comparison by Sampi. Sizs
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Figur. A14.3 Th. Log-normal Dietribution: Comparison by Sampi. Slz.
In this thesis, tests for compatibility with normality and log-normality are performed at the 5%
(P=O.05) level. If the calculated correlation coefficient (CC) falls below the critical value (C/v),
the null hypothesis of normality (or log-normality) is rejected. However, at this level of
significance, it will be rejected on one occasion in 20 when it is, in fact, true. If the calculated
CC is at or above the C/v, the null hypothesis will not be rejected and the observed distribution is
described as compatible with normality (or log-normality) at that level.
Clearly, a variety of non-identical datasets may be classified as compatible with normality (or log-
normality) by this test. The question arises as to what extremes of shape will be accepted as
normal (or log-normal). The following information attempts to give some pictorial representation
of the ranges for three different sample sizes (as used above) broadly representative of the size of
datasets examined in the thesis. Firstly, a sample size of N=50 is examined, the most closely
representative of these sizes for many of the datasets used. The situation is then compared for N
5 and 500. C/v's for the CC's (at P=0.05) for samples of these sizes are given in table A14. 1.
Table A14.l. Correlation coefficient critical value (at P = 0.05) by sample size.
Sample size N	 Correlation coefficient critical value
500	 0.997
50	 0.976 (Filiben) : 0.977 (Wilk-Shapiro)
5	 0.880 (Filiben) : 0.879 (Wilk-Shapiro)
Samnle size = 50; CIv=0.976.
Normality. Figure A 14.4 gives an indication of the range of different distribution shapes which
will be accepted by this test as compatible nith normality, and shows distributions A, B and C,
which are all symmetrical. All were produced by stepwise symmetrical adjustments of a normal
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distribution (A and B by piling up 'cases' into the centre of the distribution, C by moving them
away from the centre) in an attempt to define the distribution shapes at which non-compatibility
with normality (by this test, at this level) was reached. There is little difference in the
distribution of A and B, B having two cases (4% of the sample) with X-values different to A and
therefore being only slightly flatter than A. C is clearly much flatter, with a veiy different
appearance.
Figur. A 14.4 N = 50; fld; normality and non-normality
I 9
X-v.lu. (for .xampl., lip In Ilma	 10
unit.)
Despite the vety small difference in the distribution of A and B, by the test used distribution A is
not compatible with normality (CC = 0.975) whereas the slight change puts distribution B at the
limit of compatibility (CC = 0.980). Perhaps unexpectedly, distribution C is also compatible with
normality (CC = 0.996). In fact, even flattening the distribution completely, with 5 cases at each
X-value gives compatibility with normality (CC = 0.992; not shown). A vely wide variety of
shapes between these two extremes is thus compatible with normality, by this test.
As might be expected, none of these distributions arc compatible with log-normality (CC = 0.885
for A, CC = 0.893 for B, and CC=O.954 for C).
Log-normality. Figure A 14.5 attempts to give an idea of the skewness compatible with log-
normality. Distributions D, E and F are all right skewed. D and E arc similar in shape except that
sample E has been derived from D by being shifted by one unit leftwards along the X-axis, with a
resultant small adjustment (as can be seen) to the lengths of the tails. F appears visually to be
veiy different, and much more right skewed.
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Figur. A 14.5 N = 50; tld; 109-normality and non-log-normality
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Distribution D has a statistically significant right skew (C/s = 0.988; P=0.005), and is not
compatible with normality (CC = 0.966); however, neither is it compatible'with log-normality
(CC = 0.951). The apparently similar distribution E is also significantly right skewed (C/s =
1622; P<0 001) and also incompatible with normality (CC = 0.935) but the very small increase
of right skewness has rendered it compatible with log-normality (CC = 0.987). Despite the very
different shape ofF (C/s = 2.397; P<0.001) compared with E, conclusions are similar; that is, it is
incompatible with normality (CC = 0.914) but compatible with log-normality (CC0979). A
very wide variety of shapes between these two extremes is thus compatible with log-normality by
this test. Neither E nor F look particularly similar to the expected shape of a log-normal curve
illustrated in figure A14.l.
Compatibility with both normality and log-normality. Figure A 14.6 illustrates distribution G
(visually somewhat similar to E and F) which, although statistically significantly right skewed
(C/s = 0863, P=0.012), is compatible with both normality (CC =0982) and log-normality (CC =
0.980) by this test. Other distributions with similar characteristics, and the resulting inability to
discriminate by this test, were found (not shown).
Figur. A 14.6 N = 50; fld; compatibility with both normality and log-normality
X-valu. (for example lip In time-unit.)
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Reducing the level of significance and hence increasing the C/v may be of some help in further
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assessing such samples. For example, at P =O.10, the C/v for N=50 is 0.98 1; distribution G at this
level is compatible with nonnality, but not log-nonnality. Hence the hypothesis of log-normality
would be rejected at the 10% level of significance, but not at the 5% level, giving weak evidence
for incompatibility with log-normality.
Conclusion. Discrimination between normality and log-normality by this test, for a sample size of
50, whilst often possible is not always so. In addition, there is a wide variety in the distributions
which are compatible with normality, and with log-normality. Compatibility with either of the
two distributions does not therefore mean a sample appears visually to be, or is, the same as other
compatible distributions, nor that it is visually similar to the appropriate theoretical distribution.
Sample size - 5; CIv=O.880.
As might be inferred from figures A14.2 and A14.3, with only 5 cases in a sample, it is veiy
difficult to discriminate between distributions of different shapes.
Symmetrical examples Figure A14.7 shows two symmetrical distributions, A (completely flat)
and B (with a marked mode), each of which is compatible both with normality (CC = 0.998 for A;
CC=1.000 for B) and log-normality (CC = 0.975 for A; CC=0 980 for B).
Figur. A14.7 N = 5; f/d; symmetry, normality and log-normality
X-value. for example. I/p In lime-
unit.)
Right skewed examples Figure A14.8 shows two highly right skewed distributions, C (C/s =
1.339) andD (C/s = 1.466), both of which are compatible with log-normality (CC =0.991 for C;
CC1.000 for D). Despite such marked skewness, only D is incompatible with normality
(CC=0.898 for C; CC = 0.845 for D).
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Figur. A14.8 N=5; fid; asymm.try, normality and log-normality
X-vaIu. 110, .xampIe. l/p In lime-
unfta)
For N=5, even at a level of P=0.l0, the C/v is only 0.903; the hypothesis that distribution C is
compatible with normality would even then only just be rejected.
Sample size = 500; CIv0.997.
For a sample of size 500, results (not all shown) indicate that a wide variety of distributions are
compatible with normality, and similarly for log-normality, but that overlap, i.e. compatibility
with both, is uncommon. Therefore discrimination by this test, at this level, between the two
distributions for N=500 is usually possible.
The C/v for P=0.05, at 0.997, is very high. Nevertheless, there is broad agreement with the
findings for a sample of size 50 with regard to the varieties of shapes compatible 'vith normality,
and with log-normality. However, since one case represents a much smaller percentage of the
total sample, changes from compatibility to non-compatibility (and vice-versa) may be very
sensitive to small percentage changes in the distribution.
Example: an X-value change in 0.4% of cases. Figure A14.9 shows three sample disiributions,
A, B and C which appear to be very similar. However, they are not identical. Distnbut ion A is
symmetrical. B has 2 cases with slightly larger X values than A (arrowheads indicate changes),
and is thus asymmetrical. C has 1 case with a larger, and one with a smaller X value than A
(asterisks indicate changes), and remains symmetrical.
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Flgur. A14.9 N=500; fid; normality and non-normality
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Distribution A, by this test is compatible with normality (CC = 0.998), but not log-normality (CC
0.979). Distribution B (asymmetrical with a slight right skew; C/s = 0.093; P=0.390) is not
compatible with normality (CC = 0.996), nor with log-normality (CC = 0.970). Distribution C
(symmetrical, the original range having been symmetrically extended), is no longer compatible
with normality (CC = 0.996), nor is it compatible with log-normality (CC = 0.962).
In both B and C, a small change in the X-value of only 2 of the 500 cases (0.4%) has rendered the
distribution incompatible with normality, even though, in distribution C, it is still symmetrical.
Distribution compatibility with normality is much less sensitive to changes in the X-values of
small numbers of cases with x-values near the centre of the distribution (not shown).
Range of distributions compatible with log-normality. Figure A14. 10 shows distribution D,
made by starting with distribution A and altered by stepwise changes to X-values (i.e. one 'case'
moved one unit along, at a time, and recalculated) until it is just compatible with log-normality
by this test.
Figure A 14.10 N = 500; fld; log-nomiality (i)
90 90 90
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The numbers on the graph show the extent of the asymmetry (C/s = 0.423; P <0.000). D is, not
surprisingly, incompatible with nonnality (CC= 0.994), but has now reached compatibility with
log-normality (CC = 0.997).
Figure A14. 11 shows other distributions which are also compatible with log-normality by this test
(generated as single samples from computerised random sampling of a log-normal distribution),
to give some idea of the extent of variety possible with such a large sample. For the illustration,
the X-values have been grouped in thousands, thus the left 'tail' is not apparent
Figure A14.i1 N=500; fid; log-normality (ii)
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Maximum values and skewness for these two distributions E and F are clearly very different, and
both are different from D. However, conclusions for all 3, by this test, are similar. As for D,
distribution E (C/s 9.703; P<0.000) is incompatible with normality (CC = 0.660) but compatible
with log-normality (CC 0.998); similarly for distribution F (C/s 3.442; P<0.001; CC = 0.83 1 for
normality and 0.999 for log-normality respectively).
Summary.
For the test as used in this thesis, the possibility of discrimination is seen to be more likely as
sample size increases. The 5% significance level was chosen in order to specifically categonse,
with a high level of probability, each dataset as either compatible or not with each of the two
distributions in order to look for any recurrent pattern; it is recognised as an artificial and
arbitrary cut-off level. For samples of around 50, it will often, but not always, be possible to
discriminate at this level. It is not possible, on the basis of the work presented, to give a precise
minimum sample size for useful analysis, and further work on this issue is outside the scope of
this thesis, but it is suggested that where a distribution is found to be compatible with only one
distribution at the 5% level then a useful statement can be made about that distribution.
Conversely, when no discrimination is found at this level, evidence for the compatibility of the
observed distribution with either theoretical distribution is weakened.
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APPENDIX 15
TESTS USED IN THIS THESIS TO ESTIMATE COMPATIBILITY WITH NORMALITY
AND LOG-NORMALITY, AND TO CALCULATE COEFFICIENT OF SKEWNESS,
APPLIED TO A SELECTION OF THE DISEASES WITH SHORT INCUBATION
PERIODS SIMILAR TO THOSE EXAMINED BY SARTWELL, PLUS ONE 'PROXY'
INCUBATION PERIOD AS USED BY ARMENIAN AND LIL1ENFELD (1974).
1) Five outbreaks of 'typhoid fever' reviewed by Miner (1922) and examined by Sartwell
(1952).
Appendix A1.2 shows the histograms for the i/p f/d for these five datasets.
a) Outbreak 1, taken from Sawyer (1914); due to contaminated SpaghettL
Sample size: 93	 I/p mean: 9.5 days	 I/p SD: 5.7 days
Fid under	 Correlation Critical value Coefficient of
	 P value
analysis	 Coefficient	 at P= 0.05	 skewness (cls)	 for c/s
Normality	 0.904	 0.986
	
1.550	 <0.001
	
0.975	 0.986
	
0.687	 0.008
Conclusion from these tests: Compatible with neither normality nor log-normality; veiy marked
right skew. (This was one of the few samples which Sartwell also found to be not log-normal).
b) Outbreak 2; due to contaminated ice-cream.
Sample size: 23
	 Up mean: 7.0 days
	 Lip SD: 1.9 days
F/d under	 Correlation Critical value Coefficient of P value
analysis	 Coefficient	 at P= 0.05	 skewness (c/s)
	
for c/s
Normality	 0.947	 0.958	 1.295	 0.008
Log-normality	 0 980	 0.958	 0.8 16	 0.070
Conclusion from these tests: Compatible with log-normality, but not normality.
c) Outbreak 3; water-borne.
Sample size: 21
	 I/p mean: 13.8 days
	 Up SD: 5.8 days
F/d under	 Correlation Critical value Coefficient of P value
analysis	 Coefficient	 at P= 0.05	 skewness (c/s)	 for c/s
Normality	 0.975	 0.952	 0.492	 0.272
Log-normality	 0.972	 0.952	 -O 546	 0.225
Conclusion from these tests Compatible with both normality and log-normality.
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'0 Outbreak 4; water-borne.
Sample size: 13	 I/p mean: 19.4 days	 I/p SD: 9.2 days
F/d under	 Correlation Critical value Coefficient of	 P value
analysis	 Coefficient	 at P 0.05	 skewness (c/s)	 for c/s
Normality	 0.929	 0.930	 1.040	 0.058
Log-normality	0.971	 0.930	 0.050	 0.923
Conclusion from these tests: Compatible with log-normality but just incompatible with normality.
e) Outbreak 5; water-borne (using mid-point of the possible 4-day water-contamination
interval as i4, start).
Sample size: 181	 I/p mean: 19.5 days	 up SD: 6.1 days
FId under	 Correlation Critical value Coefficient of P value
analysis	 Coefficient	 at P= 0.05	 skewness (c/a)
	
for c/s
Normality	 0.978	 0.991	 0.809	 <0.001
Log-normality	0.998	 0.991	 0.068	 0.699
Conclusion from these tests: Compatible with log-normality but not normality.
2) Serum hepatitis (viral hepatitis type B); Camp Polk series reported by Parr (1945).
Appendix A1.3 shows the histograms for the i/p f/d for this dataset; the case at 15 days is omitted
from the calculation, as it was thought, by Parr, likely to be co-incidental.
Sample size: 1003
	 I/p mean: 96.6 days
	 I/p SD: 15.9 days
F/d under	 Correlation Critical value Coefficient of P value
analysis	 Coefficient	 at P= 0.05	 skewness (c/a)
	 for c/s
Normality	 0.993	 0.998	 0.356	 <0.001
Log-normality	0.998	 0.998	 -0.031	 0.687
Conclusion from these tests: Compatible with log-normality but not normality.
3) Measles; data from Stillerman and Thalheimer (1944).
Appendix Al.! shows the histograms for the i/p f/d for this dataset.
Sample size: 199	 I/p mean: 12.4 days
	 i/p SD: 2.14 days
F/d under	 Correlation Critical value Coefficient of P value
analysis	 Coefficient	 at P= 0.05	 skewness (c/a)
	 for c/s
Normality	 0.993	 0.993	 0.488	 0.006
Log-normality	 0.999	 0.993	 0.033	 0.844
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Conclusion from these tests: Compatible with log-normality; may also just be compatible with
nonnality but results equivocal as right skew present.
4) Measles; data from Goodall (1931), and examined by Sartwell (1952).
Sample size: 115	 Vp mean: 12.2 days 	 up SD: 3.3 days
F/d under	 Correlation Critical value Coefficient of 	 P value
analysis	 Coefficient	 at P= 0.05	 skewness (c/s) 	 for c/s
Normality	 0.983	 0.988	 0.617	 0.008
..og-normality	0.998	 0.988	 0.010	 0.962
Conclusion from these tests: Compatible with log-normality but not normality.
5) Experimental gonorrhoea using human volunteers; data from Mahoney Ct al (1946), and
examined by Sartwell (1966).
Appendix A1.5 shows the histograms for the i/p f/d for this dataset. Isolations reported on day 1
are excluded, as they are considered likely to be the result of residual inoculation material.
Sample size: 71
	 L/p mean: 5.9 days	 L/p SD: 5.2 days
F/d under	 Correlation Critical value Coefficient of 	 P value
analysis	 Coefficient	 at P= 0.05	 skewness (cls)	 for c/s
Normality	 0.807	 0.982	 3.091	 <0.001
Log-nonnality	 0.971	 0.982	 0.898	 0.003
Conclusion from these tests: Compatible with neither normality nor log-normality; veiy marked
right skew. (Again, Sartwell also found this to be not log-normal). Similar conclusions result
from inclusion of the day 1 isolation cases (not shown).
6) Leukaemia after irradiation for ankylosing spondylitis; data from Cobb, Millar and
Wald (1959).
Example of the method used for 'proxy' up; here the 'proxy' i/p used is from the mid-point of the
radiation exposure period.
Sample size: 51	 I/p mean: 51.8 months	 Up SD: 30.0 months
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F/d under	 Correlation Critical value Coefficient of 	 P value
Coefficient	 at P= 0.05	 skewness (c/s)	 for c/s
Normality	 0.960	 0.977	 1.155	 0.001
	
0.934	 0.977	 -1.557	 <0.001
Conclusion from these tests: Compatible with neither normality nor log-normality. Using the
'proxy' i/p as from the start of the exposure gave similar results and conclusions (not shown).
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APPENDIX 16
CONSTRUCTED LOG-NORMAL DISTRIBUTION FOR SELECTED DATASETS FOR
COMPARISON WITH ACTUAL DATA
The following graphs give an idea of the visual appearance of a 'typical' log-normal distribution
for selected TSE/prion disease datasets, for comparison with the actual distribution. The
distribution is constructed from the average of 10 repeats of computerised random sampling of a
log-normal distribution, using Minitab statistical software (release 7), matching the mean and
sample size with that of the original relevant dataset. Not surprisingly, all constructs are broadly
similar in shape; the exact SD of each constructed distribution is a result of the random sampling
process, dependant upon the actual random numbers selected.
Sheep. Two examples are shown; the first for comparison with figure 6.1.4.1, page 55, and the
second with figure 6.2.1.1, page 58.
Fur. A16.1 Log-normal construct for natural scrapi. in sh.ep; GLS full
dataset
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The real dataset on which this construct is based was itself compatible with log-normality, and
although the two shapes are not identical, they are broadly similar with respect to overall shape
and SD; it is unlikely that sheep would remain alive to demonstrate the largest aio values in this
construct.
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Figur. A16.2 Log-normal construct for .xparlm.ntal TSE in she.p; fuN
dataset
250
0
ID OlD 0 II) 0 In 0 ID 0 in 0 In ow 0 ID
IDIL(0(0N
I/p (months; group midpoint)
The real dataset on which this construct is based was incompatible with log-normality, but not
because of the skewness; the comparison with the 'thick' right tail in that dataset is clear.
Rodents. The figure shown is for comparison with figure 9.2.3(a), page 106, the s7p7 genotype.
Figur. A16.3 Log-normal construct for scrapi. In mic.: strain 22A In 'sunc'
s7p7 mc.
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The real, small, dataset on which this construct is based, although compatible with both normality
and log-normality, had a slight left skew. Clearly a 'typical' log-normal dataset is vely different,
and, with the same mean, takes much of the range outside the usual lifespan of a mouse, the mean
for C57BL being around 2 years, and that for VM possibly less (A Weller, personal
communication).
Humans. The first figure is for comparison with figure 10.1, page 120, and the second, a
composite, with figures 10.2.2.2 (page 123) and 10.3.1 (page 126).
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Figurs A16.4 Log-normal construct for TSE diss... ki humans (II); sporadic
CJD. UK datas.t
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The real dataset on which this is based has a significant, extended left skew; this construct
reverses that skew, giving, for matched means, an age-of-onset range extending considerably
outside a typical human lifespan.
Figure A16.5 Log-normal construct for TSE diss... ki humans (ii);
comparison of 3 datas.ts.
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Data for the above constructs.
Dataset	 N	 Mean a/o	 SD
Kuru	 18	 24.1	 10.1
Inserts (GLS)	 29	 33.7	 8.4
Cn 200 (NIH)	 69	 55.1	 10.5
Similarity of these three constructs to the original dataset decreases as the mean a/o increases; for
kuru (an infectious manifestation), and for the group with insert mutations (with an uncertain, but
possibly purely hereditary aetiology), both groups with a young mean a/o, shape and age-range
are broadly similar to the real, right-skewed datasets. For the group with codon 200 mutations
however (again with an uncertain, but possibly purely hereditary aetiology), with a much older
mean a/o, the original left skew is completely reversed, and the range, even for this small dataset,
extends to the maximum of human lifespan.
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APPENDIX 17
SELECTION OF DATA FOR ESTIMATING THE INCUBATION PERIOD AND ITS
FREQUENCY DISTRIBUTION FOR TA-AIDS.
The data-set as supplied contained many incomplete records, lacking information necessazy to
calculate an incubation period (up) in months. A few records were clearly erroneous, with for
example, report dates before diagnosis. The maximum number of transfusions for any case
recorded was three. Although some transfusions may appear to be less likely than others to be
infectious, with the exception of those transfusions recorded as after the date of diagnosis, there
is no theoretical justification for elimination of any of them on grounds of date of transfusion.
Cases with a single transfusion recorded.
Producing a 'clean', complete data-set of cases with a history of only one (presumed infectious)
transfusion, reduces numbers from 4010 to 911 (22.7%). These were used for an initial estimate
of i/p.
Cases with a traced suspect donor.
Fifty-three cases had a traced suspect donor, 34 of which were single transfusion cases. Where a
suspect transfusion was recorded, it was treated as a single transfusion case in all further
analyses.
Inclusion of cases with multiple transfusions and incomplete data in overall i/p estimate.
Data was 'cleaned' for all transfusions recorded, and mean time to onset calculated for each
transfusion.
With incomplete date recording, one way to maximise utilisable data is to assign missing
information in a reasonable way. Table A17. icompares mean time to onset estimated by two
methods for each of the three transfusions. The first method uses only the 'cleaned' data, where
complete records for all of month and year of transfusion, diagnosis, and report are given. The
second estimate for each transfusion includes additional records where year of transfusion,
diagnosis and report are known, but the month of any of these may be unknown, and is then
assigned as 'mid-year', i.e. July 1st (code 07).
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Table A17.1 Time to disease onset: Comparison of 'Cleaned' data for 1st, 2nd,
and 3rd transfusion with estimates where unknown month (coded 99) has been
replaced by month 07 (i.e. mid-year), for transfusion, diagnosis, and report dates.
Number	 Mean time	 Range	 SD
N	 (months)	 (months) (months)
1st (or only) transfusion:
'Clean' data
'07' substitution data
2nd transfusion:
'Clean' data
'07' substitution data
3rd transfusion
(no substitution needed):
'Clean' data
F explanation, see text]
2322	 57.3
	
1-264	 30.2
2433	 57.9
	
1-415	 31.4
1419	 51.9
	
1-177	 27.6
1497	 52.2
	
1-415	 29.3
Substitution results in an insignificant increase in mean time to onset for Transfusions I and 2
(P=O.677 and 0.986, non-parametric tests, respectively), and a slight increase in SD, due to range
extension, as the small number of early transfusions are now included; however, these early
transfusions cannot be eliminated with complete certainty on theoretical grounds and the means
are effectively unaltered. The 'substituted' data is therefore used in further analyses.
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APPENDIX 18
METHOD OF TRANSFUSION-WEIGHTING FOR ESTIMATING INCUBATION
PERIOD IN TA-AIDS IN MULTIPLE-TRANSFUSION CASES.
For those cases which have received more than one possibly infectious transfusion, there are
several ways of estimating i/p.
Methods considered.
For some transfusions, units of blood are known; it may be that the transfusion with the most
units is most likely to be the infecting dose (T Peterman, personal communication); however,
complete blood-unit data was available for only eight cases.
Other methods include taking the mid-point between two transfusion dates, or the central
transfusion date if there are three; or weighting years of transfusions to account for probable rate
of increase and subsequent decrease of numbers of infected donors.
The method using the mid-(or central) point was then examined. Some cases have two
transfusions recorded, but a date for only one. Comparing i/p estimate by taking the mid (or
central) point for recorded transfusion (Tx) dates for cases with all dates given with that for cases
having up to one date missing gives:-
Mean i/p (months):
SD:
Range:
N:
Cases with
all Ti dates given:
55.3
29.1
1-415
2433
Cases with
up to one Ti date missing:
55.2
29.0
1-415
2570
Estimates are almost identical; having up to one transfusion date completely missing (and
therefore ignoring that transfusion in calculations) does not alter mean i/p estimate which, not
surprisingly, lies between time to onset values for first and second transfusions; the eight cases
with three transfusions affects this veiy little. On the basis of this result, plus the assumption that
multiple transfusions are often associated with one medical problem, and therefore often clustered
in time, cases with up to one transfusion with year unrecorded were included in fuither analyses;
they were assumed infected in the known year of transfusion.
However, it was considered that weighting the transfusion dates would be likely to give the best
approximation to the actual i/p. Many ways of weighting dates of transfusion data are possible;
most require incidence data from outside the database. One method of time-weighting from
within the database, to assign weighted 'infection date' to multiple transfusion cases is described.
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The method finafly used.
The method used was to first take only single (or suspect) transfusion cases, and calculate the
proportion of transfusions by year, shown in figure A18.1.
Figure A18.1 TA-AIDS; Single transfusion cases by proportion of transfusions per year.
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For weighting purposes only, transfusions prior to 1970 and after 1989 were assumed to cariy
zero risk as their percentage in the single transfusions was zero (unless all transfusions for a
particular case were outside those limits; and in such cases all transfusions for each case had
occurred in the same year). The decrease in 1985 was assumed to be due mainly to blood
screening.
It was assumed that in multiple transfusion cases, the probability of infection from any
transfusions occurring in the same year was equal, and dates averaged. However, for multiple
transfusions in different years, the probability of infectious transfusion in any particular year was
assumed to vaiy in the same way as that for the single transfusions, and the ratio of these
probabilities used as the basis for weighting the i/p between them, appropriate additional
weighting being made for those three-transfusion cases with two transfusions in one year.
The final, weighted transfusion date was that used as the infection date for multiple transfusion
cases in all further analyses. The result (chapter 5. 1.1) is almost identical to that found by
averaging dates; less than 400 cases required weighting Out of the total of 2570, and for this set
of data, averaging the two (or three) different transfusion dates appears to have been adequate.
Since for a given problem, transfusions required are likely to be time-clustered, this may
generally be the case.
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APPENDIX 19
BACK-CALCULATION METHOD TO ESTIMATE THE MEAN INCUBATION PERIOD
OF TA-AIDS.
Calculations performed by R Sayers.
The method used to estimate the mean incubation period was based on that developed by Medley
et a! (1988a).
Suppose that infection at transfusion occurs as a Poisson process with rate r(t), where t is the time
in months measured from 1/1/70, the (unproven) assumption being made that this was the earliest
possible infectious transfusion date. Let it') be the probability density function of the disease
incubation period.
Since the distribution function for the incidence of infectious transfusion decreased sharply from
1/8/85 (most probably due to donor education/blood screening) only cases with infectious
transfusion estimated to be before this date (i.e. up to month 180) are used. A further restriction
is that case ascertainment was considered to be most reliable between 1/1/85 (month 181) and
31/12/89 (month 240) and therefore only the 724 cases reported between these dates are used.
Then if the observed incubation period and the corresponding times of infection are x1 and t1
respectively, the log likelihood for n cases is given by:-
180	 240-1
l=Elog(r(11))+ZIog(f(x1))— J r(t) J f(x)dxdi
0	 180—i
The following functions were used for r andj-
rQ)=	 exp(a+bt+c12)for0^i^180
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cix6 ' exp(—/r)f(x)=
f(fi)
a-I 
exp(—(x/fl)
/ja
exp(—(Iogx— a) 2 1(2/12))
(Gamma) or
(Weibull)	 or
(Lognormal)
A FORTRAN program then calculated the maximum Likelihood estimates of the parameters a, b,
c, m, a, /1 using subroutines from the NAG Fortran 77 Librazy, Mark 14 (NAG Ltd. Oxford,
UK).
EO4CCF - minimisation by the Simplex method.
DO1DAF - double integration.
From these results the mean incubation period was calculated as follows:-
Gamma - m+fi/
Weibull - m + flF (1+ Ya
Lognormat - m+exp(a+O.5/32)
Attempts to estimate confidence limits for the parameters using the profile likelihood were
unsuccessful due to problems with convergence in the NAG subroutines.
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APPENDIX 20
METHOD FOR ESTIMATING POTENTIAL SCRAPIE CASE NUMBERS ADJUSTED
FOR CULLING OF SHEEP IN SCRAPLE INFECTED FLOCKS FROM DATA
COLLECTED BY WOOLDRIDGE (1991).
Information abstracted from a scrapie survey (Wooldridge, 1991) of 123 farms, flock sizes
ranging from 2 to 2,150 sheep, allows an average culling pattern to be estimated for the intended
breeding flock (i.e. sheep over 1 year of age), up to five years of age.
It is assumed that an equal proportion of culled and unculled animals would have developed
disease at each age, and that there is no association between culling and incubating scrapie.
Calculations are based only on sheep from one year of age; that is sheep intended for the adult
flock.
Table A20. 1 shows the steps in calculation, and gives the resulting estimate of adjusted case
numbers.
Table A20.1 Natural sheep scrapic; Culling pattern estimate (Wooldridge, 1991)
A2e roun (years)
1-<2	 2-<3	 3-<4	 4-<5	 5+	 Total
Total 'flock' from survey 	 10,978 11,612 11,423	 8,460	 5,852 48,325
%of flock of that age	 22.7% 24.0% 23.6% 17.5% 12.1% 100%
Adjusted total for culling	 11,338 11,338	 11,338	 8,460	 5,852	 48,326
estimate(and%offlock) 23.5% 23.5% 23.5% 17.5% 12.1% 100%
%flock still alive	 100%	 100°!,	 100% 74.6% 51.6%	 -
%flock culled	 0%	 0%	 0%	 25.4% 48.4%	 -
Actual case numbers	 137	 662	 343	 123	 68	 -
Adjusted case numbers 	 137	 662	 343	 165	 132	 -
There is little change in the proportion of cases from 4-<5 years (9.2 to 11.5%); it is not possible
to estimate the distribution or maximum a/o for cases from 5 onwards, although overall the
proportion increases from 5.1% to 9.2%.
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APPENDIX 21
PRIMATE TAXONOMY RELEVANT TO DATA CLASSIFICATION USED IN THIS
THESIS.
Figure A2 1.1 shows a simplified scheme of taxonomic classification; names used in the analyses
are given in brackets (derived from Napier & Napier, 1967).
Figure A21.I
Simplfied Taxonomy of the Primates used in these Experiments.
Order	 PRIMATES
Suborder	 Prosimii	 Anthropoidea
Superfamily	 Cebidea	 Cercopitliecoidea	 Hominoidea
Family	 Catlitrichidae	 Cebdae	 Cercopithecidae	 Pongidae
I	 I	 I
Subfamily Callitrichinae	 Cebinae Atelinae	 Cercopithecinae
I	 I	 I
Genus	 Callithrix Cebus Saimiri Ateles Cercopithecus	 Macaca	 an
(Marmoset) (Capuchin) (Squirrel M) (Spider M) 	 (Macaqua)	 (Chimp)
Subgenus	 Cercopithecus
Species	 C sebaeus	 M faciculaiis M MLlatta
	
(African Green)	 (Cynomolgus)	 (Rhesus)
As shown, marmosets, capuchin, squirrel monkeys, and spider monkeys are all genera within the
superfamily ceboidea, whereas the chimpanzee is a genus in the superfamily hominoidea. African
green, cynomolgus, and rhesus monkeys are all species, within the superfamily cercopithecoidea.
Ceboidea are the new-world monkeys; cercopithecoidea, the old-world monkeys; hominoidea, the
apes and humans. It is generally considered that this order corresponds to levels of primate
evolution, i.e. new-world monkeys being lower in the evolutionaiy scale than old-world monkeys,
which are lower than apes. This is based on the assumption that Homo sapiens is 'highest' on the
evolutionary scale; this point of view may well be species-dependent. Taxonomy does however
give some indication of the closeness of the relationships between the different groupings, likely
to be reflected in genetic make-up, and therefore possibly also in disease susceptibility and
response to infection with TSE'slprion diseases.
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APPENDIX 22
PRIMATES: SELECTED NATURAL LIFE HISTORY MEASURES BY GENUS, AND
COMPARISON WiTH DATA USED IN ANALYSES.
Published longevity data is given by genus. Table A22. 1 compares maximum recorded lifespan
(Napier & Napier, 1967) for each genus represented in the analysis data with the mean and
maximum recorded experimental i/p for the primate group representing that genus in the analysis
data
Table A22.1 Primates; comparison (in months) of recorded maximum longevity with mean
and maximum i/p (and as a percentage) for full dataset by genera.
Genus	 Maximum Represented Mean Max Max i/p as
recorded	 in data by	 i/p in i/p in % of max
longevity	 species:	 data	 data longevity
Callithrix (marmosets) 	 144	 u/k	 20.7	 94	 63
Cebus (capuchin)	 480	 N	 43.8	 168	 35
Saimiri (squirrel m.)	 252	 28.3	 189	 75
Ateles (spider m.)	 240	 31.4	 86	 36
Cercopithecus (sub-	 372	 African green 47.5	 58	 15
genus cercopithecus) 	 monkey
Macaca (macaques)	 352	 Cynomolgus	 55.8	 74	 21
Rhesus	 62.9
	
102	 29
Pan	 534	 u/k	 23.8
	
86	 16
In no genus did maximum observed i/p equal maximum recorded longevity, although this
recorded longevity may be much longer than natural mean lifespan, and vary considerably by
species within genera.
Table A22.2 gives weight ranges (Napier & Napier, 1967) by genera, and the mid-point of these
ranges. There is much variation in weight both for species within genera, and in some species by
sex; since data availability varied considerably by genus, these variations are not taken into
account in this table, therefore any comparisons or conclusions using these values must be
considered a very broad guide.
Table A22.2 Primates; comparison of adult weight with certain
i/p measures, for full dataset by genera.
App rox adult weight
Genus	 Range	 Mid-	 Represen-
(kg)	 range	 ted in data
(kg)	 by species:
Callithrix (marmosets)	 0.1-0.4	 0.25	 u/ic
Cebus (capuchin)	 1.2-3.3	 2.75	 N
Saimiri (squirrel m.)	 0.4-1.1	 0.75	 N
Ateles(spiderm)	 5.4-6.9	 6.15	 N
Cercopithecus (subgenus	 1.8-6.4	 4.10	 African
cercopithecus)	 green
Macaca (macaques)	 2.5-18	 10.25 Cynomolgus
R1esus
Pan (chimps)	 40-50	 45	 u/k
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APPENDIX 23
METHOD OF ESTIMATION OF DATA OVERLAP FOR HUMAN TSEFPRION DISEASE
CASES WITH A GENETIC MUTATION, FROM THE TWO DATA SOURCES NIH
AND GLS.
Because it is known that many of these cases, being particularly interesting, have been published,
there is high probably of considerable dataset overlap. Inspection of the histograms paired by
mutation (figure A23. 1, example using codon 198 mutation; remainder not shown), shows that
age-at-onset (a/o) for many cases duplicates exactly; this may indicate possible degree of overlap.
Flgur. 23.1 TSE fri humand; Codon 198 iwtation; compadson of fld for NIH
and GLS data.
2
I
0
No (ys.,.)
Unfortunately, cases with the same a/o cannot be assumed to be the same cases. However,
maximum possible overlap would occur if duplicate a/o cases were in fact the same cases.
Duplicated a/o numbers and percentages are as fol lows:-
Dataset	 N	 Number with	 Percentage with
duplicated a/o	 duplicated a/o
NIH	 214	 60	 28.0
GLS	 123	 60	 48.8
Therefore range of possible overlap is 0-28% for NIH data, and 0-49% for GLS data. If all
duplicates are genuinely the same cases, amalgamation of the datasets would markedly distort
the a/o f/d; conversely if none are the same, then removal of one case from each duplicate pair
would again distort results.
Because mean a/o's and the lid's for each pair of sets are similar, and because they cannot be
amalgamated, individual analyses for each mutation employs whichever dataset of each pair is
largest.
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APPENDIX 24
METHOD OF ADJUSTING DATASET FOR THE EFFECT OF CULLING FOR BSE iN
CATTLE AND AS APPLIED TO CATTLE GROUP 3.
An estimate of culling was made, using lactation structure (us) recorded for daiiy herds on the
BSE database.
Data used:
The first recorded I/s for each herd supplying cases in these analyses, recorded as cow numbers
per lactation period.
Working assumptions:
1) First lactation starts at two years of age (variation is actually from about 18-30 months); a
lactation period is one year. Therefore, a cow recorded in 'lactation 1' is 2-2.99 years old.
Reduced cattle numbers between sequential age groups indicates culling.
2) Culling rates are unaffected by subclinical BSE infection (unproven); therefore numbers of
animals culled and unculled at any age contain the same proportion of infected animals, of
which the proportion which would have developed clinical disease within the next year is the
same.
3) All culling per age-group, other than for BSE, occurs prior to any animal developing overt
BSE.
4) Numbers culled with BSE are small compared with total culling, therefore the percentage
reaching the next age-group is unchanged by cases of BSE. (The validity of this is based on
an average, at 5/8/94, of 5.3 total recorded cases per dairy herd since the epidemic began,
and an average herd size of 90 cows).
Method:
1) Cattle numbers per age group are totalled over all herds.
2) Total 2 (actually 2-2.99) year old heifers are taken as 100% (the dairy herd comprises only
those replacement heifers which actually enter the adult herd).
3) Total numbers at the start of each age group are converted to a percentage of original 2-year
olds (equals percentage of original 2-year olds unculled during the previous year-of-age
group).
3) Numbers culled during each lactation are converted to a percentage of original 2-year olds.
4) Culling ratio (percentage of original 2-year olds culled during year-of-age/percentage of
original 2-year olds unculled by end of year-of-age) is calculated for each age group.
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5) Total observed numbers of BSE for each age are multiplied by the culling ratio, and rounded
to complete numbers, to give numbers in culled fraction which would have developed BSE at
that age.
6) Observed and calculated BSE cases are totalled to give 'unculled' BSE case numbers per age-
group; that is the number of cases expected if no culling had occured.
Table A24. 1 gives culling pattern, calculated culling ratios, and case number adjustment, applied
to group 3 (excluding the one case <2 years old in group 3).
Table A24.1 BSE in cattle; culling correction, and method as applied to group 3.
Age group
Stage in	 2-	 3-	 4-	 5-	 6-	 7-	 8-	 9-	 10- 11- 12- 13-
method
Culling ratio:
3)%alive:airt	 100	 95.7	 84.9	 73.6	 62.0 47.2	 32.8 21.6	 13.1	 7.4	 4.2	 1.5
4)%culledinyear	 4.3	 10.8	 11.3	 11.6	 14.8	 14.4	 11.2	 8.5	 5.7	 3.2	 2.7	 1.5
3)-4)%alive: end
	 95.7 84.9	 73.6	 62.0	 47.2 32.8	 21.6	 13.1	 7.4	 4.2	 1.5	 0
5) Ratio	 0.05	 0.13	 0.15	 0.19	 0.31	 0.44	 0.52 0.65	 0.77	 0.76	 1.80	 -
culkd/unculled
Group 3
adjustment:
Oluervedcases	 13	 675 2288	 1793	 719	 223	 67	 18	 10	 3	 0	 0
5)Culledcases	 1	 86	 351	 335	 225	 98	 35	 12	 8	 2	 ?	 9
6)Total cases	 14	 761	 2639	 2128	 944	 321	 102	 30	 18	 5	 9	 9
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APPENDIX 25
BACK-CALCULATION METHOD TO ESTIMATE THE MEAN INCUBATION PERIOD
OF BSE.
Calculations performed by R Sayers.
The method used to estimate the mean incubation period was based on that devcloped by Medley
at al (1988a).
Suppose that infection occurs at birth as a Poisson process with rate r(t), where I is the time in
months measured from 1/07/81. Also assume that from 31/07/88 (month 85) infection tails off
linearly to zero over the 21 months to 30/04/90. Letfix) be the probability density function of the
disease incubation period which equals the age of the animal at onset. The final date of
observation is taken as 28/02/94 (month 152) in view of the reporting lag for cases. Animals are
assumed to be subject to culling from the age of 24 months with the surviving proportion
represented as a function of age by k(x).
Then if the observed ages of onset and the corresponding times of birth are x and I, respectively,
the log likelihood for n cases is given by:-
106	 152—t
1 = EIog(r(11)) + Iog(f (x1 )) + flog(k(x1)) - J r(t)	 f(x)k(x)dxdt
The following functions were used for r, k andf.-
exp(a+bf+c12) for 0^I^85
exc(a+85b+7225c)( 1026j_ t ) for 85<I^106
k(x) = o for O^x^24
ex(-0.0OO243(24 - x)2 ) for x>24
f(x)=	 0 for O^x^m, the minimum incubation period.
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(Gamma) or
(Weibull) or	 for x>m
(Lognormal)
A FORTRAN program then calculated the maximum likelihood estimates of the parameters a, b,
c, m, a, /3 using subroutines from the NAG Fortran 77 Libraiy, Mark 14 (NAG Ltd. Oxford.
UK).
EO4CCF - minimisation by the Simplex method.
DO1DAF - double integration.
From these results the mean incubation period was calculated as follows:-
Gamma - m+%
Weibull - m+/3f(1+))
Lognormal - m+exp(a+O.5)
Attempts to estimate confidence limits for the parameters using the profile likelihood were
unsuccessful due to problems with convergence in the NAG subroutines.
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APPENDIX 26
CALCULATION OF THE THEORETICAL COEFFICIENT OF SKEWNESS OF A LOG-.
NORMAL FREQUENCY DISTRIBUTION USING EXCEL STATISTICAL SOFTWARE.
Theoretical basis; derivation of the expression for calculation of coefficient of skewness.
Derivation of expression for coefficient of skewness (c/s) undertaken by S Cousens.
Log-normal distribution function:-
f(x)	 expi -___________=	 1	
( (Zox_P)2)
ox 1 i 	 2o
where t, are mean and variance of the normal distribution.
Taking:-
E(X 1 ) = cxp(k+!o2k2)
E(X )=exp(p+!o2)
E(X2)=exp(2p+2cT2)
92'
E(X3)=exP[31u+ 2 
J
Calculating m2 and m3:-
Form2 :-
E(X—E(X)) 2 = E(X2)—[E(X)}2
= exp(2p+202)_exp(2p+a2)
=exp(2p+o2){e02 —1]
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For m3:-
E(X - E(X))3 = E(X3 ) - 3E(X2 )E(X) + 3[E(X)]3 - [E(X)]3
(	 92%	 (	 o2
=exP(3P+---j-3exP(2P+2o
(	 32
+2exp 3/J+----
= exP[3P+__-][exP(3o2 )_ 3exp(o2)+2]
Then coefficient of skewness is calculated as follows:-
1113
m2
- e°2 _3e02 +2
- [e_i]
Example: -
ifSD	 = 0.05
then o2	 = (0.05)2
Ie302 - 3e' +2]
c/s= V[e(005)2 - ] 2
which gives c/s = 0.150.
Method using Excel statistical software, version 4.Oa (1992).
The calculations were perfonned in this spreadsheet (methods as described in the Excel 40 Users
Guide Volumes 1 and 2, 1992) using the following functions:-
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SD was entered (cell Al)
Cell A2 = Al"2
Cell A3 (exp(3A2)) - (3*(e,(p(4&))) +2
Cell A4 = (exp(A2) - l)'(3/2)
Cell A5 = A3/A4 = theoretical c/s
This was used to calculate theoretical c/s for a range of SD values.
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APPENDIX 27
METHOD FOR SIMULATION OF SAMPLES FOR ESTIMATION OF COEFFICIENT
OF SKEWNESS.
Method for 10-observation samples.
The following method was used to generate the samples used in the first part of section 12.2.
Each sample was generated using Minitab statistical software, release 7.2 (1989) on a Prime
computer. Ten samples were randomly generated using each set of conditions (i.e. sample size
and SD), using the random log-normal command as described in the Minitab reference manual
(release 7; 1989). C/s was calculated, as previously described (appendix 12), for each of the ten
samples (and plotted, figure 12.2), and the mean and SD of the ten samples per set of conditions
calculated (results, table 12.2(i)).
Method for 5000-observation samples.
The following method was used to generate the samples used in the second part of section 12.2,
and section 12.3. Essentially, the method was as for 10-observation samples. However, in order to
increase the speed of computation, for use with larger numbers of repeat-observations, but in
particular with the increase of sample size to 1 million, each sample was generated using a Sun
Workstation, utilising a programme specificaliy written in FORTRAN, by A Mitchell. Random
numbers were generated by NAG routines (NAG Fortran Library Manual, Mark 14, 1990), using
algorithm GO5DEF. Even on the more powerful Sun, these simulations still took just over one
week to run.
Once samples were generated, c/s was calculated, using the calculation method previously
described, translated into FORTRAN By A Mitchell, and performed on the Sun, for each of the
5000 samples, and the mean and SD of the 5000 samples per set of conditions calculated (results,
table 12.2(u)). In addition, for each of the two sample sizes (5, and 1 million) the fYd of the 5000
individual c/s values was plotted (figure 12.3), examined for compatibility with normality and
log-normality (method, appendix 11) and c/s calculated.
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